Benzinga Earnings Reports - To The Moon

NewsNews
PostsPosts
SelectionSelection

- Investordude1301Investordude1301
  ·03-31 20:03
  Fantastic news for US shares and VOO!
  Stock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus
  U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.
  Stock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus
  9 Comment
  2
  Share
  Report
- Investordude1301Investordude1301
  ·03-31 20:03
  Fantastic news for US shares and VOO!
  Stock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus
  U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.
  Stock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus
  9 Comment
  2
  Share
  Report

{"themeInfo":{"themeId":"11c8fbbf839f433c9d274cef5f173382","name":"Benzinga Earnings Reports","description":"Track the latest US stocks earnings report.","image":"https://community-static.tradeup.com/news/1201dcc0482be040348fb8d4f228bb68","type":2,"style":4,"follow":false,"createTime":1773989546500,"userCounts":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":11c8fbbf839f433c9d274cef5f173382}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowSubscriptionFinancial":true,"subscriberCount":400,"allowFollow":false,"hasReward":false,"rewardScore":0,"rewardValidDate":0,"rewardEnd":false,"symbols":[],"tweetCounts":1,"categoryId":"2929bb7468f5415f853fd96fb35d7c3b","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"Benzinga Earnings Reports","tweetAmount":1,"imageIsDefault":false,"aiDerivativeIssues":[]},"tab":"news","newsList":[{"id":551298,"article_id":"2624421645","title":"iSpecimen Q4 EPS $(0.74) Up From $(6.28) YoY, Sales $51.761K Down From $1.476M YoY","subtitle":"","subtitle_show":0,"pub_time":1775080459000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51615700/ispecimen-q4-eps-0-74-up-from-6-28-yoy-sales-51-761k-down-from-1-476m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ISPC":1.5},"rights":null},{"id":551281,"article_id":"2624354230","title":"Mangoceuticals Q4 EPS $(0.13) Up From $(1.01) YoY, Sales $94.360K Down From $105.247K YoY","subtitle":"","subtitle_show":0,"pub_time":1775079568000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51615567/mangoceuticals-q4-eps-0-13-up-from-1-01-yoy-sales-94-360k-down-from-105-247k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MGRX":1},"rights":null},{"id":551279,"article_id":"2624423425","title":"RenX Enterprises Q4 EPS $(14.38) Down From $(0.49) YoY, Sales $3.284M Up From $34.364K YoY","subtitle":"","subtitle_show":0,"pub_time":1775079318000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51615515/renx-enterprises-q4-eps-14-38-down-from-0-49-yoy-sales-3-284m-up-from-34-364k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RENX":1},"rights":null},{"id":551276,"article_id":"2624386542","title":"D2L Q4 EPS $(0.02) Misses $0.13 Estimate, Sales $55.796M Beat $55.753M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775079211000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51615489/d2l-q4-eps-0-02-misses-0-13-estimate-sales-55-796m-beat-55-753m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":551259,"article_id":"2624544415","title":"Golden Minerals Q4 EPS $(0.05) Down From $(0.04) YoY","subtitle":"","subtitle_show":0,"pub_time":1775078391000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51615246/golden-minerals-q4-eps-0-05-down-from-0-04-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MTX":1.5},"rights":null},{"id":551255,"article_id":"2624544986","title":"Adagene FY Adj. EPS $(0.24) Misses $(0.15) Estimate, Sales $7.671M Beat $1.667M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775077661000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51614894/adagene-fy-adj-eps-0-24-misses-0-15-estimate-sales-7-671m-beat-1-667m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ADAG":1.5},"rights":null},{"id":551220,"article_id":"2624541255","title":"XWELL Q4 EPS $(3.29) Down From $(1.55) YoY, Sales $7.154M Down From $7.467M YoY","subtitle":"","subtitle_show":0,"pub_time":1775076123000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51614201/xwell-q4-eps-3-29-down-from-1-55-yoy-sales-7-154m-down-from-7-467m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"XWEL":1},"rights":null},{"id":551206,"article_id":"2624392541","title":"Zoned Properties Q4 EPS $(0.26) Down From $0.05 YoY, Sales $1.215M Down From $1.234M YoY","subtitle":"","subtitle_show":0,"pub_time":1775075351000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51613687/zoned-properties-q4-eps-0-26-down-from-0-05-yoy-sales-1-215m-down-from-1-234m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ZDPY":0.9},"rights":null},{"id":551190,"article_id":"2624499385","title":"VSee Health Q4 EPS $(0.31), Sales $3.926M Up From $3.859M YoY","subtitle":"","subtitle_show":0,"pub_time":1775073848000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51612592/vsee-health-q4-eps-0-31-sales-3-926m-up-from-3-859m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VSEE":0.9},"rights":null},{"id":551181,"article_id":"2624630549","title":"Bassett Furniture Indus Q1 EPS $0.13 Misses $0.18 Estimate, Sales $80.340M Miss $84.384M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775073732000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51612513/bassett-furniture-indus-q1-eps-0-13-misses-0-18-estimate-sales-80-340m-miss-84-384m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BSET":1.5},"rights":null},{"id":550997,"article_id":"2624083517","title":"Why Is Conagra Brands Stock Falling Wednesday?","subtitle":"","subtitle_show":0,"pub_time":1775058324000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/04/51603873/why-is-conagra-brands-stock-falling-wednesday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CAG":1},"rights":null},{"id":550825,"article_id":"2624051252","title":"Why Is MSC Industrial Stock Falling Wednesday?","subtitle":"","subtitle_show":0,"pub_time":1775055158000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/04/51601901/why-is-msc-industrial-stock-falling-wednesday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MSC":1.5,"MSM":1},"rights":null},{"id":550762,"article_id":"2624514157","title":"Why Is DeFi Technologies Stock Gaining Wednesday?","subtitle":"","subtitle_show":0,"pub_time":1775053620000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/movers/26/04/51600874/why-is-defi-technologies-stock-gaining-wednesday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DEFT":1},"rights":null},{"id":550609,"article_id":"2624511318","title":"A2Z Smart Techs Q4 EPS $(0.42) Misses $(0.08) Estimate, Sales $3.647M Miss $4.628M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775050855000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51598446/a2z-smart-techs-q4-eps-0-42-misses-0-08-estimate-sales-3-647m-miss-4-628m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AZ":1},"rights":null},{"id":550581,"article_id":"2624519244","title":"NeOnc Technologies Q4 EPS $(0.72) Misses $(0.37) Estimate","subtitle":"","subtitle_show":0,"pub_time":1775050144000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51597946/neonc-technologies-q4-eps-0-72-misses-0-37-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NTHI":1},"rights":null},{"id":550571,"article_id":"2624975519","title":"Cloudastructure Q4 EPS $(0.13) Misses $(0.10) Estimate, Sales $1.788M Inline","subtitle":"","subtitle_show":0,"pub_time":1775049684000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51597808/cloudastructure-q4-eps-0-13-misses-0-10-estimate-sales-1-788m-inline","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CSAI":1},"rights":null},{"id":550547,"article_id":"2624324519","title":"Massimo Q4 EPS $0.05 Up From $(0.01) YoY, Sales $21.020M Up From $20.053M YoY","subtitle":"","subtitle_show":0,"pub_time":1775049123000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51597484/massimo-q4-eps-0-05-up-from-0-01-yoy-sales-21-020m-up-from-20-053m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MAMO":1},"rights":null},{"id":550538,"article_id":"2624516025","title":"OLB Gr Q4 EPS $(0.22) Misses $(0.14) Estimate, Sales $1.775M Miss $2.409M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775048795000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51597303/olb-gr-q4-eps-0-22-misses-0-14-estimate-sales-1-775m-miss-2-409m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"OLB":1.5},"rights":null},{"id":550537,"article_id":"2624516768","title":"Cycurion Q4 EPS $(1.55) Beats $(2.45) Estimate, Sales $3.543M Miss $3.817M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775048674000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51597216/cycurion-q4-eps-1-55-beats-2-45-estimate-sales-3-543m-miss-3-817m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CYCU":1.5},"rights":null},{"id":550416,"article_id":"2624159575","title":"Lamb Weston Hldgs Q3 Adj. EPS $0.72 Beats $0.61 Estimate, Sales $1.565B Beat $1.492B Estimate","subtitle":"","subtitle_show":0,"pub_time":1775046727000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51596134/lamb-weston-hldgs-q3-adj-eps-0-72-beats-0-61-estimate-sales-1-565b-beat-1-492b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LW":0.9},"rights":null},{"id":550316,"article_id":"2624915513","title":"Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY","subtitle":"","subtitle_show":0,"pub_time":1775045397000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51595491/scinai-immunotherapeutics-fy-eps-3-56-sales-1-311m-up-from-658-000k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SCNI":1},"rights":null},{"id":550308,"article_id":"2624251367","title":"UniFirst Q2 Adj. EPS $1.29 Beats $1.21 Estimate, Sales $622.505M Beat $614.923M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775045164000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51595337/unifirst-q2-adj-eps-1-29-beats-1-21-estimate-sales-622-505m-beat-614-923m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"UNF":1.5},"rights":null},{"id":550296,"article_id":"2624513340","title":"Synergy CHC Q4 EPS $(1.35), Sales $6.070M Miss $10.830M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775044961000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51595227/synergy-chc-q4-eps-1-35-sales-6-070m-miss-10-830m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SNYR":1.5},"rights":null},{"id":550297,"article_id":"2624513343","title":"Novagold Resources Q1 EPS $(0.04) Beats $(0.07) Estimate","subtitle":"","subtitle_show":0,"pub_time":1775044958000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51595223/novagold-resources-q1-eps-0-04-beats-0-07-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NG":1.5},"rights":null},{"id":550258,"article_id":"2624518441","title":"TuHURA Biosciences Q4 EPS $(0.13) Beats $(0.14) Estimate","subtitle":"","subtitle_show":0,"pub_time":1775044358000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51594849/tuhura-biosciences-q4-eps-0-13-beats-0-14-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HURA":1},"rights":null},{"id":550234,"article_id":"2624189955","title":"Avicanna Q4 EPS $(0.01), Same YoY, Sales $6.600M Down From $6.617M YoY","subtitle":"","subtitle_show":0,"pub_time":1775043852000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51594639/avicanna-q4-eps-0-01-same-yoy-sales-6-600m-down-from-6-617m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":550186,"article_id":"2624907065","title":"Conagra Brands Q3 Adj. EPS $0.39 Misses $0.40 Estimate, Sales $2.788B Beat $2.763B Estimate","subtitle":"","subtitle_show":0,"pub_time":1775043081000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51594398/conagra-brands-q3-adj-eps-0-39-misses-0-40-estimate-sales-2-788b-beat-2-763b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CAG":0.9},"rights":null},{"id":550165,"article_id":"2624909495","title":"How To Earn $500 A Month From Lindsay Stock Ahead Of Q2 Earnings","subtitle":"","subtitle_show":0,"pub_time":1775042430000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/dividends/26/04/51594178/how-to-earn-500-a-month-from-lindsay-stock-ahead-of-q2-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LNN":1.5},"rights":null},{"id":550123,"article_id":"2624597788","title":"Tilray Brands Q3 Adj. EPS $0.02 Beats $(0.14) Estimate, Sales $206.732M Beat $201.350M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775041545000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51593811/tilray-brands-q3-adj-eps-0-02-beats-0-14-estimate-sales-206-732m-beat-201-350m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TLRY":1.5},"rights":null},{"id":550038,"article_id":"2624592041","title":"Amaze Holdings, Inc. Common Stock Q4 Adj. EPS $(0.51) Misses $(0.04) Estimate, Sales $(217.191K) Miss $1.685M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775040411000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51593407/amaze-holdings-inc-common-stock-q4-adj-eps-0-51-misses-0-04-estimate-sales-217-191k-miss-1-685m-est","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AMZE":1},"rights":null},{"id":549728,"article_id":"2624596851","title":"Will S&P 500 Open Up Or Down Today? Here's How Traders Lean After Best Rally Since May On Iran Peace Hopes","subtitle":"","subtitle_show":0,"pub_time":1775033209000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/prediction-markets/26/04/51591591/sp500-april-1-open-up-or-down-polymarket-iran-peace-rally-futures","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".SPX":1.96,"SPXU":0.6,"RSP":0.6,"SDS":0.6,"SH":0.6,"SPDN":0.6,"SPHD":0.6,"SPHQ":0.6,"SPLV":0.6,"SPMO":0.6,"SPUS":0.6,"SPUU":0.6,"SPXL":0.6,"SPXS":0.6,"OEF":0.6,"SPYD":0.6,"SPYG":0.6,"SPYI":0.6,"SPYM":0.6,"SPYQ":0.6,"SPYV":0.6,"SSO":0.6,"UPRO":0.6,"VEU":0.6,"VTI":0.6,"VTV":0.6,"XDTE":0.6,"XYLD":0.6,"ETFT":0.6,"ACWI":0.6,"ALLW":0.6,"BMAY":0.6,"DBSC":0.6,"OEX":0.6,"ESmain":0.6,"MESmain":0.6,"GPIX":0.6,"HIBL":0.6,"IVE":0.6,"IVOO":0.6,"IVV":0.6,"IVW":0.6,"JEPI":0.6,"MOAT":0.6,"NOBL":0.6},"rights":null},{"id":549567,"article_id":"2624593508","title":"MSC Industrial Direct Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1775030436000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/04/51591228/msc-industrial-direct-likely-to-report-higher-q2-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MSC":1.5,"MSM":1.5},"rights":null},{"id":549520,"article_id":"2624059867","title":"Top Wall Street Forecasters Revamp Conagra Expectations Ahead Of Q3 Earnings","subtitle":"","subtitle_show":0,"pub_time":1775029084000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/04/51591109/top-wall-street-forecasters-revamp-conagra-expectations-ahead-of-q3-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CAG":1},"rights":null},{"id":549495,"article_id":"2624560733","title":"UniFirst Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts","subtitle":"","subtitle_show":0,"pub_time":1775028362000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/04/51590986/unifirst-gears-up-for-q2-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"UNF":1.5,"CTAS":1},"rights":null},{"id":549299,"article_id":"2624561131","title":"Senvest Capital Q4 EPS $33.82 Down From $43.67 YoY, Sales $287.728M Up From $28.743M YoY","subtitle":"","subtitle_show":0,"pub_time":1775021214000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51590099/senvest-capital-q4-eps-33-82-down-from-43-67-yoy-sales-287-728m-up-from-28-743m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":549292,"article_id":"2624561674","title":"Soligenix Q4 EPS $(0.29) Beats $(0.56) Estimate","subtitle":"","subtitle_show":0,"pub_time":1775020806000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51590086/soligenix-q4-eps-0-29-beats-0-56-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SNGX":1},"rights":null},{"id":549288,"article_id":"2624561591","title":"Eastern Platinum Q4 EPS $(0.04) Up From $(0.05) YoY, Sales $22.300M Up From $17.037M YoY","subtitle":"","subtitle_show":0,"pub_time":1775020460000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51590055/eastern-platinum-q4-eps-0-04-up-from-0-05-yoy-sales-22-300m-up-from-17-037m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"EML":1.5},"rights":null},{"id":549277,"article_id":"2624819561","title":"Mountain Province Diamond Q4 EPS $(0.71) Down From $(0.29) YoY, Sales $45.742M Down From $51.996M YoY","subtitle":"","subtitle_show":0,"pub_time":1775020178000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51590003/mountain-province-diamond-q4-eps-0-71-down-from-0-29-yoy-sales-45-742m-down-from-51-996m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":549266,"article_id":"2624569720","title":"Direct Digital Holdings Q4 EPS $(22.00) Misses $0.03 Estimate, Sales $8.408M Miss $30.272M Estimate","subtitle":"","subtitle_show":0,"pub_time":1775019675000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51589986/direct-digital-holdings-q4-eps-22-00-misses-0-03-estimate-sales-8-408m-miss-30-272m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DRCT":1},"rights":null},{"id":549255,"article_id":"2624569421","title":"Else Nutrition Holdings Q4 EPS $(0.08) Up From $(0.30) YoY, Sales $776.000K Down From $1.426M YoY","subtitle":"","subtitle_show":0,"pub_time":1775019075000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51589967/else-nutrition-holdings-q4-eps-0-08-up-from-0-30-yoy-sales-776-000k-down-from-1-426m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":549254,"article_id":"2624856941","title":"High Arctic Energy Servs Q4 EPS $(0.01) Up From $(0.06) YoY, Sales $2.985M Up From $2.443M YoY","subtitle":"","subtitle_show":0,"pub_time":1775018904000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/04/51589949/high-arctic-energy-servs-q4-eps-0-01-up-from-0-06-yoy-sales-2-985m-up-from-2-443m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":549136,"article_id":"2624565938","title":"Binah Capital Group (BCG) Stock Surges 59% After Hours — Here's Why","subtitle":"","subtitle_show":0,"pub_time":1775013676000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51589660/binah-capital-stock-surges-59-after-hours","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BCG":1.5,"RSI":1},"rights":null},{"id":548812,"article_id":"2624552818","title":"Kartoon Studios Q4 EPS $(0.08) Up From $(0.14) YoY, Sales $9.693M Up From $9.421M YoY","subtitle":"","subtitle_show":0,"pub_time":1775002592000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588759/kartoon-studios-q4-eps-0-08-up-from-0-14-yoy-sales-9-693m-up-from-9-421m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TOON":0.9},"rights":null},{"id":548703,"article_id":"2624551980","title":"Alset Q4 EPS $(1.41) Down From $0.25 YoY, Sales $1.305M Down From $8.942M YoY","subtitle":"","subtitle_show":0,"pub_time":1774998753000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588241/alset-q4-eps-1-41-down-from-0-25-yoy-sales-1-305m-down-from-8-942m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AEI":1},"rights":null},{"id":548701,"article_id":"2624516815","title":"Professional Diversity Q4 EPS $(0.53) Up From $(0.55) YoY, Sales $1.669M Up From $1.620M YoY","subtitle":"","subtitle_show":0,"pub_time":1774998377000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588209/professional-diversity-q4-eps-0-53-up-from-0-55-yoy-sales-1-669m-up-from-1-620m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IPDN":1},"rights":null},{"id":548700,"article_id":"2624551507","title":"MediaCo Holding Q4 Adj. EPS $(0.11) Down From $(0.09) YoY, Sales $38.663M Up From $32.804M YoY","subtitle":"","subtitle_show":0,"pub_time":1774998254000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588196/mediaco-holding-q4-adj-eps-0-11-down-from-0-09-yoy-sales-38-663m-up-from-32-804m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MDIA":1},"rights":null},{"id":548680,"article_id":"2624513345","title":"T Stamp Q4 EPS $(0.39) Beats $(0.64) Estimate, Sales $908.859K Beat $884.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774997935000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588150/t-stamp-q4-eps-0-39-beats-0-64-estimate-sales-908-859k-beat-884-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IDAI":1},"rights":null},{"id":548669,"article_id":"2624590595","title":"Lixte Biotech Hldgs Q4 EPS $(0.34) Down From $(0.27) YoY","subtitle":"","subtitle_show":0,"pub_time":1774997572000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588121/lixte-biotech-hldgs-q4-eps-0-34-down-from-0-27-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"XBI":1.5},"rights":null},{"id":548670,"article_id":"2624559056","title":"Matinas BioPharma Hldgs Q4 EPS $(0.26) Up From $(1.68) YoY","subtitle":"","subtitle_show":0,"pub_time":1774997425000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588106/matinas-biopharma-hldgs-q4-eps-0-26-up-from-1-68-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MTNB":1},"rights":null},{"id":548667,"article_id":"2624559776","title":"Brainstorm Cell Q4 EPS $(0.20) Beats $(0.37) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774997354000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588093/brainstorm-cell-q4-eps-0-20-beats-0-37-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BCLI":0.9},"rights":null},{"id":548664,"article_id":"2624055925","title":"OSR Holdings Q4 EPS $(0.16) Misses $(0.10) Estimate, Sales $381.269K Miss $761.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774997119000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588049/osr-holdings-q4-eps-0-16-misses-0-10-estimate-sales-381-269k-miss-761-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"OSRH":1.5},"rights":null},{"id":548661,"article_id":"2624559415","title":"Safe Pro Group Q4 EPS $(0.16) Misses $(0.11) Estimate, Sales $227.704K Beat $119.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774996994000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51588034/safe-pro-group-q4-eps-0-16-misses-0-11-estimate-sales-227-704k-beat-119-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SPAI":1.5},"rights":null},{"id":548660,"article_id":"2624418559","title":"Power REIT Q4 FFO $(0.08) Up From $(0.36) YoY, Sales $506.096K Down From $570.039K YoY","subtitle":"","subtitle_show":0,"pub_time":1774996852000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587970/power-reit-q4-ffo-0-08-up-from-0-36-yoy-sales-506-096k-down-from-570-039k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PW":1.5,"REIT":1.5},"rights":null},{"id":548658,"article_id":"2624355993","title":"Kairos Pharma Q4 EPS $(0.07) Beats $(0.10) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774996678000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587940/kairos-pharma-q4-eps-0-07-beats-0-10-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KAIR":1.5,"KAPA":1.5},"rights":null},{"id":548656,"article_id":"2624595095","title":"AppTech Payments Q4 EPS $(0.04) Down From $(0.02) YoY, Sales $660.000K Up From $52.000K YoY","subtitle":"","subtitle_show":0,"pub_time":1774996363000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587907/apptech-payments-q4-eps-0-04-down-from-0-02-yoy-sales-660-000k-up-from-52-000k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"APCX":0.9},"rights":null},{"id":548655,"article_id":"2624377559","title":"Fury Gold Mines Q4 EPS $(0.01) Up From $(0.68) YoY","subtitle":"","subtitle_show":0,"pub_time":1774996177000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587892/fury-gold-mines-q4-eps-0-01-up-from-0-68-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FURY":1},"rights":null},{"id":548653,"article_id":"2624559352","title":"New Concept Energy Q4 Sales $38.000K Up From $36.000K YoY","subtitle":"","subtitle_show":0,"pub_time":1774996043000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587879/new-concept-energy-q4-sales-38-000k-up-from-36-000k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GBR":1.5},"rights":null},{"id":548652,"article_id":"2624870559","title":"Broadway Financial Q4 EPS $0.04 Down From $0.06 YoY, Sales $9.417M Up From $8.557M YoY","subtitle":"","subtitle_show":0,"pub_time":1774995895000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587863/broadway-financial-q4-eps-0-04-down-from-0-06-yoy-sales-9-417m-up-from-8-557m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BYFC":1.5},"rights":null},{"id":548649,"article_id":"2624555629","title":"Greenidge Generation Hldg Q4 EPS $0.19 Up From $(0.30) YoY, Sales $11.454M Down From $14.792M YoY","subtitle":"","subtitle_show":0,"pub_time":1774995434000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587828/greenidge-generation-hldg-q4-eps-0-19-up-from-0-30-yoy-sales-11-454m-down-from-14-792m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GREE":1.5},"rights":null},{"id":548642,"article_id":"2624565325","title":"PEDEVCO Q4 EPS $(1.79) Misses $(0.20) Estimate, Sales $23.082M Beat $14.700M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774994479000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587654/pedevco-q4-eps-1-79-misses-0-20-estimate-sales-23-082m-beat-14-700m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PED":1},"rights":null},{"id":548635,"article_id":"2624556865","title":"Allbirds Q4 EPS $(2.34) Misses $(2.30) Estimate, Sales $47.679M Miss $56.296M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774994144000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587592/allbirds-q4-eps-2-34-misses-2-30-estimate-sales-47-679m-miss-56-296m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BIRD":1.5},"rights":null},{"id":548634,"article_id":"2624555091","title":"First Mining Gold Q4 EPS $(0.02) Down From $0.02 YoY","subtitle":"","subtitle_show":0,"pub_time":1774993951000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587552/first-mining-gold-q4-eps-0-02-down-from-0-02-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":548628,"article_id":"2624550875","title":"Binah Capital Group Q4 EPS $0.01 Up From $(0.07) YoY, Sales $50.512M Up From $44.608M YoY","subtitle":"","subtitle_show":0,"pub_time":1774993814000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587525/binah-capital-group-q4-eps-0-01-up-from-0-07-yoy-sales-50-512m-up-from-44-608m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BCG":1},"rights":null},{"id":548627,"article_id":"2624555082","title":"Catheter Precision Q4 EPS $(2.88) Up From $(21.66) YoY, Sales $238.000K Up From $149.000K YoY","subtitle":"","subtitle_show":0,"pub_time":1774993805000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587517/catheter-precision-q4-eps-2-88-up-from-21-66-yoy-sales-238-000k-up-from-149-000k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VTAK":1},"rights":null},{"id":548625,"article_id":"2624552555","title":"IM Cannabis Q4 EPS $(0.86) Down From $(0.23) YoY, Sales $11.249M Up From $9.535M YoY","subtitle":"","subtitle_show":0,"pub_time":1774993563000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587492/im-cannabis-q4-eps-0-86-down-from-0-23-yoy-sales-11-249m-up-from-9-535m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNBS":1.5,"MJ":1.5,"MSOS":1.5,"MSOX":1.5,"WEED":1.5,"YOLO":1.5},"rights":null},{"id":548624,"article_id":"2624555402","title":"Onfolio Holdings Q4 EPS $(0.12) Up From $(0.16) YoY, Sales $2.028M Down From $2.536M YoY","subtitle":"","subtitle_show":0,"pub_time":1774993496000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587453/onfolio-holdings-q4-eps-0-12-up-from-0-16-yoy-sales-2-028m-down-from-2-536m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ONFO":1},"rights":null},{"id":548617,"article_id":"2624555103","title":"Greenlane Hldgs Q4 EPS $(29.14) Up From $(840.00) YoY, Sales $1.361M Down From $1.659M YoY","subtitle":"","subtitle_show":0,"pub_time":1774993362000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587333/greenlane-hldgs-q4-eps-29-14-up-from-840-00-yoy-sales-1-361m-down-from-1-659m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GNLN":1},"rights":null},{"id":548613,"article_id":"2624636555","title":"NexGel Q4 EPS $(0.12) Misses $(0.09) Estimate, Sales $2.796M Miss $3.240M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774992892000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587250/nexgel-q4-eps-0-12-misses-0-09-estimate-sales-2-796m-miss-3-240m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NXGL":1},"rights":null},{"id":548606,"article_id":"2624312555","title":"Connect Biopharma Hldgs Q4 EPS $(0.27) Beats $(0.30) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774992607000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587159/connect-biopharma-hldgs-q4-eps-0-27-beats-0-30-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNTB":1},"rights":null},{"id":548597,"article_id":"2624005553","title":"Faraday Future Q4 EPS $(0.19) Beats $(0.45) Estimate, Sales $129.000K Beat $70.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774992463000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587076/faraday-future-q4-eps-0-19-beats-0-45-estimate-sales-129-000k-beat-70-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FFAI":1.98},"rights":null},{"id":548595,"article_id":"2624655300","title":"AgEagle Aerial Sys Q4 EPS $(0.06) Up From $(8.65) YoY, Sales $2.994M Up From $2.821M YoY","subtitle":"","subtitle_show":0,"pub_time":1774992380000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51587041/ageagle-aerial-sys-q4-eps-0-06-up-from-8-65-yoy-sales-2-994m-up-from-2-821m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"UAVS":1},"rights":null},{"id":548590,"article_id":"2624553765","title":"ENDRA Life Sciences Q4 EPS $(3.25) Misses $(1.95) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774992172000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586945/endra-life-sciences-q4-eps-3-25-misses-1-95-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NDRA":1},"rights":null},{"id":548586,"article_id":"2624553280","title":"Forte Biosciences Q4 EPS $(1.45) Misses $(1.06) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774992066000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586887/forte-biosciences-q4-eps-1-45-misses-1-06-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FBRX":1},"rights":null},{"id":548581,"article_id":"2624655312","title":"CORRECTION: Allied Gold Q4 Adj. EPS $0.56 Beats $0.54 Estimate, Sales $427.820M Miss $428.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774991909000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586782/correction-allied-gold-q4-adj-eps-0-56-beats-0-54-estimate-sales-427-820m-miss-428-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AAUC":1},"rights":null},{"id":548568,"article_id":"2624553917","title":"Allied Gold Q4 EPS $(0.19) Misses $0.64 Estimate, Sales $427.820M Miss $428.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774991702000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586687/allied-gold-q4-eps-0-19-misses-0-64-estimate-sales-427-820m-miss-428-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AAUC":0.9},"rights":null},{"id":548567,"article_id":"2624553647","title":"HeartCore Enterprises Q4 EPS $(0.05) Misses $(0.01) Estimate, Sales $1.916M Miss $4.727M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774991547000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586528/heartcore-enterprises-q4-eps-0-05-misses-0-01-estimate-sales-1-916m-miss-4-727m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HTCR":1.5},"rights":null},{"id":548562,"article_id":"2624553658","title":"Femasys Q4 EPS $(0.06) Beats $(0.12) Estimate, Sales $813.387K Miss $1.450M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774991400000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586448/femasys-q4-eps-0-06-beats-0-12-estimate-sales-813-387k-miss-1-450m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FEMY":1.5},"rights":null},{"id":548560,"article_id":"2624955339","title":"374Water Q4 EPS $(0.50) Down From $(0.30) YoY, Sales $(1.683M) Down From $11.856K YoY","subtitle":"","subtitle_show":0,"pub_time":1774991248000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586390/374water-q4-eps-0-50-down-from-0-30-yoy-sales-1-683m-down-from-11-856k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SCWO":1},"rights":null},{"id":548559,"article_id":"2624553896","title":"DeFi Technologies Reports Preliminary FY 2025 Revenue Of $99.1M Vs. $31.4M YoY; Q4 Revenue Of $20.0M vs. $(19.3M) YoY","subtitle":"","subtitle_show":0,"pub_time":1774991144000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586323/defi-technologies-reports-preliminary-fy-2025-revenue-of-99-1m-vs-31-4m-yoy-q4-revenue-of-20-0m-vs-","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DEFT":0.9},"rights":null},{"id":548553,"article_id":"2624095558","title":"BioAtla Q4 EPS $(0.16) Beats $(0.30) Estimate, Sales $2.000M Beat $700.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774991010000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586243/bioatla-q4-eps-0-16-beats-0-30-estimate-sales-2-000m-beat-700-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BCAB":1.5},"rights":null},{"id":548550,"article_id":"2624582215","title":"20/20 Biolabs FY EPS $(0.76) Up From $(1.16) YoY, Sales $2.045M Up From $1.752M YoY","subtitle":"","subtitle_show":0,"pub_time":1774990843000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51586131/2020-biolabs-fy-eps-0-76-up-from-1-16-yoy-sales-2-045m-up-from-1-752m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AIDX":1},"rights":null},{"id":548548,"article_id":"2624558125","title":"Intermap Techs Q4 EPS $(0.06) Down From $0.04 YoY, Sales $1.600M Down From $7.425M YoY","subtitle":"","subtitle_show":0,"pub_time":1774990563000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585968/intermap-techs-q4-eps-0-06-down-from-0-04-yoy-sales-1-600m-down-from-7-425m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":548545,"article_id":"2624558188","title":"Metatek-Group Q4 EPS $(0.61) Down From $(0.14) YoY, Sales $7.492M Up From $4.445M YoY","subtitle":"","subtitle_show":0,"pub_time":1774990548000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585954/metatek-group-q4-eps-0-61-down-from-0-14-yoy-sales-7-492m-up-from-4-445m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":548539,"article_id":"2624586945","title":"Syntec Optics Holdings Q4 EPS $(0.01) Up From $(0.04) YoY, Sales $7.505M Up From $7.322M YoY","subtitle":"","subtitle_show":0,"pub_time":1774990293000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585832/syntec-optics-holdings-q4-eps-0-01-up-from-0-04-yoy-sales-7-505m-up-from-7-322m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"OPTX":1},"rights":null},{"id":548538,"article_id":"2624558692","title":"RH Stock Tanks After Q4 Results Miss Estimates: Details","subtitle":"","subtitle_show":0,"pub_time":1774990264000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51585814/rh-stock-tanks-after-q4-results-miss-estimates-details","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RH":1.5},"rights":null},{"id":548536,"article_id":"2624558520","title":"POET Technologies Q4 EPS $(0.32) Misses $(0.09) Estimate, Sales $341.202K Miss $400.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774990128000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585724/poet-technologies-q4-eps-0-32-misses-0-09-estimate-sales-341-202k-miss-400-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"POET":1.5},"rights":null},{"id":548531,"article_id":"2624583215","title":"VolitionRX Q4 EPS $(0.05), Inline, Sales $447.034K Miss $765.167K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774990046000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585695/volitionrx-q4-eps-0-05-inline-sales-447-034k-miss-765-167k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VNRX":1.5},"rights":null},{"id":548532,"article_id":"2624558329","title":"Kodiak Sciences Q4 EPS $(1.04) Misses $(1.00) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774990028000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585668/kodiak-sciences-q4-eps-1-04-misses-1-00-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KOD":1},"rights":null},{"id":548530,"article_id":"2624355835","title":"Seritage Growth Props Q4 EPS $(0.11) Up From $(0.22) YoY, Sales $4.167M Down From $4.382M YoY","subtitle":"","subtitle_show":0,"pub_time":1774989956000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585625/seritage-growth-props-q4-eps-0-11-up-from-0-22-yoy-sales-4-167m-down-from-4-382m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SRG":1},"rights":null},{"id":548527,"article_id":"2624558854","title":"Bit Digital Q4 EPS $(0.77) Misses $(0.02) Estimate, Sales $32.338M Miss $35.016M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774989807000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585527/bit-digital-q4-eps-0-77-misses-0-02-estimate-sales-32-338m-miss-35-016m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BTBT":1},"rights":null},{"id":548528,"article_id":"2624755885","title":"Skillz Q4 EPS $(1.07) Misses $(1.03) Estimate, Sales $30.011M Beat $26.016M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774989747000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585382/skillz-q4-eps-1-07-misses-1-03-estimate-sales-30-011m-beat-26-016m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SKLZ":1},"rights":null},{"id":548523,"article_id":"2624530757","title":"Turn Therapeutics Q4 EPS $0.01","subtitle":"","subtitle_show":0,"pub_time":1774989587000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585220/turn-therapeutics-q4-eps-0-01","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":548520,"article_id":"2624530472","title":"eXoZymes Inc. - Common Stock Q4 EPS $(0.31)","subtitle":"","subtitle_show":0,"pub_time":1774989390000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51585108/exozymes-inc-common-stock-q4-eps-0-31","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"EXOZ":1.5},"rights":null},{"id":548521,"article_id":"2624530452","title":"SEALSQ Stock Climbs After Earnings: Here's Why","subtitle":"","subtitle_show":0,"pub_time":1774989349000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51585063/sealsq-stock-climbs-after-earnings-heres-why","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LAES":1},"rights":null},{"id":548506,"article_id":"2624653092","title":"Nuvve Holding Q4 Adj. EPS $(2.74) Up From $(230.00) YoY, Sales $1.950M Up From $1.786M YoY","subtitle":"","subtitle_show":0,"pub_time":1774989237000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584887/nuvve-holding-q4-adj-eps-2-74-up-from-230-00-yoy-sales-1-950m-up-from-1-786m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NVVE":1},"rights":null},{"id":548505,"article_id":"2624530923","title":"Banzai International Q4 EPS $(0.60) Beats $(0.61) Estimate, Sales $2.811M Miss $3.187M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774989124000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584784/banzai-international-q4-eps-0-60-beats-0-61-estimate-sales-2-811m-miss-3-187m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BNZI":1},"rights":null},{"id":548500,"article_id":"2624530664","title":"Duos Technologies Group Q4 EPS $(0.15) Misses $(0.02) Estimate, Sales $9.460M Miss $10.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988949000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584618/duos-technologies-group-q4-eps-0-15-misses-0-02-estimate-sales-9-460m-miss-10-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DUOT":1.5},"rights":null},{"id":548497,"article_id":"2624505530","title":"MDB Capital Holdings Q4 EPS $0.04 Up From $(1.26) YoY","subtitle":"","subtitle_show":0,"pub_time":1774988831000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584573/mdb-capital-holdings-q4-eps-0-04-up-from-1-26-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MDB":1.5},"rights":null},{"id":548498,"article_id":"2624653050","title":"Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988803000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584543/nanobiotix-fy-eps-0-58-down-from-1-56-yoy-sales-37-943m-miss-165-540m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NBTX":1},"rights":null},{"id":548494,"article_id":"2624530542","title":"Axe Compute Q4 EPS $(122.75), Sales $8.650K Down From $8.792K YoY","subtitle":"","subtitle_show":0,"pub_time":1774988714000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584501/axe-compute-q4-eps-122-75-sales-8-650k-down-from-8-792k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AGPU":0.9},"rights":null},{"id":548495,"article_id":"2624530547","title":"Banzai International Q4 Sales $2.811M Miss $3.187M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988700000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584485/banzai-international-q4-sales-2-811m-miss-3-187m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BNZI":0.9},"rights":null},{"id":548485,"article_id":"2624303205","title":"Aqua Metals Q4 EPS $(1.57) Up From $(10.60) YoY","subtitle":"","subtitle_show":0,"pub_time":1774988558000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584390/aqua-metals-q4-eps-1-57-up-from-10-60-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AQMS":1.5},"rights":null},{"id":548484,"article_id":"2624530327","title":"Edible Garden AG Q4 EPS $(24.81) Misses $(5.60) Estimate, Sales $4.129M Miss $5.422M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988522000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584355/edible-garden-ag-q4-eps-24-81-misses-5-60-estimate-sales-4-129m-miss-5-422m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AG":1.5},"rights":null},{"id":548482,"article_id":"2624530332","title":"SEALSQ FY EPS $(0.24) Misses $(0.05) Estimate, Sales $18.252M Beat $12.900M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988462000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584305/sealsq-fy-eps-0-24-misses-0-05-estimate-sales-18-252m-beat-12-900m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LAES":1},"rights":null},{"id":548481,"article_id":"2624537026","title":"East Side Games Grp Q4 EPS $(0.14) Down From $(0.04) YoY, Sales $19.760M Miss $22.100M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988341000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51584167/east-side-games-grp-q4-eps-0-14-down-from-0-04-yoy-sales-19-760m-miss-22-100m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":548474,"article_id":"2624081537","title":"PVH Q4 Adj. EPS $3.82 Beats $3.30 Estimate, Sales $2.505B Beat $2.437B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988189000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583957/pvh-q4-adj-eps-3-82-beats-3-30-estimate-sales-2-505b-beat-2-437b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PVH":1.5},"rights":null},{"id":548475,"article_id":"2624377025","title":"KULR Tech Gr Q4 EPS $(0.97) Misses $(0.08) Estimate, Sales $2.864M Miss $8.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988184000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583952/kulr-tech-gr-q4-eps-0-97-misses-0-08-estimate-sales-2-864m-miss-8-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KULR":1.5},"rights":null},{"id":548470,"article_id":"2624372705","title":"Milestone Scientific Q4 EPS $(0.02) Misses $(0.01) Estimate, Sales $2.059M Miss $2.309M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988100000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583822/milestone-scientific-q4-eps-0-02-misses-0-01-estimate-sales-2-059m-miss-2-309m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MLSS":1.5},"rights":null},{"id":548471,"article_id":"2624537203","title":"GEN Restaurant Gr Q4 EPS $(0.36) Misses $(0.13) Estimate, Sales $49.746M Miss $58.770M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988074000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583788/gen-restaurant-gr-q4-eps-0-36-misses-0-13-estimate-sales-49-746m-miss-58-770m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GEN":1.5,"QSR":1.5},"rights":null},{"id":548467,"article_id":"2624537403","title":"Venu Holding Q4 EPS $(0.17) Beats $(0.28) Estimate, Sales $4.526M Miss $5.641M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774988027000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583752/venu-holding-q4-eps-0-17-beats-0-28-estimate-sales-4-526m-miss-5-641m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VENU":1},"rights":null},{"id":548465,"article_id":"2624537471","title":"BRC Group Holdings Q4 EPS $2.77 Up From $2.14 YoY, Sales $278.363M Down From $282.500M YoY","subtitle":"","subtitle_show":0,"pub_time":1774987998000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583719/brc-group-holdings-q4-eps-2-77-up-from-2-14-yoy-sales-278-363m-down-from-282-500m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BRC":1.5},"rights":null},{"id":548468,"article_id":"2624853740","title":"Rekor Systems Q4 EPS $(0.06) Misses $(0.04) Estimate, Sales $12.699M Miss $14.563M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987975000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583681/rekor-systems-q4-eps-0-06-misses-0-04-estimate-sales-12-699m-miss-14-563m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"REKR":0.9},"rights":null},{"id":548466,"article_id":"2624537470","title":"TOMI Environmental Solns Q4 EPS $(0.09) Misses $(0.02) Estimate, Sales $1.017M Miss $2.308M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987922000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583588/tomi-environmental-solns-q4-eps-0-09-misses-0-02-estimate-sales-1-017m-miss-2-308m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TOMZ":1},"rights":null},{"id":548459,"article_id":"2624432537","title":"Nano Dimension Q4 Sales $35.300M Up From $14.569M YoY","subtitle":"","subtitle_show":0,"pub_time":1774987840000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583483/nano-dimension-q4-sales-35-300m-up-from-14-569m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NNDM":1.5},"rights":null},{"id":548460,"article_id":"2624537430","title":"AuthID Q4 EPS $(0.28) Up From $(0.42) YoY, Sales $587.650K Up From $199.749K YoY","subtitle":"","subtitle_show":0,"pub_time":1774987824000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583462/authid-q4-eps-0-28-up-from-0-42-yoy-sales-587-650k-up-from-199-749k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AUID":0.9},"rights":null},{"id":548454,"article_id":"2624153537","title":"RH Q4 Adj. EPS $1.53 Misses $2.22 Estimate, Sales $842.623M Miss $873.323M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987759000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583379/rh-q4-adj-eps-1-53-misses-2-22-estimate-sales-842-623m-miss-873-323m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RH":1.5},"rights":null},{"id":548458,"article_id":"2624191537","title":"Workhorse Gr Q4 EPS $(2.46) Beats $(16.08) Estimate, Sales $9.743M Beat $3.500M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987740000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583348/workhorse-gr-q4-eps-2-46-beats-16-08-estimate-sales-9-743m-beat-3-500m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WKHS":1.5},"rights":null},{"id":548457,"article_id":"2624371965","title":"TruBridge Q4 Adj. EPS $(0.37) Misses $0.60 Estimate, Sales $87.192M Miss $87.876M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987721000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583319/trubridge-q4-adj-eps-0-37-misses-0-60-estimate-sales-87-192m-miss-87-876m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TBRG":0.9},"rights":null},{"id":548456,"article_id":"2624537165","title":"Birchtech Q4 EPS $(0.03) Beats $(0.06) Estimate, Sales $3.800M Beat $3.600M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987697000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583290/birchtech-q4-eps-0-03-beats-0-06-estimate-sales-3-800m-beat-3-600m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BCHT":1},"rights":null},{"id":548455,"article_id":"2624537139","title":"Barfresh Food Group Q4 Sales $5.422M Miss $5.667M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987686000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583275/barfresh-food-group-q4-sales-5-422m-miss-5-667m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BRFH":1},"rights":null},{"id":548453,"article_id":"2624537675","title":"AVAX One Technology Q4 EPS $(4.11) Up From $(16.56) YoY, Sales $1.089M Up From $26.572K YoY","subtitle":"","subtitle_show":0,"pub_time":1774987676000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583257/avax-one-technology-q4-eps-4-11-up-from-16-56-yoy-sales-1-089m-up-from-26-572k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AVX":1},"rights":null},{"id":548450,"article_id":"2624641537","title":"Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY","subtitle":"","subtitle_show":0,"pub_time":1774987655000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583210/co-diagnostics-q4-eps-16-65-down-from-10-82-yoy-sales-263-922k-up-from-149-325k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CODX":0.9},"rights":null},{"id":548451,"article_id":"2624376735","title":"Ncino Q4 Adj. EPS $0.37 Beats $0.21 Estimate, Sales $149.700M Beat $147.821M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987625000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583195/ncino-q4-adj-eps-0-37-beats-0-21-estimate-sales-149-700m-beat-147-821m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NCNO":0.9},"rights":null},{"id":548452,"article_id":"2624953767","title":"Omeros Q4 Adj. EPS $3.14 Beats $(0.57) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987594000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51583171/omeros-q4-adj-eps-3-14-beats-0-57-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"OMER":1.5},"rights":null},{"id":548449,"article_id":"2624953756","title":"BioHarvest Sciences Inc. - Common Stock Q4 EPS $(0.10), Inline, Sales $9.100M Miss $9.279M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774987451000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51582995/bioharvest-sciences-inc-common-stock-q4-eps-0-10-inline-sales-9-100m-miss-9-279m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BHST":1},"rights":null},{"id":548442,"article_id":"2624532068","title":"Branchout Food Q4 EPS $(0.16) Up From $(0.18) YoY, Sales $4.011M Up From $1.505M YoY","subtitle":"","subtitle_show":0,"pub_time":1774987133000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51582644/branchout-food-q4-eps-0-16-up-from-0-18-yoy-sales-4-011m-up-from-1-505m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BOF":1},"rights":null},{"id":548223,"article_id":"2623053317","title":"Phoenix Asia Holdings H1 2025 EPS $0.01 Down From $0.04 YoY; Revenue $3.512M Down From $3.79M YoY","subtitle":"","subtitle_show":0,"pub_time":1774970724000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51573139/phoenix-asia-holdings-h1-2025-eps-0-01-down-from-0-04-yoy-revenue-3-512m-down-from-3-79m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PHOE":1.5},"rights":null},{"id":548093,"article_id":"2623580934","title":"Galectin Therapeutics Q4 EPS $(0.08) Beats $(0.11) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774966799000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51570016/galectin-therapeutics-q4-eps-0-08-beats-0-11-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GALT":1.5},"rights":null},{"id":548090,"article_id":"2623580616","title":"Cadrenal Therapeutics Q4 EPS $(1.41) Misses $(1.18) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774966518000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51569791/cadrenal-therapeutics-q4-eps-1-41-misses-1-18-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":548066,"article_id":"2623580535","title":"Zhibao Technology H1 EPS $(0.02) Down From $(0.01) YoY, Sales $29.454M Up From $20.053M YoY","subtitle":"","subtitle_show":0,"pub_time":1774966296000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51569589/zhibao-technology-h1-eps-0-02-down-from-0-01-yoy-sales-29-454m-up-from-20-053m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ZBAO":1.5},"rights":null},{"id":547847,"article_id":"2623824325","title":"Reading Intl Q4 EPS $(0.11) Beats $(0.20) Estimate, Sales $50.272M Miss $58.746M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774963907000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51567384/reading-intl-q4-eps-0-11-beats-0-20-estimate-sales-50-272m-miss-58-746m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RDI":1},"rights":null},{"id":547843,"article_id":"2623582908","title":"NeuroSense Therapeutics FY EPS $(0.44) Misses $(0.35) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774963716000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51567298/neurosense-therapeutics-fy-eps-0-44-misses-0-35-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":547823,"article_id":"2623258257","title":"Forum Markets Q4 EPS $(12.14) Down From $(3.32) YoY, Sales $2.437M","subtitle":"","subtitle_show":0,"pub_time":1774963423000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51567150/forum-markets-q4-eps-12-14-down-from-3-32-yoy-sales-2-437m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FET":1.5},"rights":null},{"id":547813,"article_id":"2623582891","title":"Why Is T1 Energy Stock Sinking Tuesday?","subtitle":"","subtitle_show":0,"pub_time":1774963126000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51566969/why-is-t1-energy-stock-sinking-tuesday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNRG":0.9,"CTEX":0.9,"SMA":1,"TE":1},"rights":null},{"id":547746,"article_id":"2623358418","title":"TON Strategy FY 2025 EPS $(5.96) Beats $(8.03) Estimate, Sales $12.779M Beat $5.500M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774962199000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51566214/ton-strategy-fy-2025-eps-5-96-beats-8-03-estimate-sales-12-779m-beat-5-500m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TONX":0.9},"rights":null},{"id":547744,"article_id":"2623458495","title":"NextPlat FY 2025 EPS $(0.44) Up From $(0.65) YoY, Sales $54.322M Down From $66.082M YoY","subtitle":"","subtitle_show":0,"pub_time":1774962085000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51566101/nextplat-fy-2025-eps-0-44-up-from-0-65-yoy-sales-54-322m-down-from-66-082m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NXPL":1.5},"rights":null},{"id":547708,"article_id":"2623812375","title":"BIO-key Intl Q4 EPS $(0.19) Misses $(0.07) Estimate, Sales $1.241M Miss $2.200M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774961089000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51565361/bio-key-intl-q4-eps-0-19-misses-0-07-estimate-sales-1-241m-miss-2-200m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BIO":1.5},"rights":null},{"id":547697,"article_id":"2623530581","title":"Taylor Devices Q3 EPS $0.79 Misses $0.82 Estimate, Sales $11.173M Miss $12.100M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774960539000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51565134/taylor-devices-q3-eps-0-79-misses-0-82-estimate-sales-11-173m-miss-12-100m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TAYD":1.5},"rights":null},{"id":547634,"article_id":"2623946589","title":"How To Earn $500 A Month From Lamb Weston Stock Ahead Of Q3 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774959443000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/dividends/26/03/51564420/how-to-earn-500-a-month-from-lamb-weston-stock-ahead-of-q3-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LW":1,"VIG":0.9},"rights":null},{"id":547623,"article_id":"2623589993","title":"Sportsman's Warehouse Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1774959366000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51564396/sportsmans-warehouse-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-2","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SPWH":1},"rights":null},{"id":547621,"article_id":"2623589960","title":"Why Is Phreesia Stock Sinking Tuesday?","subtitle":"","subtitle_show":0,"pub_time":1774959335000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51564380/why-is-phreesia-stock-sinking-tuesday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PHR":1},"rights":null},{"id":547622,"article_id":"2623589995","title":"Cocrystal Pharma Q4 EPS $(0.17) Beats $(0.21) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774959251000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51564325/cocrystal-pharma-q4-eps-0-17-beats-0-21-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"COCP":1},"rights":null},{"id":547615,"article_id":"2623589574","title":"Imunon Q4 EPS $(1.30) Misses $(1.13) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774959155000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51564288/imunon-q4-eps-1-30-misses-1-13-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IMNN":1},"rights":null},{"id":547605,"article_id":"2623589803","title":"AlTi Global Q4 Sales $88.255M Beat $86.600M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774958777000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51564105/alti-global-q4-sales-88-255m-beat-86-600m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ALTI":1.5},"rights":null},{"id":547607,"article_id":"2623589808","title":"Solesence Q4 Sales $12.483M Down From $12.567M YoY","subtitle":"","subtitle_show":0,"pub_time":1774958773000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51564099/solesence-q4-sales-12-483m-down-from-12-567m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.9,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SLSN":1,"SQQQ":0.6,"TQQQ":0.6},"rights":null},{"id":547600,"article_id":"2623834589","title":"SPAR Group Q4 Adj. EPS $(0.39) Misses $0.02 Estimate, Sales $22.017M Down From $33.043M YoY","subtitle":"","subtitle_show":0,"pub_time":1774958746000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51564070/spar-group-q4-adj-eps-0-39-misses-0-02-estimate-sales-22-017m-down-from-33-043m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SGRP":1},"rights":null},{"id":547570,"article_id":"2623860805","title":"Purple Innovation Q4 Adj. EPS $(0.02) Beats $(0.04) Estimate, Sales $140.688M Beat $139.809M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774958586000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51563851/purple-innovation-q4-adj-eps-0-02-beats-0-04-estimate-sales-140-688m-beat-139-809m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PRPL":1},"rights":null},{"id":547561,"article_id":"2623869475","title":"OS Therapies Q4 EPS $(0.41) Misses $(0.13) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774958099000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51563471/os-therapies-q4-eps-0-41-misses-0-13-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"OSTX":1.5},"rights":null},{"id":547546,"article_id":"2623586698","title":"60 Degrees Q4 EPS $(1.47) Misses $(1.12) Estimate, Sales $303.385K Miss $400.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774957839000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51563428/60-degrees-q4-eps-1-47-misses-1-12-estimate-sales-303-385k-miss-400-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SXTP":1},"rights":null},{"id":547544,"article_id":"2623300324","title":"T1 Energy Q4 EPS $(0.70) Misses $0.02 Estimate, Sales $358.554M Miss $401.420M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774957627900,"source_id":"","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51560253/t1-energy-q4-eps-0-70-misses-0-02-estimate-sales-358-554m-miss-401-420m-estimate","is_publish_highlight":1,"top_time":0,"symbols_score_info":{"TE":1},"rights":null},{"id":547519,"article_id":"2623863935","title":"Crescita Therapeutics Q4 EPS $(0.04) Down From $(0.01) YoY, Sales $5.955M Down From $6.902M YoY","subtitle":"","subtitle_show":0,"pub_time":1774957487000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51563373/crescita-therapeutics-q4-eps-0-04-down-from-0-01-yoy-sales-5-955m-down-from-6-902m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":547495,"article_id":"2623210585","title":"PVH Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1774957053000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51563243/pvh-likely-to-report-higher-q4-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PVH":1.5},"rights":null},{"id":547468,"article_id":"2623851015","title":"Elauwit Connection Q4 EPS $(0.69) Down From $(0.20) YoY, Sales $4.679M Up From $3.312M YoY","subtitle":"","subtitle_show":0,"pub_time":1774956837000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51563060/elauwit-connection-q4-eps-0-69-down-from-0-20-yoy-sales-4-679m-up-from-3-312m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"EWLT":1.5},"rights":null},{"id":547469,"article_id":"2623102585","title":"BOS Better Online Solns Q4 EPS $0.12 Up From $0.08 YoY, Sales $12.623M Up From $10.388M YoY","subtitle":"","subtitle_show":0,"pub_time":1774956749000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51563031/bos-better-online-solns-q4-eps-0-12-up-from-0-08-yoy-sales-12-623m-up-from-10-388m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BOSC":1},"rights":null},{"id":547466,"article_id":"2623585151","title":"Palvella Therapeutics Q4 EPS $(1.08) Misses $(0.91) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774956707000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51563010/palvella-therapeutics-q4-eps-1-08-misses-0-91-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PVLA":1.5},"rights":null},{"id":547467,"article_id":"2623585152","title":"MiNK Therapeutics Q4 EPS $(0.56) Beats $(0.82) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774956653000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562975/mink-therapeutics-q4-eps-0-56-beats-0-82-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"INKT":1.5},"rights":null},{"id":547435,"article_id":"2623585879","title":"Yxt.Com Group Holding FY EPS $(0.12), Sales $48.651M","subtitle":"","subtitle_show":0,"pub_time":1774956089000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562831/yxt-com-group-holding-fy-eps-0-12-sales-48-651m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.9,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SQQQ":0.6,"TQQQ":0.6,"YXT":1},"rights":null},{"id":547384,"article_id":"2623458329","title":"Charlottes Web Holdings Q4 EPS $(0.07) Down From $(0.02) YoY, Sales $13.300M Up From $12.700M YoY","subtitle":"","subtitle_show":0,"pub_time":1774955639000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562728/charlottes-web-holdings-q4-eps-0-07-down-from-0-02-yoy-sales-13-300m-up-from-12-700m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":547385,"article_id":"2623832695","title":"Bitfarms Q4 EPS $(0.25) Misses $(0.04) Estimate, Sales $50.226M Miss $59.009M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774955621000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562719/bitfarms-q4-eps-0-25-misses-0-04-estimate-sales-50-226m-miss-59-009m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BITF":1.97,"BTFL":0.6},"rights":null},{"id":547386,"article_id":"2623583295","title":"Charlottes Web Holdings Q4 EPS $(0.07) Misses $(0.03) Estimate, Sales $13.300M Beat $12.300M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774955597000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562710/charlottes-web-holdings-q4-eps-0-07-misses-0-03-estimate-sales-13-300m-beat-12-300m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CWBHF":0.9},"rights":null},{"id":547356,"article_id":"2623583155","title":"Bitfarms Q4 EPS $(0.25) Misses $(0.03) Estimate, Sales $50.226M Miss $59.185M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774955154000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562401/bitfarms-q4-eps-0-25-misses-0-03-estimate-sales-50-226m-miss-59-185m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":547355,"article_id":"2623583158","title":"Aya Gold & Silver Q4 EPS $0.12 Misses $0.17 Estimate, Sales $75.320M Beat $75.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774955040000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562259/aya-gold-silver-q4-eps-0-12-misses-0-17-estimate-sales-75-320m-beat-75-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":547350,"article_id":"2623583612","title":"Chagee Holdings Q4 Adj. EPS $0.07 Misses $0.19 Estimate, Sales $425.346M Beat $413.410M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774954964000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562212/chagee-holdings-q4-adj-eps-0-07-misses-0-19-estimate-sales-425-346m-beat-413-410m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CHA":1.98},"rights":null},{"id":547325,"article_id":"2623583598","title":"Xtant Medical Hldgs Q4 Sales $32.357M Beat $30.750M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774954910000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562181/xtant-medical-hldgs-q4-sales-32-357m-beat-30-750m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"XTNT":1.5},"rights":null},{"id":547324,"article_id":"2623583593","title":"American Shared Hospital Q4 EPS $(0.09) Misses $0.02 Estimate, Sales $7.728M Miss $8.780M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774954889000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562163/american-shared-hospital-q4-eps-0-09-misses-0-02-estimate-sales-7-728m-miss-8-780m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AFG":1.5},"rights":null},{"id":547329,"article_id":"2623835605","title":"TD Synnex Q1 Adj. EPS $4.73 Beats $3.31 Estimate, Sales $17.161B Beat $15.591B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774954876000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51562153/td-synnex-q1-adj-eps-4-73-beats-3-31-estimate-sales-17-161b-beat-15-591b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SNX":1.5,"TD":1.5},"rights":null},{"id":547319,"article_id":"2623838875","title":"Top Wall Street Forecasters Revamp RH Expectations Ahead Of Q4 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774954638000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51561961/top-wall-street-forecasters-revamp-rh-expectations-ahead-of-q4-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RH":1.5},"rights":null},{"id":547318,"article_id":"2623583882","title":"FactSet Research Systems Q2 Adj. EPS $4.46 Beats $4.37 Estimate, Sales $611.019M Beat $604.510M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774954567000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51561940/factset-research-systems-q2-adj-eps-4-46-beats-4-37-estimate-sales-611-019m-beat-604-510m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FDS":1.5},"rights":null},{"id":547291,"article_id":"2623588296","title":"J.Jill Q4 Adj. EPS $(0.02) Beats $(0.12) Estimate, Sales $138.410M Beat $135.812M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774954065000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51561791/j-jill-q4-adj-eps-0-02-beats-0-12-estimate-sales-138-410m-beat-135-812m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"JILL":1},"rights":null},{"id":547286,"article_id":"2623588280","title":"iFabric Q4 EPS $(0.02) Down From $0.04 YoY, Sales $10.976M Up From $10.496M YoY","subtitle":"","subtitle_show":0,"pub_time":1774953902000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51561705/ifabric-q4-eps-0-02-down-from-0-04-yoy-sales-10-976m-up-from-10-496m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":547266,"article_id":"2623885285","title":"Toyo Co FY Adj. EPS $1.48 Beats $0.78 Estimate, Sales $427.383M Miss $561.895M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774953281000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51561543/toyo-co-fy-adj-eps-1-48-beats-0-78-estimate-sales-427-383m-miss-561-895m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TOYO":1},"rights":null},{"id":547265,"article_id":"2623540588","title":"AIRO Group Holdings Q4 Sales $48.278M Miss $52.200M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774953217000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51561432/airo-group-holdings-q4-sales-48-278m-miss-52-200m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AIRO":1.5},"rights":null},{"id":547250,"article_id":"2623883545","title":"McCormick & Co Q1 Adj. EPS $0.66 Beats $0.60 Estimate, Sales $1.874B Beat $1.787B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774953080000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51561390/mccormick-co-q1-adj-eps-0-66-beats-0-60-estimate-sales-1-874b-beat-1-787b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MKC":1},"rights":null},{"id":547228,"article_id":"2623002683","title":"Touchstone Exploration Q4 EPS $0.04 Beats $(0.01) Estimate, Sales $11.001M Miss $17.376M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774952422000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51561014/touchstone-exploration-q4-eps-0-04-beats-0-01-estimate-sales-11-001m-miss-17-376m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":547227,"article_id":"2623001053","title":"LENSAR Q4 EPS $(0.12) Misses $(0.07) Estimate, Sales $16.025M Miss $20.300M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774952378000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51560967/lensar-q4-eps-0-12-misses-0-07-estimate-sales-16-025m-miss-20-300m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LNSR":1},"rights":null},{"id":547203,"article_id":"2623901300","title":"Sound Group FY 2025 Adj. EPS $7.00, Sales $443.688M","subtitle":"","subtitle_show":0,"pub_time":1774952100000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51560815/sound-group-fy-2025-adj-eps-7-00-sales-443-688m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.9,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SOGP":1,"SQQQ":0.6,"TQQQ":0.6},"rights":null},{"id":547202,"article_id":"2623001813","title":"iHuman Q4 Adj. EPS $0.04 Down From $0.07 YoY, Sales $27.300M Down From $31.878M YoY","subtitle":"","subtitle_show":0,"pub_time":1774952069000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51560791/ihuman-q4-adj-eps-0-04-down-from-0-07-yoy-sales-27-300m-down-from-31-878m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IH":1.5},"rights":null},{"id":547184,"article_id":"2623300322","title":"Jiayin Gr Q4 EPS $0.28 Down From $0.72 YoY, Sales $155.896M Down From $192.415M YoY","subtitle":"","subtitle_show":0,"pub_time":1774951464000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51560384/jiayin-gr-q4-eps-0-28-down-from-0-72-yoy-sales-155-896m-down-from-192-415m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"JFIN":1},"rights":null},{"id":547187,"article_id":"2623130032","title":"Super Hi International Q4 EPS $0.01 Misses $0.04 Estimate, Sales $229.974M Miss $239.270M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774951287000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51560254/super-hi-international-q4-eps-0-01-misses-0-04-estimate-sales-229-974m-miss-239-270m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HDL":1},"rights":null},{"id":547147,"article_id":"2623079093","title":"Stock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus","subtitle":"","subtitle_show":0,"pub_time":1774950374000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51560112/stock-market-today-sp-500-dow-futures-jump-as-trump-hints-at-ending-iran-war-even-if-hormuz-remains-closed-allbirds-rocket-labs-nebius-in-focus","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".SPX":1.5,"ALLW":0.6,"BIRD":1.5,"DBSC":0.6,"GPIX":0.6,"HIBL":0.6,"IVE":0.6,"IVOO":0.6,"JEPI":0.6,"MOAT":0.6,"NBIG":0.6,"NBIL":0.6,"NBIZ":0.6,"NEBX":0.6,"NKE":1,"OEF":0.6,"OEX":0.6,"RKLZ":0.6,"RSP":0.6,"SCHG":1.5,"SPCE":1,"SPDN":0.6,"SPHD":0.6,"SPLV":0.6,"SPMO":0.6,"SPUS":0.6,"SPUU":0.6,"SPXL":0.6,"SPXU":0.6,"SPY":1.5,"SPYG":0.6,"SPYI":0.6,"SPYM":0.6,"SPYQ":0.6,"SPYV":0.6,"SSO":0.6,"TECL":0.6,"UPRO":0.6,"VEU":0.6,"VOO":1.5,"VOOG":1.5,"VTI":0.6,"VTV":0.6,"VUG":1.5,"VYM":1.5,"XDTE":0.6},"rights":null},{"id":547024,"article_id":"2623304945","title":"MINISO Group Holding Q4 Adj. EPS $0.40 Up From $0.28 YoY, Sales $894.320M Beat $859.030M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774946776000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51559633/miniso-group-holding-q4-adj-eps-0-40-up-from-0-28-yoy-sales-894-320m-beat-859-030m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MNSO":1},"rights":null},{"id":546854,"article_id":"2623306238","title":"McCormick, Allbirds And 3 Stocks To Watch Heading Into Tuesday","subtitle":"","subtitle_show":0,"pub_time":1774941865000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/long-ideas/26/03/51559117/mccormick-allbirds-and-3-stocks-to-watch-tuesday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BIRD":1.5,"MKC":1,"NKE":1,"SNX":1,"SPCE":1},"rights":null},{"id":546793,"article_id":"2623655305","title":"AleAnna Q4 Sales $9.135M Up From $771.700K YoY, Net Income $258.09K Up From Loss Of $9.414M YoY","subtitle":"","subtitle_show":0,"pub_time":1774939791000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51558959/aleanna-q4-sales-9-135m-up-from-771-700k-yoy-net-income-258-09k-up-from-loss-of-9-414m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.82,"ANNA":1,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SQQQ":0.6,"TQQQ":0.6},"rights":null},{"id":546779,"article_id":"2623305555","title":"Kore Group Holdings Q4 Sales $73.861M Miss $76.950M Estimate; Net Loss $18.5M Down From $25.45M YoY","subtitle":"","subtitle_show":0,"pub_time":1774939461000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51558943/kore-group-holdings-q4-sales-73-861m-miss-76-950m-estimate-net-loss-18-5m-down-from-25-45m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KORE":1},"rights":null},{"id":545852,"article_id":"2623223243","title":"Ainos Q4 EPS $(0.85) Up From $(1.30) YoY, Sales $11.120K","subtitle":"","subtitle_show":0,"pub_time":1774908760000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51556012/ainos-q4-eps-0-85-up-from-1-30-yoy-sales-11-120k","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AIMD":1},"rights":null},{"id":545848,"article_id":"2623322399","title":"TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY","subtitle":"","subtitle_show":0,"pub_time":1774908638000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51555962/therapeuticsmd-q4-eps-0-06-down-from-0-01-yoy-sales-893-000k-up-from-667-000k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TXMD":1.5},"rights":null},{"id":545847,"article_id":"2623322808","title":"Nakamoto Q4 EPS $0.07 Beats $(0.01) Estimate, Sales $444.924K Beat $400.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774908502000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51555929/nakamoto-q4-eps-0-07-beats-0-01-estimate-sales-444-924k-beat-400-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NAKA":1},"rights":null},{"id":545844,"article_id":"2623324041","title":"CXApp Q4 EPS $(0.20) Misses $(0.19) Estimate, Sales $1.022M Miss $1.100M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774908212000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51555823/cxapp-q4-eps-0-20-misses-0-19-estimate-sales-1-022m-miss-1-100m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CXAI":1.5},"rights":null},{"id":545839,"article_id":"2623242993","title":"Boston Omaha Q4 EPS $(0.22) Misses $(0.03) Estimate, Sales $29.708M Beat $29.150M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774907532000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51555154/boston-omaha-q4-eps-0-22-misses-0-03-estimate-sales-29-708m-beat-29-150m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BOC":1},"rights":null},{"id":545811,"article_id":"2623248523","title":"Ensysce Biosciences Q4 EPS $(0.75) Misses $(0.70) Estimate, Sales $1.882M Beat $500.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774905896000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51554124/ensysce-biosciences-q4-eps-0-75-misses-0-70-estimate-sales-1-882m-beat-500-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ENSC":1},"rights":null},{"id":545800,"article_id":"2623460321","title":"GlucoTrack Q4 EPS $(3.97) Up From $(1.24 thousand) YoY","subtitle":"","subtitle_show":0,"pub_time":1774904930000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553960/glucotrack-q4-eps-3-97-up-from-1-24-thousand-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.7,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GCTK":1,"GPIQ":0.6,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SQQQ":0.6,"TQQQ":0.6},"rights":null},{"id":545798,"article_id":"2623459321","title":"Falcons Beyond Global Q4 EPS $(0.01) Up From $(0.16) YoY, Sales $6.585M Up From $1.361M YoY","subtitle":"","subtitle_show":0,"pub_time":1774904679000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553895/falcons-beyond-global-q4-eps-0-01-up-from-0-16-yoy-sales-6-585m-up-from-1-361m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FBYD":1},"rights":null},{"id":545786,"article_id":"2623432115","title":"Vox Royalty Q4 EPS $0.09 Beats $(0.01) Estimate, Sales $7.361M Beat $6.200M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774904462000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553798/vox-royalty-q4-eps-0-09-beats-0-01-estimate-sales-7-361m-beat-6-200m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VOXR":1},"rights":null},{"id":545784,"article_id":"2623604321","title":"Prairie Operating Q4 EPS $0.31 Beats $0.25 Estimate, Sales $83.010M Miss $106.333M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774904200000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553719/prairie-operating-q4-eps-0-31-beats-0-25-estimate-sales-83-010m-miss-106-333m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PROP":1},"rights":null},{"id":545770,"article_id":"2623216833","title":"Jasper Therapeutics Q4 EPS $(0.32) Beats $(0.64) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774904023000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553686/jasper-therapeutics-q4-eps-0-32-beats-0-64-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"JSPR":1.5},"rights":null},{"id":545768,"article_id":"2623321579","title":"DiaMedica Therapeutics Q4 EPS $(0.17) Beats $(0.18) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774903815000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553653/diamedica-therapeutics-q4-eps-0-17-beats-0-18-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":545767,"article_id":"2623215743","title":"Aptera Motors Q4 Adj. EPS $(0.32) Down From $(0.23) YoY","subtitle":"","subtitle_show":0,"pub_time":1774903799000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553643/aptera-motors-q4-adj-eps-0-32-down-from-0-23-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SEV":1.5},"rights":null},{"id":545759,"article_id":"2623832134","title":"Lulus Fashion Lounge Q4 EPS $(0.14) Misses $(0.09) Estimate, Sales $63.018M Miss $63.500M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774903558000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553600/lulus-fashion-lounge-q4-eps-0-14-misses-0-09-estimate-sales-63-018m-miss-63-500m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LVLU":0.9},"rights":null},{"id":545763,"article_id":"2623321343","title":"Bio Green Med Solution Q4 EPS $(2.21) Up From $(847.61) YoY, Sales $666.000K","subtitle":"","subtitle_show":0,"pub_time":1774903550000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553591/bio-green-med-solution-q4-eps-2-21-up-from-847-61-yoy-sales-666-000k","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BGMS":1},"rights":null},{"id":545747,"article_id":"2623218493","title":"Ruanyun Edai Technology H1 EPS $(0.14) Down From $(0.02) YoY, Sales $366.256K Down From $4.109M YoY","subtitle":"","subtitle_show":0,"pub_time":1774903330000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553522/ruanyun-edai-technology-h1-eps-0-14-down-from-0-02-yoy-sales-366-256k-down-from-4-109m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RYET":1.5},"rights":null},{"id":545742,"article_id":"2623329715","title":"Oxbridge Re Holdings Q4 EPS $0.02 Beats $(0.01) Estimate, Sales $576.000K Miss $662.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774902980000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553448/oxbridge-re-holdings-q4-eps-0-02-beats-0-01-estimate-sales-576-000k-miss-662-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"OXBR":1.5},"rights":null},{"id":545741,"article_id":"2623932920","title":"AEON Biopharma Q4 EPS $(3.72)","subtitle":"","subtitle_show":0,"pub_time":1774902885000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553435/aeon-biopharma-q4-eps-3-72","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AEON":1.5},"rights":null},{"id":545734,"article_id":"2623329413","title":"Lexeo Therapeutics Q4 EPS $(0.27) Beats $(0.34) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774902604000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553286/lexeo-therapeutics-q4-eps-0-27-beats-0-34-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LXEO":1.5},"rights":null},{"id":545732,"article_id":"2623329149","title":"DeFi Development Q4 Adj. EPS $1.88 Beats $(0.11) Estimate, Sales $4.600M Beat $3.425M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774902467000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553245/defi-development-q4-adj-eps-1-88-beats-0-11-estimate-sales-4-600m-beat-3-425m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DFDVW":1.5},"rights":null},{"id":545729,"article_id":"2623972329","title":"RenovoRx Q4 EPS $(0.08), Inline, Sales $238.000K Miss $419.750K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774902159000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553172/renovorx-q4-eps-0-08-inline-sales-238-000k-miss-419-750k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RNXT":1.5},"rights":null},{"id":545730,"article_id":"2623329974","title":"Lantern Pharma Q4 EPS $(0.36) Beats $(0.46) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774902126000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553154/lantern-pharma-q4-eps-0-36-beats-0-46-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LTRN":1.5},"rights":null},{"id":545725,"article_id":"2623296013","title":"Innventure Q4 EPS $(0.18) Beats $(0.37) Estimate, Sales $822.000K","subtitle":"","subtitle_show":0,"pub_time":1774902023000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51553124/innventure-q4-eps-0-18-beats-0-37-estimate-sales-822-000k","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"INV":1},"rights":null},{"id":545724,"article_id":"2623295723","title":"Inventiva FY EPS $(2.14) Misses $(1.66) Estimate, Sales $5.064M Miss $6.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901751000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552957/inventiva-fy-eps-2-14-misses-1-66-estimate-sales-5-064m-miss-6-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IVA":1},"rights":null},{"id":545710,"article_id":"2623329365","title":"Fathom Holdings Q4 EPS $(0.21) Misses $(0.14) Estimate, Sales $90.606M Miss $97.547M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901561000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552885/fathom-holdings-q4-eps-0-21-misses-0-14-estimate-sales-90-606m-miss-97-547m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FTHM":1.5},"rights":null},{"id":545709,"article_id":"2623366329","title":"Beeline Holdings Q4 Sales $2.500M Miss $2.712M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901541000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552870/beeline-holdings-q4-sales-2-500m-miss-2-712m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BLNE":1.5},"rights":null},{"id":545708,"article_id":"2623298763","title":"Off The Hook YS Q4 EPS $(0.031) Up From $(0.034) YoY, Sales $37.274M Up From $29.770M YoY","subtitle":"","subtitle_show":0,"pub_time":1774901491000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552839/off-the-hook-ys-q4-eps-0-031-up-from-0-034-yoy-sales-37-274m-up-from-29-770m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"OTH":0.9},"rights":null},{"id":545706,"article_id":"2623329830","title":"Arko Petroleum Q4 EPS $0.23 Beats $0.13 Estimate, Sales $1.306B Beat $1.273B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901393000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552807/arko-petroleum-q4-eps-0-23-beats-0-13-estimate-sales-1-306b-beat-1-273b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"APC":1},"rights":null},{"id":545702,"article_id":"2623329831","title":"Kenon Hldgs Q4 EPS $0.50, Sales $227.929M","subtitle":"","subtitle_show":0,"pub_time":1774901353000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552797/kenon-hldgs-q4-eps-0-50-sales-227-929m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KEN":1.5},"rights":null},{"id":545703,"article_id":"2623232983","title":"Progress Software Q1 Adj. EPS $1.60 Beats $1.57 Estimate, Sales $247.799M Beat $246.401M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901339000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552787/progress-software-q1-adj-eps-1-60-beats-1-57-estimate-sales-247-799m-beat-246-401m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PRGS":1.5},"rights":null},{"id":545704,"article_id":"2623832985","title":"Virgin Galactic Hldgs Q4 EPS $(0.98) Beats $(1.05) Estimate, Sales $312.000K Miss $495.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901305000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552751/virgin-galactic-hldgs-q4-eps-0-98-beats-1-05-estimate-sales-312-000k-miss-495-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SPCE":1.5},"rights":null},{"id":545695,"article_id":"2623326011","title":"HireQuest Q4 Adj. EPS $0.19 Beats $0.13 Estimate, Sales $7.032M Miss $7.412M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901239000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552721/hirequest-q4-adj-eps-0-19-beats-0-13-estimate-sales-7-032m-miss-7-412m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HQI":1},"rights":null},{"id":545700,"article_id":"2623832604","title":"Spruce Power Holding Q4 EPS $(0.38) Down From $(0.29) YoY, Sales $24.028M Up From $20.226M YoY","subtitle":"","subtitle_show":0,"pub_time":1774901211000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552707/spruce-power-holding-q4-eps-0-38-down-from-0-29-yoy-sales-24-028m-up-from-20-226m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PW":1.5},"rights":null},{"id":545699,"article_id":"2623041326","title":"Helius Medical Tech Q4 EPS $4.25, Sales $5.228M","subtitle":"","subtitle_show":0,"pub_time":1774901191000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552686/helius-medical-tech-q4-eps-4-25-sales-5-228m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HSDT":0.9},"rights":null},{"id":545697,"article_id":"2623326010","title":"Intellinetics Q4 EPS $(0.05) Beats $(0.10) Estimate, Sales $4.324M Miss $4.460M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901189000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552685/intellinetics-q4-eps-0-05-beats-0-10-estimate-sales-4-324m-miss-4-460m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"INLX":1},"rights":null},{"id":545696,"article_id":"2623014326","title":"ZSPACE Q4 Sales $4.800M Miss $6.198M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901173000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552664/zspace-q4-sales-4-800m-miss-6-198m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ZSPC":1},"rights":null},{"id":545698,"article_id":"2623326045","title":"Annexon Q4 EPS $(0.28) Beats $(0.32) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901169000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552662/annexon-q4-eps-0-28-beats-0-32-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ANNX":1.5},"rights":null},{"id":545693,"article_id":"2623532671","title":"Phreesia Q4 EPS $0.02 Misses $0.07 Estimate, Sales $127.067M Beat $126.617M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774901048000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552534/phreesia-q4-eps-0-02-misses-0-07-estimate-sales-127-067m-beat-126-617m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PHR":1},"rights":null},{"id":545675,"article_id":"2623326249","title":"INmune Bio Q4 EPS $(0.18) Beats $(0.24) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774900975000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552447/inmune-bio-q4-eps-0-18-beats-0-24-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"INMB":1},"rights":null},{"id":545674,"article_id":"2623243326","title":"Electro-Sensors Q4 EPS $0.03 Down From $0.06 YoY, Sales $2.755M Up From $2.400M YoY","subtitle":"","subtitle_show":0,"pub_time":1774900973000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552443/electro-sensors-q4-eps-0-03-down-from-0-06-yoy-sales-2-755m-up-from-2-400m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ELSE":1.5},"rights":null},{"id":545671,"article_id":"2623032621","title":"Sangamo Therapeutics Q4 EPS $(0.11) Misses $(0.06) Estimate, Sales $14.200M Miss $16.475M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774900968000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552440/sangamo-therapeutics-q4-eps-0-11-misses-0-06-estimate-sales-14-200m-miss-16-475m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":545669,"article_id":"2623326449","title":"CVD Equipment Q4 EPS $(0.18) Down From $0.02 YoY, Sales $4.950M Down From $7.414M YoY","subtitle":"","subtitle_show":0,"pub_time":1774900876000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51552353/cvd-equipment-q4-eps-0-18-down-from-0-02-yoy-sales-4-950m-down-from-7-414m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CVV":1.5},"rights":null},{"id":545636,"article_id":"2623325487","title":"Why This Top Analyst Expects Carnival Stock To Explode 86%","subtitle":"","subtitle_show":0,"pub_time":1774898431000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/03/51550914/why-this-top-analyst-expects-carnival-stock-to-explode-86","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CCL":1.5,"CUK":0.9},"rights":null},{"id":545635,"article_id":"2623325196","title":"USA Rare Earth Shares Dip After Disappointing Q4 EPS","subtitle":"","subtitle_show":0,"pub_time":1774898140000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51550769/usa-rare-earth-shares-dip-after-disappointing-q4-eps","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"USAR":1.98,"USAX":0.6,"USGG":0.6},"rights":null},{"id":545542,"article_id":"2623355328","title":"Why Are Sigma Lithium Shares Trading Higher On Monday?","subtitle":"","subtitle_show":0,"pub_time":1774891717000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51547561/why-are-sigma-lithium-shares-trading-higher-on-monday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LIT":1.5,"SGML":1},"rights":null},{"id":545481,"article_id":"2623342561","title":"Why Is Rezolve AI Stock Gaining Monday?","subtitle":"","subtitle_show":0,"pub_time":1774885885000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51544099/why-is-rezolve-ai-stock-gaining-monday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AGIX":1.5,"AI":0.69,"AIPO":1.5,"AIYY":0.6,"CHAT":1.5,"RZLV":1.5},"rights":null},{"id":545337,"article_id":"2623349622","title":"Fermi Q4 EPS $(0.18) Misses $(0.02) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774881026000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51540583/fermi-q4-eps-0-18-misses-0-02-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FRMI":1.5},"rights":null},{"id":545250,"article_id":"2623345770","title":"Soluna Holdings Q4 EPS $(0.21) Beats $(0.85) Estimate, Sales $9.207M Miss $10.400M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774878933000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51538865/soluna-holdings-q4-eps-0-21-beats-0-85-estimate-sales-9-207m-miss-10-400m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SLNH":1},"rights":null},{"id":545208,"article_id":"2623451533","title":"Veradermics Q4 EPS $(0.62) Beats $(0.66) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774878312000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51538413/veradermics-q4-eps-0-62-beats-0-66-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MANE":1.5},"rights":null},{"id":545173,"article_id":"2623683345","title":"PDS Biotechnology Q4 EPS $(0.14) Beats $(0.20) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774878063000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51538363/pds-biotechnology-q4-eps-0-14-beats-0-20-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PDS":1.5},"rights":null},{"id":545148,"article_id":"2623343051","title":"Pulsenmore FY EPS $(0.77), Sales $12.547M","subtitle":"","subtitle_show":0,"pub_time":1774877531000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51538226/pulsenmore-fy-eps-0-77-sales-12-547m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PLSM":1.5},"rights":null},{"id":545141,"article_id":"2623334329","title":"Vor Biopharma Q4 Adj. EPS $(1.63) Beats $(1.64) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774877394000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51538095/vor-biopharma-q4-adj-eps-1-63-beats-1-64-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VOR":1},"rights":null},{"id":545132,"article_id":"2623343671","title":"Knightscope Q4 EPS $(0.92) Misses $(0.78) Estimate, Sales $2.538M Miss $2.873M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774876856000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51537892/knightscope-q4-eps-0-92-misses-0-78-estimate-sales-2-538m-miss-2-873m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KSCP":1},"rights":null},{"id":545103,"article_id":"2623634820","title":"Tempest Therapeutics Q4 EPS $(0.62) Beats $(3.52) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774875996000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51537545/tempest-therapeutics-q4-eps-0-62-beats-3-52-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":545044,"article_id":"2623107603","title":"MediPharm Labs Q4 EPS $(0.02) Down From $(0.01) YoY, Sales $11.062M Miss $11.823M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774874708000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51536861/medipharm-labs-q4-eps-0-02-down-from-0-01-yoy-sales-11-062m-miss-11-823m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":545028,"article_id":"2623531091","title":"Pulsenmore FY 2025 Sales $12.547M, Up 374% YoY, Net Loss Of $5M Vs. $10M YoY","subtitle":"","subtitle_show":0,"pub_time":1774874165000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51536703/pulsenmore-fy-2025-sales-12-547m-up-374-yoy-net-loss-of-5m-vs-10m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PLSM":1.5},"rights":null},{"id":545014,"article_id":"2623310888","title":"AMD Stock Gains Momentum As UBS Eyes 54% Upside On AI Megadeals","subtitle":"","subtitle_show":0,"pub_time":1774873665000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51536372/amd-stock-gains-momentum-as-ubs-eyes-54-upside-on-ai-megadeals","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AMD":1.98,"AMDD":0.6,"AMDG":0.6,"AMDL":0.6,"AMDU":0.6,"AMDW":0.6,"AMDY":0.6,"AMUU":0.6,"AMYY":0.6,"DAMD":0.6,"MSFD":0.6,"MSFL":0.6,"MSFO":0.6,"MSFU":0.6,"MSFW":0.6,"MSFX":0.6,"MSFY":0.6,"UBS":0.62},"rights":null},{"id":545000,"article_id":"2623317422","title":"Nano Labs FY EPS $0.82 Up From $(0.84) YoY, Sales $3.821M Up From $2.206M YoY","subtitle":"","subtitle_show":0,"pub_time":1774873192000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51536244/nano-labs-fy-eps-0-82-up-from-0-84-yoy-sales-3-821m-up-from-2-206m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NA":1.5},"rights":null},{"id":544994,"article_id":"2623317104","title":"Top Wall Street Forecasters Revamp Phreesia Expectations Ahead Of Q4 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774873026000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51536193/top-wall-street-forecasters-revamp-phreesia-expectations-ahead-of-q4-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PHR":1},"rights":null},{"id":544972,"article_id":"2623317609","title":"How To Earn $500 A Month From TD Synnex Stock Ahead Of Q1 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774872681000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/dividends/26/03/51536011/how-to-earn-500-a-month-from-td-synnex-stock-ahead-of-q1-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SNX":1.5,"TD":1.5},"rights":null},{"id":544965,"article_id":"2623317570","title":"Rezolve AI FY EPS $(0.38) Misses $0.03 Estimate, Sales $46.800M Beat $26.841M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774872541000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51535926/rezolve-ai-fy-eps-0-38-misses-0-03-estimate-sales-46-800m-beat-26-841m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AGIX":1.5,"AIPO":1.5,"CHAT":1.5,"RZLV":1.5},"rights":null},{"id":544956,"article_id":"2623317531","title":"MediPharm Labs Q4 EPS $(0.01), Same YoY, Sales $7.934M Down From $9.151M YoY","subtitle":"","subtitle_show":0,"pub_time":1774872415000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51535873/medipharm-labs-q4-eps-0-01-same-yoy-sales-7-934m-down-from-9-151m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MEDIF":0.9},"rights":null},{"id":544955,"article_id":"2623312099","title":"Nike, Virgin Galactic, Bitfarms and More Stocks With Earnings This Week","subtitle":"","subtitle_show":0,"pub_time":1774872194000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51535737/nike-virgin-galactic-bitfarms-and-more-stocks-with-earnings-this-week","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BITF":1.94,"BTBT":1.9,"BTFL":0.6,"BYND":1.9,"CAG":1.9,"CALM":1.9,"FDS":1.9,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"GRRR":1.91,"IYW":0.6,"JEPQ":0.6,"KITT":1.9,"KULR":1.9,"LAES":1.9,"MKC":1.9,"NG":1.9,"NKE":1.96,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"RH":1.9,"RZLV":1.92,"SPCE":1.95,"SQQQ":0.6,"TE":1.9,"TLRY":1.91,"TQQQ":0.6},"rights":null},{"id":544935,"article_id":"2623312093","title":"PAVmed Q4 2025 Adj. EPS $(1.05) Beats $(4.62) Estimate, Sales $52.000K Beat $25.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774872171000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51535717/pavmed-q4-2025-adj-eps-1-05-beats-4-62-estimate-sales-52-000k-beat-25-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PAVM":1.5},"rights":null},{"id":544922,"article_id":"2623121653","title":"Reviva Pharmaceuticals Q4 EPS $(0.57) Misses $(0.10) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774871832000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51535379/reviva-pharmaceuticals-q4-eps-0-57-misses-0-10-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RVPH":1},"rights":null},{"id":544904,"article_id":"2623312951","title":"Unicycive Therapeutics Q4 EPS $(0.82) Misses $0.03 Estimate","subtitle":"","subtitle_show":0,"pub_time":1774871623000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51535325/unicycive-therapeutics-q4-eps-0-82-misses-0-03-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"UNCY":1.5},"rights":null},{"id":544902,"article_id":"2623985312","title":"Sensei Biotherapeutics Q4 EPS $(3.74) Beats $(4.11) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774871445000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51535280/sensei-biotherapeutics-q4-eps-3-74-beats-4-11-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SNSE":1.5},"rights":null},{"id":544895,"article_id":"2623594312","title":"EXCLUSIVE: Penny Stock Scienture Reports Revenue Surge, Expanding Market Access In 2025","subtitle":"","subtitle_show":0,"pub_time":1774871167000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51535239/exclusive-penny-stock-scienture-reports-revenue-surge-expanding-market-access-in-2025","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SCNX":1},"rights":null},{"id":544894,"article_id":"2623312374","title":"Scienture FY25 Revenue $431.6K Vs $136.6K YoY; Net Loss Per Common Share $(2.70) Vs $(5.41) YoY","subtitle":"","subtitle_show":0,"pub_time":1774871116000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51535218/scienture-fy25-revenue-431-6k-vs-136-6k-yoy-net-loss-per-common-share-2-70-vs-5-41-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SCNX":0.9},"rights":null},{"id":544865,"article_id":"2623314774","title":"Soluna Holdings Q4 Sales $9.200M Miss $10.400M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774870797000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51535147/soluna-holdings-q4-sales-9-200m-miss-10-400m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SLNH":0.9},"rights":null},{"id":544835,"article_id":"2623231443","title":"Bicara Therapeutics Q4 EPS $(0.68), Inline","subtitle":"","subtitle_show":0,"pub_time":1774870397000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51535064/bicara-therapeutics-q4-eps-0-68-inline","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BCAX":1.5},"rights":null},{"id":544831,"article_id":"2623149173","title":"Terrestrial Energy FY EPS $(0.39) Beats $(0.42) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774870112000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51534844/terrestrial-energy-fy-eps-0-39-beats-0-42-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IMSR":1.5},"rights":null},{"id":544808,"article_id":"2623314373","title":"Neumora Therapeutics Q4 EPS $(0.35) Misses $(0.33) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774869716000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51534728/neumora-therapeutics-q4-eps-0-35-misses-0-33-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NMRA":1.5},"rights":null},{"id":544804,"article_id":"2623311094","title":"Aura Biosciences Q4 EPS $(0.37) Beats $(0.45) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774869453000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51534614/aura-biosciences-q4-eps-0-37-beats-0-45-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AURA":1.5},"rights":null},{"id":544769,"article_id":"2623831146","title":"PDS Biotechnology Corp Reported FY25 EPS Loss Of $0.74/Share, Cash Balance Of $26.7M","subtitle":"","subtitle_show":0,"pub_time":1774868933000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51534346/pds-biotechnology-corp-reported-fy25-eps-loss-of-0-74share-cash-balance-of-26-7m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PDS":1.5},"rights":null},{"id":544714,"article_id":"2623197923","title":"Americas Gold And Silver Q4 EPS $(0.14) Down From $(0.09) YoY, Sales $36.864M Up From $23.797M YoY","subtitle":"","subtitle_show":0,"pub_time":1774867921000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51533861/americas-gold-and-silver-q4-eps-0-14-down-from-0-09-yoy-sales-36-864m-up-from-23-797m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":544708,"article_id":"2623331973","title":"Americas Gold And Silver Q4 EPS $(0.14) Misses $0.04 Estimate, Sales $37.064M Beat $33.229M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774867879000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51533849/americas-gold-and-silver-q4-eps-0-14-misses-0-04-estimate-sales-37-064m-beat-33-229m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"USAS":1},"rights":null},{"id":544589,"article_id":"2623315759","title":"CBAK Energy Tech Q4 EPS $(0.08) Misses $(0.03) Estimate, Sales $58.803M Miss $64.572M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774864968000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51532681/cbak-energy-tech-q4-eps-0-08-misses-0-03-estimate-sales-58-803m-miss-64-572m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CBAT":1},"rights":null},{"id":544418,"article_id":"2623390731","title":"Top Wall Street Forecasters Revamp DiaMedica Therapeutics Expectations Ahead Of Q4 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774860982000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51532022/top-wall-street-forecasters-revamp-diamedica-therapeutics-expectations-ahead-of-q4-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":544195,"article_id":"2623650394","title":"Phreesia, Progress Software And 3 Stocks To Watch Heading Into Monday","subtitle":"","subtitle_show":0,"pub_time":1774855759000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51531440/phreesia-progress-software-and-3-stocks-to-watch-monday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"APC":1,"ENTX":1,"PHR":1,"PRGS":1.5,"USAS":0.9},"rights":null},{"id":542964,"article_id":"2622380545","title":"Enveric Biosciences Q4 EPS $(0.50) Up From $(57.96) YoY","subtitle":"","subtitle_show":0,"pub_time":1774648340000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51525640/enveric-biosciences-q4-eps-0-50-up-from-57-96-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ENVB":1.5},"rights":null},{"id":542963,"article_id":"2622051178","title":"Presidio Property Trust Q4 FFO $(0.87), Sales $4.115M","subtitle":"","subtitle_show":0,"pub_time":1774648114000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51525578/presidio-property-trust-q4-ffo-0-87-sales-4-115m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.9,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SQFT":1,"SQQQ":0.6,"TQQQ":0.6},"rights":null},{"id":542958,"article_id":"2622055038","title":"Electra Battery Materials Q4 EPS $(1.05) Down From $(0.44) YoY","subtitle":"","subtitle_show":0,"pub_time":1774647213000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51525476/electra-battery-materials-q4-eps-1-05-down-from-0-44-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.66,"ELBM":1,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SQQQ":0.6,"TQQQ":0.6},"rights":null},{"id":542954,"article_id":"2622803080","title":"Magellan Aerospace Q4 EPS $0.19 Misses $0.28 Estimate, Sales $278.325M Beat $269.309M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774646398000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51525237/magellan-aerospace-q4-eps-0-19-misses-0-28-estimate-sales-278-325m-beat-269-309m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":542952,"article_id":"2622803205","title":"Retractable Technologies Q4 EPS $(0.08) Down From $0.13 YoY, Sales $9.440M Up From $9.074M YoY","subtitle":"","subtitle_show":0,"pub_time":1774645973000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51525114/retractable-technologies-q4-eps-0-08-down-from-0-13-yoy-sales-9-440m-up-from-9-074m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RVP":1.5},"rights":null},{"id":542935,"article_id":"2622803814","title":"Lifeloc Technologies Q4 EPS $(0.55) Down From $(0.11) YoY, Sales $2.273M Up From $1.910M YoY","subtitle":"","subtitle_show":0,"pub_time":1774644253000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51524589/lifeloc-technologies-q4-eps-0-55-down-from-0-11-yoy-sales-2-273m-up-from-1-910m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LCTC":0.9},"rights":null},{"id":542934,"article_id":"2622180381","title":"Origin Mat Q4 Adj. EPS $(3.04) Down From $(2.70) YoY, Sales $3.022M Down From $9.222M YoY","subtitle":"","subtitle_show":0,"pub_time":1774644253000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51524590/origin-mat-q4-adj-eps-3-04-down-from-2-70-yoy-sales-3-022m-down-from-9-222m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ORGN":1},"rights":null},{"id":542910,"article_id":"2622808575","title":"Verde Clean Fuels Q4 EPS $(0.17) Down From $(0.14) YoY","subtitle":"","subtitle_show":0,"pub_time":1774642832000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51523925/verde-clean-fuels-q4-eps-0-17-down-from-0-14-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VGAS":1.5},"rights":null},{"id":542904,"article_id":"2622808895","title":"Presurance Holdings, Inc. - Common Stock Q4 Adj. EPS $(1.24) Up From $(2.11) YoY, Sales $5.687M Down From $12.708M YoY","subtitle":"","subtitle_show":0,"pub_time":1774642404000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51523674/presurance-holdings-inc-common-stock-q4-adj-eps-1-24-up-from-2-11-yoy-sales-5-687m-down-from-12-708","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PRHI":1.5},"rights":null},{"id":542903,"article_id":"2622830808","title":"Entera Bio Q4 EPS $(0.06) Beats $(0.09) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774642248000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51523572/entera-bio-q4-eps-0-06-beats-0-09-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.62,"ENTX":1,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SQQQ":0.6,"TQQQ":0.6},"rights":null},{"id":542822,"article_id":"2622872852","title":"Commercial Metals Analysts Slash Their Forecasts After Q2 Results","subtitle":"","subtitle_show":0,"pub_time":1774634206000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51519132/commercial-metals-analysts-slash-their-forecasts-after-q2-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CMC":1.5},"rights":null},{"id":542819,"article_id":"2622719874","title":"These Analysts Cut Their Forecasts On WhiteFiber Following Q4 Loss","subtitle":"","subtitle_show":0,"pub_time":1774633610000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51518655/these-analysts-cut-their-forecasts-on-whitefiber-following-q4-loss","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WYFI":1.5},"rights":null},{"id":542795,"article_id":"2622871481","title":"Monopar Therapeutics Q4 EPS $(0.61) Misses $(0.54) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774631173000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51517102/monopar-therapeutics-q4-eps-0-61-misses-0-54-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MNPR":1.5},"rights":null},{"id":542703,"article_id":"2622875562","title":"Rezolve AI Gears Up For FY Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts","subtitle":"","subtitle_show":0,"pub_time":1774624894000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51512897/rezolve-ai-gears-up-for-fy-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AGIX":1.5,"AIPO":1.5,"CHAT":1.5,"RZLV":1.5},"rights":null},{"id":542668,"article_id":"2622873313","title":"Argan Stock Surges After Surprising Q4 Results","subtitle":"","subtitle_show":0,"pub_time":1774623210000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51511507/argan-stock-surges-after-surprising-q4-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AGX":1.5},"rights":null},{"id":542424,"article_id":"2622240518","title":"Carnival Q1 Adj. EPS $0.20, Inline, Sales $6.165B Miss $6.179B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774617377000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51506599/carnival-q1-adj-eps-0-20-inline-sales-6-165b-miss-6-179b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CCL":1.5},"rights":null},{"id":542405,"article_id":"2622382497","title":"United-Guardian Q4 EPS $0.14 Up From $0.11 YoY, Sales $2.962M Up From $2.477M YoY","subtitle":"","subtitle_show":0,"pub_time":1774616739000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51506270/united-guardian-q4-eps-0-14-up-from-0-11-yoy-sales-2-962m-up-from-2-477m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"UG":1.5},"rights":null},{"id":542372,"article_id":"2622821524","title":"enVVeno Medical Q4 EPS $(6.05) Misses $(0.30) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774615435000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51505609/envveno-medical-q4-eps-6-05-misses-0-30-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NVNO":1},"rights":null},{"id":542349,"article_id":"2622829107","title":"Adagio Medical Holdings Q4 EPS $(0.21) Beats $(0.31) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774614342000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51505277/adagio-medical-holdings-q4-eps-0-21-beats-0-31-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ADGM":1},"rights":null},{"id":542347,"article_id":"2622485829","title":"BTCS Q4 EPS $0.48 Beats $0.16 Estimate, Sales $7.088M Beat $4.500M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774614242000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51505262/btcs-q4-eps-0-48-beats-0-16-estimate-sales-7-088m-beat-4-500m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BTCS":1.99},"rights":null},{"id":542343,"article_id":"2622295498","title":"Senti Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate, Sales $22.000K Miss $666.667K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774613967000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51505086/senti-biosciences-q4-eps-0-53-misses-0-48-estimate-sales-22-000k-miss-666-667k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SNTI":1},"rights":null},{"id":542340,"article_id":"2622829599","title":"TMC Metals Q4 2025 EPS $(0.08) Misses $(0.06) Estimate, Cash Of Approximately $117.6M","subtitle":"","subtitle_show":0,"pub_time":1774613761000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51505035/tmc-metals-q4-2025-eps-0-08-misses-0-06-estimate-cash-of-approximately-117-6m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TMC":1.5},"rights":null},{"id":542321,"article_id":"2622782826","title":"PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M","subtitle":"","subtitle_show":0,"pub_time":1774613123000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51504675/prf-technologies-in-fy25-had-4-1m-in-cash-cash-equivalents-short-term-deposits-and-restricted-cash-","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IXJ":0.9,"PRF":1.5,"PRFX":0.9,"VHT":0.9},"rights":null},{"id":542311,"article_id":"2622440826","title":"LM Funding America Q4 EPS $(1.33) Up From $(0.86) YoY","subtitle":"","subtitle_show":0,"pub_time":1774613031000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51504631/lm-funding-america-q4-eps-1-33-up-from-0-86-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LMFA":1.5},"rights":null},{"id":542267,"article_id":"2622272825","title":"How To Earn $500 A Month From FactSet Research Stock Ahead Of Q2 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774611801000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/dividends/26/03/51504166/how-to-earn-500-a-month-from-factset-research-stock-ahead-of-q2-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FDS":1.5},"rights":null},{"id":542260,"article_id":"2622254858","title":"51 Talk Online Education Q4 Adj. EPS $(1.03) Down From $(0.20) YoY, Sales $30.622M Up From $16.236M YoY","subtitle":"","subtitle_show":0,"pub_time":1774611534000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51504139/51-talk-online-education-q4-adj-eps-1-03-down-from-0-20-yoy-sales-30-622m-up-from-16-236m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":542253,"article_id":"2622906825","title":"LM Funding America Q4 Sales $2.366M Miss $2.800M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774611260000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51504057/lm-funding-america-q4-sales-2-366m-miss-2-800m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LMFA":1.5},"rights":null},{"id":542183,"article_id":"2622823296","title":"Kopin Q4 Sales $8.400M Miss $10.947M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774610140000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51503705/kopin-q4-sales-8-400m-miss-10-947m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KOPN":1.5},"rights":null},{"id":542175,"article_id":"2622823937","title":"Instil Bio Q4 Adj. EPS $(0.97) Beats $(2.03) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774609702000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51503611/instil-bio-q4-adj-eps-0-97-beats-2-03-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TIL":1.5},"rights":null},{"id":542158,"article_id":"2622823588","title":"Legence Q4 EPS $(0.55) Misses $0.02 Estimate, Sales $737.642M Beat $620.307M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774609390000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51503514/legence-q4-eps-0-55-misses-0-02-estimate-sales-737-642m-beat-620-307m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LGN":1.5},"rights":null},{"id":542157,"article_id":"2622782330","title":"Werewolf Therapeutics Q4 EPS $(0.20) Beats $(0.35) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774609356000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51503502/werewolf-therapeutics-q4-eps-0-20-beats-0-35-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HOWL":1.5},"rights":null},{"id":542156,"article_id":"2622823878","title":"Humacyte Q4 EPS $(0.13), Inline, Sales $467.000K Miss $1.343M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774609316000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51503477/humacyte-q4-eps-0-13-inline-sales-467-000k-miss-1-343m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HUMA":0.9},"rights":null},{"id":542037,"article_id":"2622847212","title":"Yunji FY Adj. EPS $(3.86), Sales $45.333M","subtitle":"","subtitle_show":0,"pub_time":1774606032000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51502499/yunji-fy-adj-eps-3-86-sales-45-333m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"YJ":1.5},"rights":null},{"id":542015,"article_id":"2622847306","title":"Carnival, Unity Software And 3 Stocks To Watch Heading Into Friday","subtitle":"","subtitle_show":0,"pub_time":1774605494000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51502232/carnival-unity-software-and-3-stocks-to-watch-heading-into-friday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AGX":1,"CCL":1.5,"LGN":1,"SBC":1,"U":1.5,"UNX":0.6,"URA3":1},"rights":null},{"id":541885,"article_id":"2622388844","title":"Huize Holding FY Adj. EPS $0.06, Sales $226.257M","subtitle":"","subtitle_show":0,"pub_time":1774602757000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51501862/huize-holding-fy-adj-eps-0-06-sales-226-257m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.9,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"HUIZ":1,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SQQQ":0.6,"TQQQ":0.6},"rights":null},{"id":540859,"article_id":"2622437894","title":"Global Atomic Q4 EPS $(0.02) Down From $0.04 YoY, Sales $200.973K Down From $281.020K YoY","subtitle":"","subtitle_show":0,"pub_time":1774562611000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498538/global-atomic-q4-eps-0-02-down-from-0-04-yoy-sales-200-973k-down-from-281-020k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":540857,"article_id":"2622189418","title":"Quantum BioPharma Q4 EPS $(0.71) Beats $(0.93) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774562337000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498487/quantum-biopharma-q4-eps-0-71-beats-0-93-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"QNTM":1},"rights":null},{"id":540855,"article_id":"2622889494","title":"Rein Therapeutics Q4 Adj. EPS $(0.11) Beats $(0.24) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774562129000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498474/rein-therapeutics-q4-adj-eps-0-11-beats-0-24-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":540849,"article_id":"2622697894","title":"BioRestorative Therapies Q4 EPS $(0.32) Misses $(0.30) Estimate, Sales $19.600K Miss $520.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774561750000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498441/biorestorative-therapies-q4-eps-0-32-misses-0-30-estimate-sales-19-600k-miss-520-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BRTX":1},"rights":null},{"id":540848,"article_id":"2622946948","title":"DBV Technologies Q4 EPS $(0.23) Beats $(0.63) Estimate, Sales $645.000K Miss $655.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774561712000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498429/dbv-technologies-q4-eps-0-23-beats-0-63-estimate-sales-645-000k-miss-655-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DBV":1.5},"rights":null},{"id":540842,"article_id":"2622894654","title":"Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774561636000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498361/microbot-medical-q4-eps-0-04-beats-0-06-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MBOT":1},"rights":null},{"id":540838,"article_id":"2622894658","title":"Linkhome Holdings Q4 EPS $(0.01), Sales $5.078M","subtitle":"","subtitle_show":0,"pub_time":1774561511000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498325/linkhome-holdings-q4-eps-0-01-sales-5-078m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LHAI":1.5},"rights":null},{"id":540834,"article_id":"2622894584","title":"Western Copper & Gold Q4 EPS $(0.01), Inline","subtitle":"","subtitle_show":0,"pub_time":1774561285000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498239/western-copper-gold-q4-eps-0-01-inline","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"COPX":1.5,"WRN":1.5},"rights":null},{"id":540825,"article_id":"2622289486","title":"Inspira Technologies Oxy FY EPS $(0.45) Misses $(0.44) Estimate, Sales $289.000K Miss $19.493M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774560762000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498114/inspira-technologies-oxy-fy-eps-0-45-misses-0-44-estimate-sales-289-000k-miss-19-493m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IINN":1},"rights":null},{"id":540824,"article_id":"2622089483","title":"Southland Holdings Q4 Adj. EPS $(4.00) Misses $(0.18) Estimate, Sales $103.957M Miss $212.121M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774560602000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51498069/southland-holdings-q4-adj-eps-4-00-misses-0-18-estimate-sales-103-957m-miss-212-121m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SLND":1.5},"rights":null},{"id":540814,"article_id":"2622891421","title":"Dermata Therapeutics Q4 EPS $(1.52) Beats $(1.54) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774559921000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51497892/dermata-therapeutics-q4-eps-1-52-beats-1-54-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DRMA":1.5},"rights":null},{"id":540813,"article_id":"2622789146","title":"Lassonde Industries Q4 Adj. EPS $7.52 Beats $5.93 Estimate, Sales $768.100M Beat $757.390M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774559788000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51497760/lassonde-industries-q4-adj-eps-7-52-beats-5-93-estimate-sales-768-100m-beat-757-390m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":540810,"article_id":"2622891437","title":"LeonaBio Q4 EPS $(2.77) Misses $(0.84) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774559715000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51497693/leonabio-q4-eps-2-77-misses-0-84-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LONA":1},"rights":null},{"id":540800,"article_id":"2622089199","title":"Nortech Systems Q4 EPS $0.31 Up From $(0.54) YoY, Sales $30.313M Up From $28.620M YoY","subtitle":"","subtitle_show":0,"pub_time":1774559225000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51497480/nortech-systems-q4-eps-0-31-up-from-0-54-yoy-sales-30-313m-up-from-28-620m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NSYS":1.5},"rights":null},{"id":540778,"article_id":"2622740899","title":"Vivani Medical Q4 EPS $(0.09) Beats $(0.10) Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774558173000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51496998/vivani-medical-q4-eps-0-09-beats-0-10-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VANI":1},"rights":null},{"id":540762,"article_id":"2622294899","title":"AmpliTech Gr Q4 EPS $(0.14) Misses $(0.09) Estimate, Sales $4.477M Miss $5.000M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774557824000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51496721/amplitech-gr-q4-eps-0-14-misses-0-09-estimate-sales-4-477m-miss-5-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AMPG":1},"rights":null},{"id":540760,"article_id":"2622994408","title":"SANUWAVE Health Q4 EPS $0.03 Misses $0.14 Estimate, Sales $13.094M Miss $13.250M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774557610000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51496553/sanuwave-health-q4-eps-0-03-misses-0-14-estimate-sales-13-094m-miss-13-250m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SNWV":0.9},"rights":null},{"id":540759,"article_id":"2622899147","title":"Zentalis Pharma Q4 EPS $(0.49) Misses $(0.44) Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774557564000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51496486/zentalis-pharma-q4-eps-0-49-misses-0-44-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ZNTL":1},"rights":null},{"id":540740,"article_id":"2622089952","title":"LB Pharmaceuticals Q4 EPS $(0.45) Beats $(0.63) Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774557043000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51496123/lb-pharmaceuticals-q4-eps-0-45-beats-0-63-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LB":1.5,"LBRX":1.5},"rights":null},{"id":540720,"article_id":"2622896078","title":"SpyGlass Pharma Q4 EPS $(5.72) Down From $(4.58) YoY","subtitle":"","subtitle_show":0,"pub_time":1774556467000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495858/spyglass-pharma-q4-eps-5-72-down-from-4-58-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SGP":1.5},"rights":null},{"id":540717,"article_id":"2622896039","title":"Wrap Technologies Q4 Sales $1.400M Up From $865.000K YoY","subtitle":"","subtitle_show":0,"pub_time":1774556321000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495782/wrap-technologies-q4-sales-1-400m-up-from-865-000k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WRAP":0.9},"rights":null},{"id":540715,"article_id":"2622960348","title":"BitGo Holdings Q4 EPS $(1.03) Beats $(1.29) Estimate, Sales $6.157M Miss $59.189M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774556270000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495710/bitgo-holdings-q4-eps-1-03-beats-1-29-estimate-sales-6-157m-miss-59-189m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BTGO":1.5},"rights":null},{"id":540712,"article_id":"2622896734","title":"Iridex Q4 EPS $(0.01) Beats $(0.02) Estimate, Sales $14.724M Miss $14.740M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774556152000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495536/iridex-q4-eps-0-01-beats-0-02-estimate-sales-14-724m-miss-14-740m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IRIX":1},"rights":null},{"id":540713,"article_id":"2622730896","title":"Newsmax Q4 EPS $0.04 Beats $(0.09) Estimate, Sales $52.240M Beat $43.993M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774556075000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495447/newsmax-q4-eps-0-04-beats-0-09-estimate-sales-52-240m-beat-43-993m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NMAX":1.5},"rights":null},{"id":540710,"article_id":"2622896210","title":"CapsoVision Q4 EPS $0.02 Beats $(0.14) Estimate, Sales $3.918M Miss $4.151M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774556019000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495415/capsovision-q4-eps-0-02-beats-0-14-estimate-sales-3-918m-miss-4-151m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CV":1.5},"rights":null},{"id":540708,"article_id":"2622256896","title":"Xos Q4 EPS $(0.86) Misses $(0.60) Estimate, Sales $5.220M Miss $11.500M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774555859000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495252/xos-q4-eps-0-86-misses-0-60-estimate-sales-5-220m-miss-11-500m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"XOS":1},"rights":null},{"id":540707,"article_id":"2622896255","title":"VirTra Q4 EPS $(0.09) Misses $0.02 Estimate, Sales $2.900M Miss $5.373M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774555830000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495214/virtra-q4-eps-0-09-misses-0-02-estimate-sales-2-900m-miss-5-373m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VTSI":1},"rights":null},{"id":540709,"article_id":"2622989625","title":"Insight Molecular Q4 Adj. EPS $(0.27) Misses $(0.24) Estimate, Sales $1.139M Down From $1.486M Last Year","subtitle":"","subtitle_show":0,"pub_time":1774555805000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495180/insight-molecular-q4-adj-eps-0-27-misses-0-24-estimate-sales-1-139m-down-from-1-486m-last-year","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IMDX":1},"rights":null},{"id":540704,"article_id":"2622896464","title":"Vroom Q4 EPS $(2.22) Up From $(20.07) YoY, Sales $38.902M Down From $42.460M YoY","subtitle":"","subtitle_show":0,"pub_time":1774555733000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495084/vroom-q4-eps-2-22-up-from-20-07-yoy-sales-38-902m-down-from-42-460m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VRM":1.5},"rights":null},{"id":540706,"article_id":"2622896414","title":"Worksport Q4 EPS $(0.72) Misses $(0.54) Estimate, Sales $4.743M Miss $4.822M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774555709000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51495027/worksport-q4-eps-0-72-misses-0-54-estimate-sales-4-743m-miss-4-822m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WKSP":1},"rights":null},{"id":540700,"article_id":"2622896113","title":"Alpha Cognition Q4 EPS $(0.30) Misses $(0.27) Estimate, Sales $2.793M Miss $3.197M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774555646000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51494959/alpha-cognition-q4-eps-0-30-misses-0-27-estimate-sales-2-793m-miss-3-197m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ACOG":1},"rights":null},{"id":540701,"article_id":"2622961148","title":"Spero Therapeutics Q4 EPS $0.53 Beats $(0.40) Estimate, Sales $41.297M Up From $15.044M YoY","subtitle":"","subtitle_show":0,"pub_time":1774555616000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51494928/spero-therapeutics-q4-eps-0-53-beats-0-40-estimate-sales-41-297m-up-from-15-044m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":540702,"article_id":"2622115896","title":"Innovate Q4 EPS $(0.58) Up From $(1.29) YoY, Sales $382.700M Up From $236.600M YoY","subtitle":"","subtitle_show":0,"pub_time":1774555580000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51494870/innovate-q4-eps-0-58-up-from-1-29-yoy-sales-382-700m-up-from-236-600m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VATE":1},"rights":null},{"id":540695,"article_id":"2622896949","title":"Dare Bioscience Q4 EPS $(0.02) Beats $(0.43) Estimate, Sales $1.024M Beat $375.750K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774555535000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51494828/dare-bioscience-q4-eps-0-02-beats-0-43-estimate-sales-1-024m-beat-375-750k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DARE":1.5},"rights":null},{"id":540697,"article_id":"2622896915","title":"CV Sciences Q4 Sales $3.307M Down From $3.884M YoY.","subtitle":"","subtitle_show":0,"pub_time":1774555495000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51494739/cv-sciences-q4-sales-3-307m-down-from-3-884m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CV":1.5},"rights":null},{"id":540696,"article_id":"2622969848","title":"Inhibikase Therapeutics Q1 EPS $(0.10) Beats $(0.13) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774555488000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51494726/inhibikase-therapeutics-q1-eps-0-10-beats-0-13-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IKT":1.5},"rights":null},{"id":540686,"article_id":"2622966828","title":"Kyverna Therapeutics Q4 EPS $(0.80) Beats $(0.85) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774555409000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51494642/kyverna-therapeutics-q4-eps-0-80-beats-0-85-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KYTX":1.5},"rights":null},{"id":540525,"article_id":"2622867969","title":"Blink Charging Stock Drops Ahead Of Its Q4 Earnings Report","subtitle":"","subtitle_show":0,"pub_time":1774543938000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51489264/blink-charging-stock-drops-ahead-of-its-q4-earnings-report","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BLNK":1.5},"rights":null},{"id":540451,"article_id":"2622118864","title":"This Steady Growth Mid Cap Stock Just Hiked Dividend","subtitle":"","subtitle_show":0,"pub_time":1774539675000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51486745/this-steady-growth-mid-cap-stock-just-hiked-dividend","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CMC":1},"rights":null},{"id":540252,"article_id":"2622904866","title":"JBS Q4 2025 GAAP EPS $0.39, Sales $23.063M Up From $19.974M YoY.","subtitle":"","subtitle_show":0,"pub_time":1774534756000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51483473/jbs-q4-2025-gaap-eps-0-39-sales-23-063m-up-from-19-974m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"JBS":1.5},"rights":null},{"id":540200,"article_id":"2622386522","title":"WhiteFiber Stock Falls After Q4 Earnings Miss And Wider Loss","subtitle":"","subtitle_show":0,"pub_time":1774533517000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51482428/whitefiber-stock-falls-after-q4-earnings-miss-and-wider-loss","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WYFI":1.5},"rights":null},{"id":540104,"article_id":"2622863607","title":"Adcore Q4 EPS $(0.01) Down From $0.01 YoY, Sales $12.104M Up From $11.168M YoY","subtitle":"","subtitle_show":0,"pub_time":1774531535000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51481202/adcore-q4-eps-0-01-down-from-0-01-yoy-sales-12-104m-up-from-11-168m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":540077,"article_id":"2622863887","title":"Why Is Pony AI Stock Falling Thursday?","subtitle":"","subtitle_show":0,"pub_time":1774531155000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51481059/why-is-pony-ai-stock-falling-thursday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"02026":1.98,"03160":0.6,"AI":0.6,"BIDG":0.6,"KBDU":0.6,"LYFX":0.6,"PONY":1.98,"UBEW":0.6,"UBRL":0.6},"rights":null},{"id":540012,"article_id":"2622686418","title":"GigaMedia Q4 EPS $(0.06) Down From $(0.04) YoY, Sales $831.000K Up From $755.000K YoY.","subtitle":"","subtitle_show":0,"pub_time":1774530251000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51480563/gigamedia-q4-eps-0-06-down-from-0-04-yoy-sales-831-000k-up-from-755-000k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GIGM":1.5},"rights":null},{"id":540041,"article_id":"2622868649","title":"Interlink Electronics Q4 EPS $(0.04) Misses $(0.03) Estimate, Sales $2.853M Miss $3.200M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774530218000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51480528/interlink-electronics-q4-eps-0-04-misses-0-03-estimate-sales-2-853m-miss-3-200m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LINK":1},"rights":null},{"id":540005,"article_id":"2622850010","title":"Foresight Autonomous Q4 Adj. EPS $(0.02) Beats $(3.33) Estimate, Sales $61.000K Miss $420.630K Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774529912000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51480216/foresight-autonomous-q4-adj-eps-0-02-beats-3-33-estimate-sales-61-000k-miss-420-630k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"UBER":1.5},"rights":null},{"id":539988,"article_id":"2622502938","title":"Aptevo Therapeutics Q4 EPS $(6.23) Beats $(8.10) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774529740000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51480151/aptevo-therapeutics-q4-eps-6-23-beats-8-10-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"APVO":1.5},"rights":null},{"id":539947,"article_id":"2622085031","title":"Formula Sys (1985) Q4 EPS $0.27 Down From $1.28 YoY, Sales $708.376M Up From $691.499M YoY","subtitle":"","subtitle_show":0,"pub_time":1774528763000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51479628/formula-sys-1985-q4-eps-0-27-down-from-1-28-yoy-sales-708-376m-up-from-691-499m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FORTY":1},"rights":null},{"id":539940,"article_id":"2622850898","title":"MetaVia Q4 EPS $(0.42) Beats $(1.73) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774528623000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51479543/metavia-q4-eps-0-42-beats-1-73-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MTVA":1},"rights":null},{"id":539921,"article_id":"2622857001","title":"CollPlant Biotechnologies Q4 Adj. EPS $(0.25) Misses $(0.19) Estimate, Sales $60.000K Miss $1.524M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774528448000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51479456/collplant-biotechnologies-q4-adj-eps-0-25-misses-0-19-estimate-sales-60-000k-miss-1-524m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CLGN":1},"rights":null},{"id":539908,"article_id":"2622985779","title":"Quoin Pharmaceuticals Q4 EPS $(1.74) Beats $(4.02) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774528331000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51479392/quoin-pharmaceuticals-q4-eps-1-74-beats-4-02-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"QNRX":1.5},"rights":null},{"id":539907,"article_id":"2622574158","title":"MeiraGTx Hldgs Q4 EPS $0.19 Beats $(0.61) Estimate, Sales $75.364M Beat $3.869M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774527993000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51479201/meiragtx-hldgs-q4-eps-0-19-beats-0-61-estimate-sales-75-364m-beat-3-869m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MGTX":1},"rights":null},{"id":539864,"article_id":"2622857195","title":"Acumen Pharmaceuticals Q4 EPS $(0.41) Beats $(0.43) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774527794000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51479120/acumen-pharmaceuticals-q4-eps-0-41-beats-0-43-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ABOS":1.5},"rights":null},{"id":539841,"article_id":"2622852749","title":"Dynacor Group Q4 EPS $0.17 Beats $0.11 Estimate, Sales $137.406M Beat $87.500M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774526744000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51478564/dynacor-group-q4-eps-0-17-beats-0-11-estimate-sales-137-406m-beat-87-500m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":539824,"article_id":"2622852194","title":"Lucid Diagnostics Q4 Adj. EPS $(0.10), Inline, Sales $1.504M Beat $1.379M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774526489000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51478406/lucid-diagnostics-q4-adj-eps-0-10-inline-sales-1-504m-beat-1-379m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LCID":1.5},"rights":null},{"id":539790,"article_id":"2622785280","title":"Auxly Cannabis Group Q4 EPS $0.00, Sales $28.770M Up From $24.758M YoY","subtitle":"","subtitle_show":0,"pub_time":1774525792000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51478123/auxly-cannabis-group-q4-eps-0-00-sales-28-770m-up-from-24-758m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNBS":1.5,"MJ":1.5,"MSOS":1.5,"MSOX":1.5,"WEED":1.5,"YOLO":1.5},"rights":null},{"id":539770,"article_id":"2622996854","title":"Rupert Resources Q4 EPS $(0.01), Same YoY","subtitle":"","subtitle_show":0,"pub_time":1774524971000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477885/rupert-resources-q4-eps-0-01-same-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":539769,"article_id":"2622647854","title":"REX American Resources Q4 EPS $1.32 Beats $0.29 Estimate, Sales $157.959M Miss $161.850M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774524896000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477863/rex-american-resources-q4-eps-1-32-beats-0-29-estimate-sales-157-959m-miss-161-850m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"REX":1.5},"rights":null},{"id":539763,"article_id":"2622285465","title":"Cognition Therapeutics Q4 EPS $(0.01) Beats $(0.05) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774524779000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477830/cognition-therapeutics-q4-eps-0-01-beats-0-05-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CGTX":1.5},"rights":null},{"id":539759,"article_id":"2622687854","title":"Metalla Royalty Q4 EPS $(0.03) Misses $0.01 Estimate, Sales $3.323M Miss $4.200M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774524723000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477820/metalla-royalty-q4-eps-0-03-misses-0-01-estimate-sales-3-323m-miss-4-200m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MTA":1},"rights":null},{"id":539725,"article_id":"2622854823","title":"Verde AgriTech Q4 EPS $(0.06) Up From $(0.24) YoY, Sales $3.080M Up From $2.888M YoY","subtitle":"","subtitle_show":0,"pub_time":1774524062000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477643/verde-agritech-q4-eps-0-06-up-from-0-24-yoy-sales-3-080m-up-from-2-888m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":539709,"article_id":"2622517878","title":"Argan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1774523769000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51477527/argan-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AGX":1.5},"rights":null},{"id":539700,"article_id":"2622292851","title":"Gain Therapeutics Q4 EPS $(0.11) Beats $(0.17) Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774523696000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477505/gain-therapeutics-q4-eps-0-11-beats-0-17-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GANX":1.5},"rights":null},{"id":539666,"article_id":"2622485190","title":"How To Earn $500 A Month From McCormick Stock Ahead Of Q1 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774523281000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/dividends/26/03/51477267/how-to-earn-500-a-month-from-mccormick-stock-ahead-of-q1-earnings-2","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MKC":1,"UL":1,"ULVR.UK":0.6,"UN":0.6,"VIG":0.9},"rights":null},{"id":539664,"article_id":"2622851957","title":"MapLight Therapeutics Q4 EPS $(2.47) Misses $(0.96) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774523234000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477253/maplight-therapeutics-q4-eps-2-47-misses-0-96-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MPLT":1.5},"rights":null},{"id":539665,"article_id":"2622851950","title":"Acumen Pharmaceuticals FY2025 EPS Loss Of $2.00 Vs. Loss Of $1.71 YoY, Cash, Cash Equivalents And Marketable Securities Of $116.9M With Cash Runway Into Early 2027","subtitle":"","subtitle_show":0,"pub_time":1774523191000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/general/biotech/26/03/51477238/acumen-pharmaceuticals-fy2025-eps-loss-of-2-00-vs-loss-of-1-71-yoy-cash-cash-equivalents-and-mark","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ABOS":1.5},"rights":null},{"id":539658,"article_id":"2622851647","title":"Tidewater Renewables Q4 EPS $(0.38) Misses $(0.14) Estimate, Sales $54.700M Beat $49.800M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774523050000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477178/tidewater-renewables-q4-eps-0-38-misses-0-14-estimate-sales-54-700m-beat-49-800m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TDW":1.5},"rights":null},{"id":539651,"article_id":"2622785156","title":"Whitefiber Q4 EPS $(0.67) Misses $(0.18) Estimate, Sales $23.561M Miss $23.791M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774522957000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477139/whitefiber-q4-eps-0-67-misses-0-18-estimate-sales-23-561m-miss-23-791m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WYFI":0.9},"rights":null},{"id":539645,"article_id":"2622897851","title":"Lovesac Q4 EPS $2.19 Beats $2.01 Estimate, Sales $248.046M Beat $242.775M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774522860000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51477084/lovesac-q4-eps-2-19-beats-2-01-estimate-sales-248-046m-beat-242-775m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LOVE":1},"rights":null},{"id":539652,"article_id":"2622590458","title":"Designer Brands Q4 Adj. EPS $(0.31) Beats $(0.49) Estimate, Sales $713.589M Miss $718.910M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774522798000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51476992/designer-brands-q4-adj-eps-0-31-beats-0-49-estimate-sales-713-589m-miss-718-910m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DBI":1},"rights":null},{"id":539614,"article_id":"2622591798","title":"Dixie Gr Q4 EPS $(0.20) Up From $(0.47) YoY, Sales $63.487M Down From $64.388M YoY","subtitle":"","subtitle_show":0,"pub_time":1774522364000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51476919/dixie-gr-q4-eps-0-20-up-from-0-47-yoy-sales-63-487m-down-from-64-388m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DXYN":0.9},"rights":null},{"id":539522,"article_id":"2622885653","title":"Lumexa Imaging Holdings Q4 Adj. EPS $(0.20) Misses $0.07 Estimate, Sales $267.734M Beat $261.206M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774520254000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51476498/lumexa-imaging-holdings-q4-adj-eps-0-20-misses-0-07-estimate-sales-267-734m-beat-261-206m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LMRI":1.5},"rights":null},{"id":539502,"article_id":"2622000855","title":"BRP Q4 Adj. EPS $1.59 Beats $1.49 Estimate, Sales $1.771B Beat $1.690B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774519847000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51476311/brp-q4-adj-eps-1-59-beats-1-49-estimate-sales-1-771b-beat-1-690b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DOO":0.9},"rights":null},{"id":539493,"article_id":"2622885575","title":"Rockwell Medical Q4 2025 Adj. EPS $0.02, Inline, Sales $18.345M Miss $18.581M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774519602000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51476148/rockwell-medical-q4-2025-adj-eps-0-02-inline-sales-18-345m-miss-18-581m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RMTI":1.5},"rights":null},{"id":539478,"article_id":"2622855416","title":"GreenFirst Forest Prods Q4 EPS $(1.43) Down From $(1.39) YoY, Sales $76.949M Up From $69.948M YoY","subtitle":"","subtitle_show":0,"pub_time":1774519432000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51476033/greenfirst-forest-prods-q4-eps-1-43-down-from-1-39-yoy-sales-76-949m-up-from-69-948m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":539480,"article_id":"2622551328","title":"22nd Century Group Q4 EPS $(5.89) Beats $(7.35) Estimate, Sales $3.537M Miss $4.100M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774519257000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51475951/22nd-century-group-q4-eps-5-89-beats-7-35-estimate-sales-3-537m-miss-4-100m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"XXII":1.5},"rights":null},{"id":539377,"article_id":"2622858304","title":"Pony AI Q4 Adj. EPS $(0.12) Misses $0.22 Estimate, Sales $29.125M Beat $23.935M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774516378000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51475469/pony-ai-q4-adj-eps-0-12-misses-0-22-estimate-sales-29-125m-beat-23-935m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"02026":1.98,"PONY":1.98},"rights":null},{"id":539274,"article_id":"2622837940","title":"Oxford Industries Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1774513691000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51475146/oxford-industries-likely-to-report-lower-q4-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"OXM":1.5},"rights":null},{"id":539168,"article_id":"2622834408","title":"ProSiebenSat 1 Media Q4 Adj. EPS $0.15 Down From $0.19 YoY, Sales $1.350B Up From $1.347B YoY","subtitle":"","subtitle_show":0,"pub_time":1774511189000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51474879/prosiebensat-1-media-q4-adj-eps-0-15-down-from-0-19-yoy-sales-1-350b-up-from-1-347b-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PBSFY":0.9},"rights":null},{"id":539147,"article_id":"2622490831","title":"Navan (NAVN) Stock Jumps 23% After Hours — Here's Why","subtitle":"","subtitle_show":0,"pub_time":1774509976000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51474661/navan-navn-stock-jumps-23-after-hours-heres-why","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NAVN":1.5},"rights":null},{"id":539065,"article_id":"2622350568","title":"Why Southland Holdings (SLND) Surged 53% After Hours","subtitle":"","subtitle_show":0,"pub_time":1774506193000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51474269/why-southland-holdings-slnd-surged-53-after-hours","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"RSI":1,"SLND":1.5},"rights":null},{"id":539055,"article_id":"2622835444","title":"Innate Pharma FY EPS $(0.64) Beats $(0.65) Estimate, Sales $10.483M Beat $7.230M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774505661000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51474250/innate-pharma-fy-eps-0-64-beats-0-65-estimate-sales-10-483m-beat-7-230m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IPHYF":1.5},"rights":null},{"id":538495,"article_id":"2622000050","title":"Draganfly Stock Sheds 21% Post-Earnings — Here's Why It's Still A Buy","subtitle":"","subtitle_show":0,"pub_time":1774477286000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51472372/draganfly-stock-sheds-21-post-earnings-heres-why-its-still-a-buy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"POST":1.5},"rights":null},{"id":538493,"article_id":"2622000762","title":"Kiora Pharmaceuticals Q4 EPS $(1.60) Misses $(0.67) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774477065000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51472342/kiora-pharmaceuticals-q4-eps-1-60-misses-0-67-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KPRX":1.5},"rights":null},{"id":538492,"article_id":"2622000756","title":"Cosciens Biopharma Q4 EPS $(0.69) Up From $(2.15) YoY, Sales $1.766M Down From $3.300M YoY","subtitle":"","subtitle_show":0,"pub_time":1774476950000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51472326/cosciens-biopharma-q4-eps-0-69-up-from-2-15-yoy-sales-1-766m-down-from-3-300m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CSCIF":0.9},"rights":null},{"id":538491,"article_id":"2622000248","title":"Immix Biopharma Q4 EPS $(0.28) Misses $(0.16) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774476811000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51472287/immix-biopharma-q4-eps-0-28-misses-0-16-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"IMMX":1},"rights":null},{"id":538488,"article_id":"2622000452","title":"Dakota Gold Q4 EPS $(0.08) Misses $(0.02) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774476439000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51472146/dakota-gold-q4-eps-0-08-misses-0-02-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DC":1},"rights":null},{"id":538485,"article_id":"2622000109","title":"Lionheart Q4 EPS $0.07","subtitle":"","subtitle_show":0,"pub_time":1774476211000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51472091/lionheart-q4-eps-0-07","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LCAPU":1.5},"rights":null},{"id":538486,"article_id":"2622001040","title":"Texas Community Q4 EPS $0.31 Up From $(0.16) YoY, Sales $4.446M Up From $3.191M YoY","subtitle":"","subtitle_show":0,"pub_time":1774476111000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51472070/texas-community-q4-eps-0-31-up-from-0-16-yoy-sales-4-446m-up-from-3-191m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TCBS":1},"rights":null},{"id":538483,"article_id":"2622700091","title":"Transportadora de Gas Q4 EPS $0.13 Misses $0.51 Estimate, Sales $392.845M Beat $367.060M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774475940000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51472023/transportadora-de-gas-q4-eps-0-13-misses-0-51-estimate-sales-392-845m-beat-367-060m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TGS":1},"rights":null},{"id":538472,"article_id":"2622335000","title":"Inovalis REIT Q4 FFO $(0.23) Down From $0.02 YoY, Sales $4.267M Down From $5.258M YoY","subtitle":"","subtitle_show":0,"pub_time":1774474614000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51471834/inovalis-reit-q4-ffo-0-23-down-from-0-02-yoy-sales-4-267m-down-from-5-258m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"REIT":1.5},"rights":null},{"id":538461,"article_id":"2622074250","title":"Global Self Storage Q4 FFO $0.09 Misses $0.10 Estimate, Sales $3.159M Beat $3.126M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774473545000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51471153/global-self-storage-q4-ffo-0-09-misses-0-10-estimate-sales-3-159m-beat-3-126m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SELF":1.5},"rights":null},{"id":538452,"article_id":"2622071360","title":"Marpai Q4 EPS $(0.26) Down From $(0.08) YoY, Sales $3.988M Down From $6.591M YoY","subtitle":"","subtitle_show":0,"pub_time":1774473135000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51471041/marpai-q4-eps-0-26-down-from-0-08-yoy-sales-3-988m-down-from-6-591m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":538448,"article_id":"2622007986","title":"Enerpac Tool Group Q2 Adj. EPS $0.39, Inline, Sales $154.807M Beat $147.800M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774472842000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51470889/enerpac-tool-group-q2-adj-eps-0-39-inline-sales-154-807m-beat-147-800m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"EPAC":1.5},"rights":null},{"id":538432,"article_id":"2622241002","title":"Pizza Pizza Royalty Q4 Adj. EPS $0.24, Inline, Sales $10.553M","subtitle":"","subtitle_show":0,"pub_time":1774471396000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51470372/pizza-pizza-royalty-q4-adj-eps-0-24-inline-sales-10-553m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":538433,"article_id":"2622002236","title":"Medicus Pharma Q4 EPS $(0.83) Misses $(0.15) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774471240000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51470321/medicus-pharma-q4-eps-0-83-misses-0-15-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MDCX":1.5},"rights":null},{"id":538427,"article_id":"2622800296","title":"Exicure Q4 EPS $(0.22) Up From $(3.39) YoY.","subtitle":"","subtitle_show":0,"pub_time":1774470930000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51470045/exicure-q4-eps-0-22-up-from-3-39-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".IXIC":0.75,"FTEC":0.6,"MNQmain":0.6,"NQmain":0.6,"GPIQ":0.6,"IYW":0.6,"JEPQ":0.6,"NVIW.SI":0.6,"PSQ":0.6,"QDTE":0.6,"QID":0.6,"QLD":0.6,"QQQE":0.6,"QQQJ":0.6,"QQQY":0.6,"QYLG":0.6,"SQQQ":0.6,"TQQQ":0.6,"XCUR":1},"rights":null},{"id":538428,"article_id":"2622002661","title":"These Analysts Increase Their Forecasts On AAR Following Upbeat Q3 Results","subtitle":"","subtitle_show":0,"pub_time":1774470740000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51469961/these-analysts-increase-their-forecasts-on-aar-following-upbeat-q3-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AIR":1},"rights":null},{"id":538397,"article_id":"2622002351","title":"Equillium Q4 EPS $(0.04) Beats $(0.14) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774470335000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469739/equillium-q4-eps-0-04-beats-0-14-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"EQ":1},"rights":null},{"id":538394,"article_id":"2622002893","title":"Dyadic International Q4 EPS $(0.06) Misses $(0.04) Estimate, Sales $565.526K Miss $1.343M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774470148000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469634/dyadic-international-q4-eps-0-06-misses-0-04-estimate-sales-565-526k-miss-1-343m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DYAI":1},"rights":null},{"id":538389,"article_id":"2622300288","title":"These Analysts Cut Their Forecasts On Concentrix Following Q1 Results","subtitle":"","subtitle_show":0,"pub_time":1774470091000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51469599/these-analysts-cut-their-forecasts-on-concentrix-following-q1-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNXC":1},"rights":null},{"id":538392,"article_id":"2622002886","title":"Jefferies Financial Gr Q1 Sales $2.017B Miss $2.070B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774470031000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469568/jefferies-financial-gr-q1-sales-2-017b-miss-2-070b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"JEF":1},"rights":null},{"id":538391,"article_id":"2622002885","title":"Journey Medical Q4 EPS $(0.04) Beats $(0.06) Estimate, Sales $16.079M Miss $18.863M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774470022000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469549/journey-medical-q4-eps-0-04-beats-0-06-estimate-sales-16-079m-miss-18-863m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DERM":1.5},"rights":null},{"id":538387,"article_id":"2622100472","title":"Marchex Q4 Adj. EPS $(0.04) Misses $(0.01) Estimate, Sales $10.848M Miss $10.969M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774469946000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469509/marchex-q4-adj-eps-0-04-misses-0-01-estimate-sales-10-848m-miss-10-969m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MCHX":1.5},"rights":null},{"id":538383,"article_id":"2622004733","title":"CaliberCos Q4 EPS $(1.24) Misses $(0.29) Estimate, Sales $4.127M Miss $4.803M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469833000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469418/calibercos-q4-eps-1-24-misses-0-29-estimate-sales-4-127m-miss-4-803m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CWD":1},"rights":null},{"id":538386,"article_id":"2622781004","title":"Worthington Steel Q3 Adj. EPS $0.27 Misses $0.46 Estimate, Sales $769.800M Miss $882.950M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774469832000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469416/worthington-steel-q3-adj-eps-0-27-misses-0-46-estimate-sales-769-800m-miss-882-950m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WOR":1.5},"rights":null},{"id":538384,"article_id":"2622004789","title":"Core & Main Analysts Slash Their Forecasts After Q4 Results","subtitle":"","subtitle_show":0,"pub_time":1774469806000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51469391/core-main-analysts-slash-their-forecasts-after-q4-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNM":1.5},"rights":null},{"id":538377,"article_id":"2622004453","title":"Orezone Gold Q4 Adj. EPS $0.05 Misses $0.15 Estimate, Sales $130.500M Miss $261.546M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469519000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469120/orezone-gold-q4-adj-eps-0-05-misses-0-15-estimate-sales-130-500m-miss-261-546m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":538369,"article_id":"2622004124","title":"Modiv Industrial Q4 FFO $0.32 Misses $0.35 Estimate, Sales $11.008M Miss $11.399M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469503000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469096/modiv-industrial-q4-ffo-0-32-misses-0-35-estimate-sales-11-008m-miss-11-399m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MDV":1},"rights":null},{"id":538368,"article_id":"2622004126","title":"GCT Semiconductor Hldgs Q4 EPS $(0.16) Beats $(0.21) Estimate, Sales $758.000K Miss $975.667K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469464000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469053/gct-semiconductor-hldgs-q4-eps-0-16-beats-0-21-estimate-sales-758-000k-miss-975-667k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GCT":1.5},"rights":null},{"id":538373,"article_id":"2622178004","title":"CytoSorbents Q4 Adj. EPS $(0.07) Misses $(0.05) Estimate, Sales $9.234M Miss $9.587M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469461000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469052/cytosorbents-q4-adj-eps-0-07-misses-0-05-estimate-sales-9-234m-miss-9-587m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CTSO":1},"rights":null},{"id":538370,"article_id":"2622122004","title":"Stran & Co Q4 EPS $0.01 Up From $(0.03) YoY, Sales $28.939M Up From $26.990M YoY","subtitle":"","subtitle_show":0,"pub_time":1774469436000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469026/stran-co-q4-eps-0-01-up-from-0-03-yoy-sales-28-939m-up-from-26-990m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SWAG":0.9},"rights":null},{"id":538371,"article_id":"2622700412","title":"Precigen Q4 EPS $(0.01) Beats $(0.08) Estimate, Sales $4.565M Miss $8.286M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469429000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469014/precigen-q4-eps-0-01-beats-0-08-estimate-sales-4-565m-miss-8-286m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PGEN":1.5},"rights":null},{"id":538372,"article_id":"2622004120","title":"Dolphin Entertainment Q4 Sales $15.600M Beat $15.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469426000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51469013/dolphin-entertainment-q4-sales-15-600m-beat-15-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DLPN":1},"rights":null},{"id":538367,"article_id":"2622185004","title":"Health In Tech Q4 EPS $(0.01), Inline, Sales $7.509M Beat $7.274M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469352000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468963/health-in-tech-q4-eps-0-01-inline-sales-7-509m-beat-7-274m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HIT":1},"rights":null},{"id":538366,"article_id":"2622049710","title":"ATA Creativity Glb Q4 Adj. EPS $(0.12) Down From $0.06 YoY, Sales $12.745M Down From $13.825M YoY","subtitle":"","subtitle_show":0,"pub_time":1774469293000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468901/ata-creativity-glb-q4-adj-eps-0-12-down-from-0-06-yoy-sales-12-745m-down-from-13-825m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AACG":1},"rights":null},{"id":538362,"article_id":"2622049380","title":"WidePoint Q4 EPS $(0.09) Misses $(0.02) Estimate, Sales $42.355M Beat $40.277M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469243000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468831/widepoint-q4-eps-0-09-misses-0-02-estimate-sales-42-355m-beat-40-277m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WYY":1.5},"rights":null},{"id":538365,"article_id":"2622935004","title":"SeaStar Medical Holding Q4 EPS $(0.80) Beats $(1.01) Estimate, Sales $420.000K Beat $372.500K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469239000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468830/seastar-medical-holding-q4-eps-0-80-beats-1-01-estimate-sales-420-000k-beat-372-500k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ICU":1},"rights":null},{"id":538361,"article_id":"2622980004","title":"Cyngn Q4 EPS $(0.78) Beats $(1.00) Estimate, Sales $68.100K Miss $300.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469226000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468828/cyngn-q4-eps-0-78-beats-1-00-estimate-sales-68-100k-miss-300-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CYN":1.5},"rights":null},{"id":538363,"article_id":"2622004933","title":"Navan Q4 Adj. EPS $0.02 Beats $(0.12) Estimate, Sales $177.918M Beat $162.000M Estimate.","subtitle":"","subtitle_show":0,"pub_time":1774469226000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468829/navan-q4-adj-eps-0-02-beats-0-12-estimate-sales-177-918m-beat-162-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NAVN":1.5},"rights":null},{"id":538364,"article_id":"2622004987","title":"Noodles Q4 Adj. EPS $(0.43) Beats $(1.04) Estimate, Sales $122.776M Beat $122.400M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469186000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468798/noodles-q4-adj-eps-0-43-beats-1-04-estimate-sales-122-776m-beat-122-400m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NDLS":1.5},"rights":null},{"id":538360,"article_id":"2622603004","title":"MillerKnoll Q3 Adj. EPS $0.43 Misses $0.45 Estimate, Sales $926.600M Miss $941.960M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774469185000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468797/millerknoll-q3-adj-eps-0-43-misses-0-45-estimate-sales-926-600m-miss-941-960m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MLKN":1.5},"rights":null},{"id":538337,"article_id":"2622004374","title":"Nkarta Q4 EPS $(0.37) Misses $(0.34) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774468958000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468630/nkarta-q4-eps-0-37-misses-0-34-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NKTX":1.5},"rights":null},{"id":538336,"article_id":"2622300482","title":"Celcuity Q4 Adj. EPS $(0.73) Beats $(1.04) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774468897000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51468577/celcuity-q4-adj-eps-0-73-beats-1-04-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CELC":1},"rights":null},{"id":538310,"article_id":"2622700901","title":"RV Maker Winnebago Stock Slides As Unit Volume Falls","subtitle":"","subtitle_show":0,"pub_time":1774465748000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51467148/rv-maker-winnebago-stock-slides-as-unit-volume-falls","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WGO":1.5},"rights":null},{"id":538301,"article_id":"2622009730","title":"Jefferies Financial Likely To Report Higher Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1774465296000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51466936/jefferies-financial-likely-to-report-higher-q1-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"JEF":1},"rights":null},{"id":538186,"article_id":"2622040003","title":"Chewy CEO Sees Resilient Pet Industry, Expanding Profitability In 2026","subtitle":"","subtitle_show":0,"pub_time":1774458950000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51463980/chewy-ceo-sees-resilient-pet-industry-expanding-profitability-in-2026","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CHWY":1},"rights":null},{"id":537983,"article_id":"2622070227","title":"PDD Holdings (PDD) Q4 2025 Earnings Call Transcript","subtitle":"","subtitle_show":0,"pub_time":1774453100000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51460719/pdd-holdings-pdd-q4-2025-earnings-call-transcript","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KPDD":0.6,"PDD":1.98,"PDDL":0.6},"rights":null},{"id":537721,"article_id":"2622077607","title":"Chewy Q4 2025 Earnings Call Transcript","subtitle":"","subtitle_show":0,"pub_time":1774450782000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51459162/chewy-q4-2025-earnings-call-transcript","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":536914,"article_id":"2622380079","title":"CORRECTION: Enlivex Therapeutics Q4 Adj. EPS $(0.20) Misses $(0.01) Estimate. Adj EPS Excludes Change In Fair Value Of Digital Assets Purchase Option","subtitle":"","subtitle_show":0,"pub_time":1774443939000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51454991/correction-enlivex-therapeutics-q4-adj-eps-0-20-misses-0-01-estimate-adj-eps-excludes-change-in-fai","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":536627,"article_id":"2622076629","title":"Temu 'Hyper-Growth' Era Over? PDD Misses Estimates Due To Higher Costs, Weak Demand","subtitle":"","subtitle_show":0,"pub_time":1774443104000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51454416/temu-hyper-growth-era-over-pdd-misses-estimates-due-to-higher-costs-weak-demand","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BABO":0.6,"BABU":0.6,"BABW":0.6,"BABX":0.6,"BBYY":0.6,"ALBmain":0.6,"KBAB":0.6,"KPDD":0.6,"PDD":1.97,"PDDL":0.6},"rights":null},{"id":536514,"article_id":"2622507505","title":"Enlivex Therapeutics Q4 EPS $26.83 Beats $(0.13) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774442369000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51454162/enlivex-therapeutics-q4-eps-26-83-beats-0-13-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":536468,"article_id":"2622075254","title":"BeyondSpring Q4 EPS $(0.05)","subtitle":"","subtitle_show":0,"pub_time":1774442134000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51453963/beyondspring-q4-eps-0-05","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BYSI":1},"rights":null},{"id":536424,"article_id":"2622075468","title":"Paychex Projects $200M–$210M Interest Income On Client Funds In Fiscal 2026, Reaffirms Overall Outlook","subtitle":"","subtitle_show":0,"pub_time":1774442024000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51453934/paychex-projects-200m-210m-interest-income-on-client-funds-in-fiscal-2026-reaffirms-overall-outlook","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PAYX":1.5},"rights":null},{"id":536426,"article_id":"2622075464","title":"Cintas Q3 2026 EPS $1.24 Beats $1.23 Estimate, Sales $2.841B Beat $2.821B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774441934000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51453884/cintas-q3-2026-eps-1-24-beats-1-23-estimate-sales-2-841b-beat-2-821b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CTAS":1.5},"rights":null},{"id":536381,"article_id":"2622901075","title":"Paychex Q3 Adj. EPS $1.71 Beats $1.67 Estimate, Sales $1.808B Beat $1.790B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774441883000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51453844/paychex-q3-adj-eps-1-71-beats-1-67-estimate-sales-1-808b-beat-1-790b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PAYX":1.5},"rights":null},{"id":536154,"article_id":"2622073923","title":"ProMIS Neurosciences Q4 EPS $(21.83) Misses $(0.21) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774440333000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51453181/promis-neurosciences-q4-eps-21-83-misses-0-21-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PMN":1},"rights":null},{"id":536122,"article_id":"2622073640","title":"QT Imaging Holdings Q4 EPS $(0.10) Beats $(0.13) Estimate, Sales $8.275M Beat $6.520M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774440162000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51453093/qt-imaging-holdings-q4-eps-0-10-beats-0-13-estimate-sales-8-275m-beat-6-520m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"QTI":1},"rights":null},{"id":536071,"article_id":"2622018078","title":"How To Earn $500 A Month From Commercial Metals Stock Ahead Of Q2 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774439772000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/dividends/26/03/51452790/how-to-earn-500-a-month-from-commercial-metals-stock-ahead-of-q2-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CMC":1.5},"rights":null},{"id":536036,"article_id":"2622760078","title":"Kingsoft Cloud Holdings Q4 Adj. EPS $(0.04) Beats $(0.12) Estimate, Sales $394.873M Beat $378.120M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774439554000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51452758/kingsoft-cloud-holdings-q4-adj-eps-0-04-beats-0-12-estimate-sales-394-873m-beat-378-120m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KC":1},"rights":null},{"id":535895,"article_id":"2622307858","title":"Edap TMS Q4 EPS $(0.25) Misses $(0.16) Estimate, Sales $21.880M Beat $21.320M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774438442000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51452405/edap-tms-q4-eps-0-25-misses-0-16-estimate-sales-21-880m-beat-21-320m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"EDAP":1},"rights":null},{"id":535780,"article_id":"2622020296","title":"KNOT Offshore Partners Q4 Adj. EPS $0.41 Beats $0.39 Estimate, Sales $96.487M Beat $92.242M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774437721000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51452259/knot-offshore-partners-q4-adj-eps-0-41-beats-0-39-estimate-sales-96-487m-beat-92-242m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KNOP":1},"rights":null},{"id":535741,"article_id":"2622209060","title":"Local Bounti Q4 EPS $(0.38) Beats $(0.60) Estimate, Sales $12.457M Miss $15.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774437424000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51452211/local-bounti-q4-eps-0-38-beats-0-60-estimate-sales-12-457m-miss-15-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LOCL":1.5},"rights":null},{"id":535709,"article_id":"2622020631","title":"Energous Q4 Adj. EPS $(0.05) Beats $(0.81) Estimate, Sales $3.040M Beat $2.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774437205000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51452147/energous-q4-adj-eps-0-05-beats-0-81-estimate-sales-3-040m-beat-2-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WATT":1.5},"rights":null},{"id":535690,"article_id":"2622020378","title":"Cognyte Software Q4 2025 Adj. EPS $0.10 Beats $0.04 Estimate, Sales $106.242M Miss $106.292M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774436946000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51452043/cognyte-software-q4-2025-adj-eps-0-10-beats-0-04-estimate-sales-106-242m-miss-106-292m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CGNT":0.9},"rights":null},{"id":535653,"article_id":"2622020336","title":"Chewy Q4 2025 Adj. EPS $0.27 Beats $0.20 Estimate, Sales $3.265B Beat $3.262B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774436783000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51451877/chewy-q4-2025-adj-eps-0-27-beats-0-20-estimate-sales-3-265b-beat-3-262b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CHWY":0.9},"rights":null},{"id":535622,"article_id":"2622102085","title":"Maze Therapeutics Q4 EPS $(0.65) Beats $(0.71) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774436753000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51451848/maze-therapeutics-q4-eps-0-65-beats-0-71-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MAZE":1.5},"rights":null},{"id":535342,"article_id":"2622022101","title":"PDD Holdings Q4 Adj. EPS $2.53 Misses $3.21 Estimate, Sales $17.719B Miss $17.930B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774434747000,"source_id":"","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51451291/pdd-holdings-q4-adj-eps-2-53-misses-3-21-estimate-sales-17-719b-miss-17-930b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KPDD":0.6,"PDD":1.98,"PDDL":0.6},"rights":null},{"id":535257,"article_id":"2622225620","title":"Baozun Q4 Adj. EPS $0.39 Up From $0.11 YoY, Sales $453.622M Up From $410.237M YoY","subtitle":"","subtitle_show":0,"pub_time":1774434042000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51451173/baozun-q4-adj-eps-0-39-up-from-0-11-yoy-sales-453-622m-up-from-410-237m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BZUN":1.5},"rights":null},{"id":535178,"article_id":"2622024294","title":"ACT Energy Technologies Q4 EPS $0.08 Down From $0.38 YoY, Sales $109.301M Down From $128.083M YoY","subtitle":"","subtitle_show":0,"pub_time":1774433351000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51451016/act-energy-technologies-q4-eps-0-08-down-from-0-38-yoy-sales-109-301m-down-from-128-083m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ACT":1.5},"rights":null},{"id":535134,"article_id":"2622486024","title":"Viomi Technology Co FY Adj. EPS $0.32, Same YoY, Sales $347.232M Miss $419.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774433084000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51450871/viomi-technology-co-fy-adj-eps-0-32-same-yoy-sales-347-232m-miss-419-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VIOT":1.5},"rights":null},{"id":535126,"article_id":"2622024975","title":"Waterdrop Q4 Adj. EPS $0.07 Beats $0.04 Estimate, Sales $201.806M Beat $115.690M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774432960000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51450778/waterdrop-q4-adj-eps-0-07-beats-0-04-estimate-sales-201-806m-beat-115-690m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WDH":1},"rights":null},{"id":534899,"article_id":"2622021636","title":"Zhihu Q4 Adj. EPS $(0.07) Down From $0.15 YoY, Sales $92.021M Down From $117.712M YoY","subtitle":"","subtitle_show":0,"pub_time":1774431335000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51450500/zhihu-q4-adj-eps-0-07-down-from-0-15-yoy-sales-92-021m-down-from-117-712m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ZH":1.5},"rights":null},{"id":534785,"article_id":"2622195029","title":"So-Young Intl Q4 Adj. EPS $(0.13) Down From $(0.01) YoY, Sales $65.882M Up From $50.582M YoY","subtitle":"","subtitle_show":0,"pub_time":1774430301000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51450452/so-young-intl-q4-adj-eps-0-13-down-from-0-01-yoy-sales-65-882m-up-from-50-582m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SY":1},"rights":null},{"id":534715,"article_id":"2622029878","title":"DouYu Intl Hldgs Q4 Adj. EPS $0.06 Up From $(0.31) YoY, Sales $131.383M Down From $155.631M YoY","subtitle":"","subtitle_show":0,"pub_time":1774429748000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51450407/douyu-intl-hldgs-q4-adj-eps-0-06-up-from-0-31-yoy-sales-131-383m-down-from-155-631m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DOYU":1.5},"rights":null},{"id":533998,"article_id":"2622407910","title":"Ag Growth International Q4 Adj. EPS $0.09 Misses $1.06 Estimate, Sales $395.770M Beat $362.734M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774423553000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51449654/ag-growth-international-q4-adj-eps-0-09-misses-1-06-estimate-sales-395-770m-beat-362-734m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":533822,"article_id":"2622168047","title":"Fractyl Health (GUTS) Stock Jumps 21% After Hours: Here's What You Should Know","subtitle":"","subtitle_show":0,"pub_time":1774421811000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51449415/fractyl-health-guts-stock-jumps-overnight","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GUTS":1.5,"RSI":1},"rights":null},{"id":533711,"article_id":"2622042700","title":"Chewy, AAR And 3 Stocks To Watch Heading Into Wednesday","subtitle":"","subtitle_show":0,"pub_time":1774420534000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/long-ideas/26/03/51449308/chewy-aar-and-3-stocks-to-watch-heading-into-wednesday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AIR":1.91,"ARMG":0.6,"ARMU":0.6,"ARMW":0.6,"CHWY":1.92,"CTAS":1.88,"PAYX":1.87},"rights":null},{"id":531907,"article_id":"2622016273","title":"17 Education & Technology Q4 Adj. EPS $(0.55) Up From $(0.63) YoY, Sales $5.568M Up From $5.013M YoY","subtitle":"","subtitle_show":0,"pub_time":1774389714000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51447212/17-education-technology-q4-adj-eps-0-55-up-from-0-63-yoy-sales-5-568m-up-from-5-013m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"YQ":1},"rights":null},{"id":531894,"article_id":"2622016462","title":"Energy Focus Q4 EPS $(0.06) Down From $(0.05) YoY, Sales $975.000K Down From $1.278M YoY","subtitle":"","subtitle_show":0,"pub_time":1774389276000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51447156/energy-focus-q4-eps-0-06-down-from-0-05-yoy-sales-975-000k-down-from-1-278m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"EFOI":1.5},"rights":null},{"id":531893,"article_id":"2622016467","title":"Integra Resources Q4 Adj. EPS $0.09 Beats $0.05 Estimate, Sales $55.151M Beat $53.600M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774389255000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51447147/integra-resources-q4-adj-eps-0-09-beats-0-05-estimate-sales-55-151m-beat-53-600m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ITRG":0.9},"rights":null},{"id":531873,"article_id":"2622016436","title":"Willamette Valley Q4 EPS $0.05 Up From $(0.02) YoY, Sales $11.107M Down From $11.276M YoY","subtitle":"","subtitle_show":0,"pub_time":1774389052000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51447108/willamette-valley-q4-eps-0-05-up-from-0-02-yoy-sales-11-107m-down-from-11-276m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"WVVI":1},"rights":null},{"id":531857,"article_id":"2622601613","title":"VirnetX Holding Q4 EPS $(1.83) Down From $(1.73) YoY, Sales $56.000K","subtitle":"","subtitle_show":0,"pub_time":1774388833000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51447059/virnetx-holding-q4-eps-1-83-down-from-1-73-yoy-sales-56-000k","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VHC":1.5},"rights":null},{"id":531828,"article_id":"2622016634","title":"Erdene Resource Dev Q4 EPS $0.05 Up From $(0.03) YoY","subtitle":"","subtitle_show":0,"pub_time":1774388363000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51446975/erdene-resource-dev-q4-eps-0-05-up-from-0-03-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":531821,"article_id":"2622016505","title":"Skeena Resources Q4 EPS $(0.43) Misses $(0.06) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774388275000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51446957/skeena-resources-q4-eps-0-43-misses-0-06-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SKE":1},"rights":null},{"id":531743,"article_id":"2622016359","title":"Epsilon Energy Q4 Adj. EPS $0.43 Beats $0.04 Estimate, Sales $14.818M Beat $11.362M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774387671000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51446807/epsilon-energy-q4-adj-eps-0-43-beats-0-04-estimate-sales-14-818m-beat-11-362m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"EPSN":1},"rights":null},{"id":531589,"article_id":"2622015188","title":"M-Tron Industries Q4 EPS $0.99 Beats $0.59 Estimate, Sales $14.233M Miss $14.250M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774386064000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51446252/m-tron-industries-q4-eps-0-99-beats-0-59-estimate-sales-14-233m-miss-14-250m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MPTI":1},"rights":null},{"id":531542,"article_id":"2622015680","title":"Braze Stock Shoots Higher After Q4 Revenue Surprises To Upside","subtitle":"","subtitle_show":0,"pub_time":1774385726000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51446130/braze-stock-shoots-higher-after-q4-revenue-surprises-to-upside","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BRZE":1.5},"rights":null},{"id":531503,"article_id":"2622701558","title":"Draganfly Q4 EPS $(0.24) Misses $(0.13) Estimate, Sales $1.371M Miss $1.690M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774385485000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51446046/draganfly-q4-eps-0-24-misses-0-13-estimate-sales-1-371m-miss-1-690m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DPRO":1},"rights":null},{"id":531477,"article_id":"2622015807","title":"Noah Holdings Q4 Adj. EPS $0.05 Down From $0.26 YoY, Sales $104.853M Beat $89.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774385266000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51445963/noah-holdings-q4-adj-eps-0-05-down-from-0-26-yoy-sales-104-853m-beat-89-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NOAH":1.5},"rights":null},{"id":531324,"article_id":"2622013189","title":"Spectral AI Q4 Adj. EPS $(0.11) Beats $(0.13) Estimate, Sales $3.849M Beat $2.923M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774384226000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51445265/spectral-ai-q4-adj-eps-0-11-beats-0-13-estimate-sales-3-849m-beat-2-923m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MDAI":1},"rights":null},{"id":531308,"article_id":"2622912013","title":"KB Home Stock Sinks After Q1 Revenues Fall 23%","subtitle":"","subtitle_show":0,"pub_time":1774384176000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51445198/kb-home-stock-sinks-after-q1-revenues-fall-23","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KB":1.5,"KBH":1.5},"rights":null},{"id":531233,"article_id":"2622013366","title":"Blaize Holdings Q4 EPS $(0.03) Beats $(0.20) Estimate, Sales $23.776M Beat $21.936M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774383442000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444816/blaize-holdings-q4-eps-0-03-beats-0-20-estimate-sales-23-776m-beat-21-936m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BZAI":1},"rights":null},{"id":531209,"article_id":"2622013825","title":"Intrusion Q4 EPS $(0.14) Misses $(0.09) Estimate, Sales $1.482M Miss $2.055M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774383255000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444662/intrusion-q4-eps-0-14-misses-0-09-estimate-sales-1-482m-miss-2-055m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"INTZ":1},"rights":null},{"id":531195,"article_id":"2622013835","title":"BioCardia Q4 EPS $(0.06) Beats $(0.17) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774383237000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444648/biocardia-q4-eps-0-06-beats-0-17-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BCDA":1.5},"rights":null},{"id":531176,"article_id":"2622001804","title":"PaySign Q4 EPS $0.02, Inline, Sales $22.755M Beat $21.544M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774383110000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444570/paysign-q4-eps-0-02-inline-sales-22-755m-beat-21-544m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PAYS":0.9},"rights":null},{"id":531174,"article_id":"2622018049","title":"Fractyl Health Q4 EPS $(0.07) Beats $(0.19) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774383062000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444522/fractyl-health-q4-eps-0-07-beats-0-19-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GUTS":1.5},"rights":null},{"id":531175,"article_id":"2622018042","title":"Biomea Fusion Q4 EPS $0.27 Beats $(0.23) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774383031000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444478/biomea-fusion-q4-eps-0-27-beats-0-23-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BMEA":1.5},"rights":null},{"id":531177,"article_id":"2622023018","title":"Comstock Q4 EPS $(0.22) Misses $(0.15) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774383023000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444468/comstock-q4-eps-0-22-misses-0-15-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CHCI":1.5},"rights":null},{"id":531169,"article_id":"2622187090","title":"Absci Q4 EPS $(0.20), Inline, Sales $650.000K Miss $1.100M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774382916000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444406/absci-q4-eps-0-20-inline-sales-650-000k-miss-1-100m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ABSI":1},"rights":null},{"id":531142,"article_id":"2622018767","title":"Braze Q4 Adj. EPS $0.10 Misses $0.14 Estimate, Sales $205.170M Beat $198.208M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774382850000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444359/braze-q4-adj-eps-0-10-misses-0-14-estimate-sales-205-170m-beat-198-208m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BRZE":1.5},"rights":null},{"id":531143,"article_id":"2622018760","title":"Velo3D Q4 Adj. EPS $(0.54) Beats $(0.56) Estimate, Sales $9.441M Beat $8.682M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774382805000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444301/velo3d-q4-adj-eps-0-54-beats-0-56-estimate-sales-9-441m-beat-8-682m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VELO":1},"rights":null},{"id":531089,"article_id":"2622018225","title":"MaxCyte Q4 EPS $(0.09), Inline, Sales $7.300M Miss $9.398M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774382744000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444223/maxcyte-q4-eps-0-09-inline-sales-7-300m-miss-9-398m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MXCT":1.5},"rights":null},{"id":531077,"article_id":"2622001840","title":"GameStop Q4 Adj. EPS $0.49 Beats $0.37 Estimate, Sales $1.104B Miss $1.467B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774382606000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51444071/gamestop-q4-adj-eps-0-49-beats-0-37-estimate-sales-1-104b-miss-1-467b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GME":1.99,"GMEU":0.6,"GMEY":0.6,"IGME":0.6},"rights":null},{"id":530964,"article_id":"2622090969","title":"Ondas Reloads With $1.5B Cash, Aggressive Deals And 100%+ Upside Target","subtitle":"","subtitle_show":0,"pub_time":1774379206000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51442559/ondas-reloads-with-1-5b-cash-aggressive-deals-and-100-upside-target","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ONDG":0.6,"ONDL":0.6,"ONDS":1.98,"ONDU":0.6},"rights":null},{"id":530761,"article_id":"2622470092","title":"What's Happening With Velo3D Stock Before Q4 Earnings?","subtitle":"","subtitle_show":0,"pub_time":1774375160000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51440678/whats-happening-with-velo3d-stock-before-q4-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"VELO":1},"rights":null},{"id":529308,"article_id":"2621098467","title":"Leatt Q4 EPS $0.08 Up From $(0.07) YoY, Sales $16.020M Up From $11.200M YoY","subtitle":"","subtitle_show":0,"pub_time":1774360747000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51432026/leatt-q4-eps-0-08-up-from-0-07-yoy-sales-16-020m-up-from-11-200m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LEAT":0.9},"rights":null},{"id":529250,"article_id":"2621098911","title":"Concentrix Stock Sinks To 52-Week Low - Here's Why","subtitle":"","subtitle_show":0,"pub_time":1774360272000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51431690/concentrix-stock-sinks-to-52-week-low-heres-why","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNXC":1},"rights":null},{"id":528936,"article_id":"2621406081","title":"Bioage Labs Q4 EPS $(0.72) Beats $(0.73) Estimate, Sales $3.078M Beat $1.915M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774357707000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51430292/bioage-labs-q4-eps-0-72-beats-0-73-estimate-sales-3-078m-beat-1-915m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BIOA":1},"rights":null},{"id":528913,"article_id":"2621306705","title":"BioLine Rx Q4 EPADS $(0.34) Beats $(0.54) Estimate, Sales $194.000K Miss $651.598K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774357604000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51430236/bioline-rx-q4-epads-0-34-beats-0-54-estimate-sales-194-000k-miss-651-598k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BLRX":1.5},"rights":null},{"id":528522,"article_id":"2621628200","title":"Casey's General Stores Q3 Earnings Beat Fuels Stock's Quality Rank Surge As Stephens Analyst Sees 'Momentum Across The Board'","subtitle":"","subtitle_show":0,"pub_time":1774355235000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51428683/caseys-general-stores-q3-earnings-beat-fuels-stocks-quality-rank-surge-as-stephens-analyst-sees-momentum-across-the-board","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CASY":1.5},"rights":null},{"id":528498,"article_id":"2621064053","title":"How To Earn $500 A Month From Cintas Stock Ahead Of Q3 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774354814000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/dividends/26/03/51428539/how-to-earn-500-a-month-from-cintas-stock-ahead-of-q3-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CTAS":1.5},"rights":null},{"id":528405,"article_id":"2621506495","title":"Leatt Q4 2025 Sales $16.020M Up From $11.200M YoY, With Net Income Of $464,808, Up 204% YoY","subtitle":"","subtitle_show":0,"pub_time":1774353993000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51428120/leatt-q4-2025-sales-16-020m-up-from-11-200m-yoy-with-net-income-of-464-808-up-204-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LEAT":0.9},"rights":null},{"id":528367,"article_id":"2621953064","title":"Hour Loop Q4 EPS $(0.02) Up From $(0.04) YoY, Sales $56.075M Up From $54.426M YoY","subtitle":"","subtitle_show":0,"pub_time":1774353983000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51428100/hour-loop-q4-eps-0-02-up-from-0-04-yoy-sales-56-075m-up-from-54-426m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HOUR":1},"rights":null},{"id":528253,"article_id":"2621806433","title":"LENZ Therapeutics Q4 EPS $(1.16) Misses $(0.96) Estimate, Sales $1.588M Miss $1.886M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774353685000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51427800/lenz-therapeutics-q4-eps-1-16-misses-0-96-estimate-sales-1-588m-miss-1-886m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":528193,"article_id":"2621061289","title":"KB Home Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1774353068000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51427472/kb-home-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-4","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"KB":1.5,"KBH":1.5},"rights":null},{"id":528131,"article_id":"2621061510","title":"Neurogene Q4 EPS $(1.13), Inline","subtitle":"","subtitle_show":0,"pub_time":1774352366000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51427296/neurogene-q4-eps-1-13-inline","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NGNE":1},"rights":null},{"id":528106,"article_id":"2621061377","title":"Compass Pathways Q4 EPS $(1.00) Misses $(0.37) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774352230000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51427246/compass-pathways-q4-eps-1-00-misses-0-37-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CMPS":1},"rights":null},{"id":528063,"article_id":"2621061856","title":"Core & Main Q4 Adj. EPS $0.52 Beats $0.42 Estimate, Sales $1.581B Miss $1.599B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774351925000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51427045/core-main-q4-adj-eps-0-52-beats-0-42-estimate-sales-1-581b-miss-1-599b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNM":1.5},"rights":null},{"id":528031,"article_id":"2621069025","title":"Achieve Life Sciences Q4 EPS $(0.28) Misses $(0.27) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774351918000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51427039/achieve-life-sciences-q4-eps-0-28-misses-0-27-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ACHV":1},"rights":null},{"id":528037,"article_id":"2621690750","title":"Concentrix Q1 Adj. EPS $2.61 Misses $2.65 Estimate, Sales $2.500B Beat $2.492B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774351877000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51427009/concentrix-q1-adj-eps-2-61-misses-2-65-estimate-sales-2-500b-beat-2-492b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNXC":1},"rights":null},{"id":527933,"article_id":"2621696570","title":"Fennec Pharmaceuticals Q4 GAAP EPS $(0.17) Misses $0.04 Estimate, Sales $13.777M Miss $13.993M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774350988000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51426763/fennec-pharmaceuticals-q4-gaap-eps-0-17-misses-0-04-estimate-sales-13-777m-miss-13-993m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FENC":1},"rights":null},{"id":527848,"article_id":"2621082066","title":"Fennec Pharmaceuticals Q4 EPS $(0.17) Misses $0.04 Estimate, Sales $13.777M Miss $13.993M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774350240000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51426551/fennec-pharmaceuticals-q4-eps-0-17-misses-0-04-estimate-sales-13-777m-miss-13-993m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":527798,"article_id":"2621206620","title":"LightInTheBox Holding Q4 EPS $0.18 Up From $0.02 YoY, Sales $62.960M Up From $57.750M YoY","subtitle":"","subtitle_show":0,"pub_time":1774350206000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51426540/lightinthebox-holding-q4-eps-0-18-up-from-0-02-yoy-sales-62-960m-up-from-57-750m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LITB":1.5},"rights":null},{"id":527796,"article_id":"2621662090","title":"Sanara MedTech Q4 EPS $(0.13) Misses $0.11 Estimate, Sales $27.546M Beat $27.400M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774350186000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51426520/sanara-medtech-q4-eps-0-13-misses-0-11-estimate-sales-27-546m-beat-27-400m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SMTI":1},"rights":null},{"id":527807,"article_id":"2621208066","title":"Perma-Fix Envirn Servs Q4 EPS $(0.31) Misses $(0.09) Estimate, Sales $15.700M Miss $17.700M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774350167000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51426467/perma-fix-envirn-servs-q4-eps-0-31-misses-0-09-estimate-sales-15-700m-miss-17-700m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PESI":1},"rights":null},{"id":527766,"article_id":"2621066287","title":"Dollarama Q4 EPS $1.43 Beats $1.40 Estimate, Sales $2.101B Beat $2.075B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774350113000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51426391/dollarama-q4-eps-1-43-beats-1-40-estimate-sales-2-101b-beat-2-075b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":527423,"article_id":"2621063731","title":"Aimia Q4 EPS $(0.13) Beats $(0.36) Estimate, Sales $118.500M Beat $35.200M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774347070000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51425584/aimia-q4-eps-0-13-beats-0-36-estimate-sales-118-500m-beat-35-200m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":527412,"article_id":"2621063236","title":"Vertical Aerospace FY EPS $(0.75) Misses $(0.01) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774346997000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51425521/vertical-aerospace-fy-eps-0-75-misses-0-01-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"EVTL":1.5},"rights":null},{"id":527407,"article_id":"2621063476","title":"Cadeler Q4 EPS $0.65, Inline, Sales $195.076M Beat $168.750M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774346969000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51425502/cadeler-q4-eps-0-65-inline-sales-195-076m-beat-168-750m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CDLR":1},"rights":null},{"id":526867,"article_id":"2621057667","title":"Cheetah Mobile Q4 Adj. EPS $(0.16) Up From $(0.93) YoY, Sales $44.165M Up From $32.481M YoY","subtitle":"","subtitle_show":0,"pub_time":1774341786000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51424686/cheetah-mobile-q4-adj-eps-0-16-up-from-0-93-yoy-sales-44-165m-up-from-32-481m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CMCM":1.5},"rights":null},{"id":526865,"article_id":"2621057363","title":"Hesai Gr Q4 Adj. EPS $0.16 Down From $0.17 YoY, Sales $143.100M Up From $98.606M YoY","subtitle":"","subtitle_show":0,"pub_time":1774341485000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51424666/hesai-gr-q4-adj-eps-0-16-down-from-0-17-yoy-sales-143-100m-up-from-98-606m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"02525":1.98,"HSAI":1.98},"rights":null},{"id":524335,"article_id":"2621080617","title":"MAIA Biotechnology Q4 EPS $(0.08) Beats $(0.13) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774303872000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51421811/maia-biotechnology-q4-eps-0-08-beats-0-13-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MAIA":1.5},"rights":null},{"id":524331,"article_id":"2621080577","title":"NRX Pharmaceuticals Q4 EPS $0.20 Up From $(0.77) YoY, Sales $983.000K","subtitle":"","subtitle_show":0,"pub_time":1774303683000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51421788/nrx-pharmaceuticals-q4-eps-0-20-up-from-0-77-yoy-sales-983-000k","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"NRXP":1},"rights":null},{"id":524271,"article_id":"2621779087","title":"Smithfield Foods Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1774302367000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51421566/smithfield-foods-likely-to-report-higher-q4-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SFD":1.5},"rights":null},{"id":524234,"article_id":"2621410087","title":"Lument Finance Trust Reported Q4 Adj EPS $0.00 and Sales $5.366M Miss $18.503M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774301914000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51421477/lument-finance-trust-reported-q4-adj-eps-0-00-and-sales-5-366m-miss-18-503m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LFT":1},"rights":null},{"id":523833,"article_id":"2621082936","title":"Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story","subtitle":"","subtitle_show":0,"pub_time":1774299037000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51420498/bionano-genomics-stock-soars-as-efficiency-gains-meet-growth-story","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BNGO":1.5},"rights":null},{"id":523736,"article_id":"2621868082","title":"Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1774298428000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51420308/fennec-pharmaceuticals-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FENC":1},"rights":null},{"id":523496,"article_id":"2621308457","title":"Context Therapeutics Q4 EPS $(0.14) Misses $(0.10) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774297237000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51419676/context-therapeutics-q4-eps-0-14-misses-0-10-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":523438,"article_id":"2621308107","title":"Mobilicom FY EPS $(2.68) Down From $(0.48) YoY, Sales $3.364M Miss $5.000M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774296878000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51419446/mobilicom-fy-eps-2-68-down-from-0-48-yoy-sales-3-364m-miss-5-000m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MOB":1},"rights":null},{"id":523418,"article_id":"2621810590","title":"Sutro Biopharma Q4 EPS $(5.29) Misses $(4.35) Estimate, Sales $11.647M Beat $8.341M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774296793000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51419384/sutro-biopharma-q4-eps-5-29-misses-4-35-estimate-sales-11-647m-beat-8-341m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"STRO":1},"rights":null},{"id":523388,"article_id":"2621081271","title":"Surrozen Q4 EPS $(20.13) Misses $(1.08) Estimate, Sales $500.000K Inline","subtitle":"","subtitle_show":0,"pub_time":1774296541000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51419251/surrozen-q4-eps-20-13-misses-1-08-estimate-sales-500-000k-inline","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SRZN":1},"rights":null},{"id":523348,"article_id":"2621608140","title":"Bionano Genomics Q4 Sales $7.951M Beat $7.853M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774296448000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51419176/bionano-genomics-q4-sales-7-951m-beat-7-853m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BNGO":1.5},"rights":null},{"id":523349,"article_id":"2621405081","title":"Aardvark Therapeutics Q4 EPS $(0.81) Beats $(0.91) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774296385000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51419139/aardvark-therapeutics-q4-eps-0-81-beats-0-91-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AARD":1.5},"rights":null},{"id":523350,"article_id":"2621081403","title":"Public Policy Holding Co Q4 Adj. EPS $0.42 Misses $0.65 Estimate, Sales $49.900M Miss $97.400M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774296370000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51419113/public-policy-holding-co-q4-adj-eps-0-42-misses-0-65-estimate-sales-49-900m-miss-97-400m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PPHC":1},"rights":null},{"id":522833,"article_id":"2621083484","title":"Carnival Heads Into Earnings With Fuel Risks — But Oil Relief Lifts Stock","subtitle":"","subtitle_show":0,"pub_time":1774287322000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/03/51414993/carnival-heads-into-earnings-with-fuel-risks-but-oil-relief-lifts-stock","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CCL":1.5},"rights":null},{"id":521396,"article_id":"2621701460","title":"WeRide Doubles Down On Driverless Dream With 123% Revenue Spike","subtitle":"","subtitle_show":0,"pub_time":1774274548000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51406587/weride-doubles-down-on-driverless-dream-with-123-revenue-spike","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"00800":1.98,"WRD":1.98},"rights":null},{"id":521257,"article_id":"2621070183","title":"Homestolife FY EPS $0.185 Up From $0.094 YoY, Sales $377.876M Up From $335.061M YoY","subtitle":"","subtitle_show":0,"pub_time":1774273607000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51405729/homestolife-fy-eps-0-185-up-from-0-094-yoy-sales-377-876m-up-from-335-061m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"HTLM":0.9},"rights":null},{"id":520773,"article_id":"2621706353","title":"Envoy Medical Q4 EPS $(0.26) Beats $(0.30) Estimate, Sales $75.000K Beat $70.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774270487000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51403602/envoy-medical-q4-eps-0-26-beats-0-30-estimate-sales-75-000k-beat-70-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"COCH":1},"rights":null},{"id":520638,"article_id":"2621770529","title":"Talphera Q4 EPS $(0.06) Beats $(0.14) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774269785000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51403363/talphera-q4-eps-0-06-beats-0-14-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"TLPH":1},"rights":null},{"id":520534,"article_id":"2621575705","title":"Conifex Timber Q4 EPS $(0.28) Down From $(0.27) YoY, Sales $26.100M Down From $31.000M YoY","subtitle":"","subtitle_show":0,"pub_time":1774269204000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51403115/conifex-timber-q4-eps-0-28-down-from-0-27-yoy-sales-26-100m-down-from-31-000m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":520416,"article_id":"2621741703","title":"AEO Stock Undervalued? Value Score Jumps As American Eagle's Record Q4 Earnings Meet 35% YTD Market Sell-Off","subtitle":"","subtitle_show":0,"pub_time":1774268611000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51402790/aeo-stock-undervalued-value-score-jumps-as-american-eagles-record-q4-earnings-meet-35-ytd-market-sell-off","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AEO":1.5},"rights":null},{"id":520414,"article_id":"2621703749","title":"Cheer Holding FY EPS $24.07 Down From $125.72 YoY, Sales $148.835M Up From $147.196M YoY","subtitle":"","subtitle_show":0,"pub_time":1774268532000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51402772/cheer-holding-fy-eps-24-07-down-from-125-72-yoy-sales-148-835m-up-from-147-196m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CHR":1},"rights":null},{"id":520393,"article_id":"2621101703","title":"Ondas Holdings Q4 EPS $(0.36) Misses $(0.05) Estimate, Sales $30.112M Beat $27.628M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774268320000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51402747/ondas-holdings-q4-eps-0-36-misses-0-05-estimate-sales-30-112m-beat-27-628m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ONDG":0.6,"ONDL":0.6,"ONDS":1.98,"ONDU":0.6},"rights":null},{"id":519961,"article_id":"2621639708","title":"Arbutus Biopharma Q4 EPS $(0.01) Beats $(0.03) Estimate, Sales $1.051M Miss $1.233M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774266290000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51401887/arbutus-biopharma-q4-eps-0-01-beats-0-03-estimate-sales-1-051m-miss-1-233m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ABUS":1.5},"rights":null},{"id":519877,"article_id":"2621019770","title":"Cabaletta Bio Q4 EPS $(0.40) Beats $(0.47) Estimate","subtitle":"","subtitle_show":0,"pub_time":1774265737000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51401713/cabaletta-bio-q4-eps-0-40-beats-0-47-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CABA":1.5},"rights":null},{"id":519852,"article_id":"2621711770","title":"Lithium Argentina Q4 EPS $(0.01) Misses $0.04 Estimate","subtitle":"","subtitle_show":0,"pub_time":1774265622000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51401684/lithium-argentina-q4-eps-0-01-misses-0-04-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LIT":1.5},"rights":null},{"id":519646,"article_id":"2621770568","title":"BioLine Rx Q4 Sales $194.000K Miss $651.598K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774264582000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51401341/bioline-rx-q4-sales-194-000k-miss-651-598k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BLRX":1.5},"rights":null},{"id":519637,"article_id":"2621770301","title":"WeRide Q4 EPS $(0.24) Up From $(0.33) YoY, Sales $44.900M Up From $19.293M YoY","subtitle":"","subtitle_show":0,"pub_time":1774264557000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51401317/weride-q4-eps-0-24-up-from-0-33-yoy-sales-44-900m-up-from-19-293m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"00800":1.98,"WRD":1.98},"rights":null},{"id":519601,"article_id":"2621770801","title":"Pyxis Oncology Q4 EPS $(0.29) Beats $(0.33) Estimate, Sales $11.038M","subtitle":"","subtitle_show":0,"pub_time":1774264373000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51401228/pyxis-oncology-q4-eps-0-29-beats-0-33-estimate-sales-11-038m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PYXS":1.5},"rights":null},{"id":519579,"article_id":"2621897770","title":"Avalo Therapeutics Q4 EPS $(0.48) Beats $(1.47) Estimate, Sales $59.000K Down From $192.000K YoY","subtitle":"","subtitle_show":0,"pub_time":1774264225000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51401143/avalo-therapeutics-q4-eps-0-48-beats-1-47-estimate-sales-59-000k-down-from-192-000k-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LENZ":1.5},"rights":null},{"id":519501,"article_id":"2621777742","title":"Quarterhill Q4 EPS $(0.29), Sales $38.463M Miss $39.650M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774263890000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51400997/quarterhill-q4-eps-0-29-sales-38-463m-miss-39-650m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{},"rights":null},{"id":518954,"article_id":"2621774674","title":"Gamehaus Holdings Q2 EPS $0.02 Up From $0.01 YoY, Sales $26.295M Down From $28.519M YoY","subtitle":"","subtitle_show":0,"pub_time":1774260111000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51399782/gamehaus-holdings-q2-eps-0-02-up-from-0-01-yoy-sales-26-295m-down-from-28-519m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"GMHS":1},"rights":null},{"id":517233,"article_id":"2621212457","title":"Nasdaq Tumbles 2% Amid Rate-Hike Fears: Fear & Greed Index Remains In 'Extreme Fear' Zone","subtitle":"","subtitle_show":0,"pub_time":1774242779000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51398180/nasdaq-tumbles-2-amid-rate-hike-fears-fear-greed-index-remains-in-extreme-fear-zone","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".DJI":1.88,".IXIC":1.94,".SPX":1.9,"DJX":1.88,"EVS.SI":0.6,"PLU":0.6,"XPEG":0.6},"rights":null},{"id":517213,"article_id":"2621407721","title":"United Airlines, AGI And 3 Stocks To Watch Heading Into Monday","subtitle":"","subtitle_show":0,"pub_time":1774242549000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/long-ideas/26/03/51398158/united-airlines-agi-and-3-stocks-to-watch-heading-into-monday","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"AGBK":1.5,"AGI":1.5,"BNGO":1,"CMCL":0.9,"CTNT":1,"UAL":1.5},"rights":null},{"id":514238,"article_id":"2621751698","title":"FiEE Q4 EPS $0.35, Sales $4.545M","subtitle":"","subtitle_show":0,"pub_time":1774037551000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51391300/fiee-q4-eps-0-35-sales-4-545m","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FIEE":0.9},"rights":null},{"id":513473,"article_id":"2621254758","title":"Nasdaq Down Over 1%; XPeng Shares Fall After Q4 Results","subtitle":"","subtitle_show":0,"pub_time":1774024424000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/market-summary/26/03/51384244/nasdaq-down-over-1-xpeng-shares-fall-after-q4-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BARK":1,"CODX":1,"EVS.SI":0.6,"PLU":0.6,"SCHL":1,"SMCC":0.6,"SMCL":0.6,"SMCX":0.6,"SMCY":0.6,"SMCZ":0.6,"SMYY":0.6,"UMAC":0.9,"XPEG":0.6,"XPEV":1},"rights":null},{"id":513259,"article_id":"2620773012","title":"Intuitive Machines Analysts Increase Their Forecasts After Q4 Results","subtitle":"","subtitle_show":0,"pub_time":1774021276000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51382666/intuitive-machines-analysts-increase-their-forecasts-after-q4-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"LUNL":0.6,"LUNR":1.5},"rights":null},{"id":513260,"article_id":"2620122730","title":"Why Milestone Pharma Stock Is Taking A Dive Today","subtitle":"","subtitle_show":0,"pub_time":1774021220000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/health-care/26/03/51382636/why-milestone-pharma-stock-is-taking-a-dive-today","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MIST":1,"SMA":1,"SURI":0.9},"rights":null},{"id":513246,"article_id":"2620730913","title":"These Analysts Cut Their Forecasts On Accenture Following Q2 Results","subtitle":"","subtitle_show":0,"pub_time":1774020967000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51382500/these-analysts-cut-their-forecasts-on-accenture-following-q2-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ACN":1},"rights":null},{"id":513204,"article_id":"2620730652","title":"Signet Jewelers Analysts Boost Their Forecasts After Strong Q4 Results","subtitle":"","subtitle_show":0,"pub_time":1774020676000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51382349/signet-jewelers-analysts-boost-their-forecasts-after-strong-q4-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SIG":1.5},"rights":null},{"id":512995,"article_id":"2620737188","title":"Planet Labs Stock: To The Moon And Back(log)","subtitle":"","subtitle_show":0,"pub_time":1774018864000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51381319/planet-labs-stock-to-the-moon-and-backlog","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PL":1,"PLU":0.6},"rights":null},{"id":512856,"article_id":"2620321107","title":"Ming Shing Group Holdings H1 EPS $(0.28) Down From $0.09 YoY, Sales $8.431M Down From $17.408M YoY","subtitle":"","subtitle_show":0,"pub_time":1774017463000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51380475/ming-shing-group-holdings-h1-eps-0-28-down-from-0-09-yoy-sales-8-431m-down-from-17-408m-yoy","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MSW":0.9},"rights":null},{"id":512718,"article_id":"2620734279","title":"These Analysts Increase Their Forecasts On FedEx Following Upbeat Q3 Results","subtitle":"","subtitle_show":0,"pub_time":1774016252000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51379616/these-analysts-increase-their-forecasts-on-fedex-following-upbeat-q3-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FDX":1.5},"rights":null},{"id":512703,"article_id":"2620734435","title":"These Analysts Slash Their Forecasts On Alibaba Following Weak Q3 Results","subtitle":"","subtitle_show":0,"pub_time":1774015977000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51379400/these-analysts-slash-their-forecasts-on-alibaba-following-weak-q3-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"89988":0.6,"09988":1.98,"BABA":1.98,"BABO":0.6,"BABU":0.6,"BABW":0.6,"BABX":0.6,"BBYY":0.6,"ALBmain":0.6,"HBBD.SI":0.6,"KBAB":0.6},"rights":null},{"id":512035,"article_id":"2620736974","title":"Top Wall Street Forecasters Revamp Core & Main Expectations Ahead Of Q4 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774010829000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51376673/top-wall-street-forecasters-revamp-core-main-expectations-ahead-of-q4-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"CNM":1.5},"rights":null},{"id":512033,"article_id":"2620073692","title":"These Analysts Increase Their Forecasts On Darden Restaurants Following Upbeat Results","subtitle":"","subtitle_show":0,"pub_time":1774010775000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51376626/these-analysts-increase-their-forecasts-on-darden-restaurants-following-upbeat-results","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"DRI":1.5},"rights":null},{"id":511773,"article_id":"2620735857","title":"Phunware Q4 EPS $(0.11) Beats $(0.14) Estimate, Sales $800.000K Beat $605.000K Estimate","subtitle":"","subtitle_show":0,"pub_time":1774008681000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51375766/phunware-q4-eps-0-11-beats-0-14-estimate-sales-800-000k-beat-605-000k-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"PHUN":1},"rights":null},{"id":511622,"article_id":"2620733382","title":"How To Earn $500 A Month From Smithfield Foods Stock Ahead Of Q4 Earnings","subtitle":"","subtitle_show":0,"pub_time":1774007332000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/trading-ideas/dividends/26/03/51375149/how-to-earn-500-a-month-from-smithfield-foods-stock-ahead-of-q4-earnings","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"SFD":1.5},"rights":null},{"id":511494,"article_id":"2620738517","title":"Milestone Pharmaceuticals Q4 EPS $(0.16), Inline, Sales $1.546M Beat $1.200M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774006000000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51374878/milestone-pharmaceuticals-q4-eps-0-16-inline-sales-1-546m-beat-1-200m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"MIST":1},"rights":null},{"id":511414,"article_id":"2620078021","title":"Ermenegildo Zegna FY EPS $0.43 Misses $0.45 Estimate, Sales $2.166B Miss $2.360B Estimate","subtitle":"","subtitle_show":0,"pub_time":1774005233000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51374692/ermenegildo-zegna-fy-eps-0-43-misses-0-45-estimate-sales-2-166b-miss-2-360b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"ZGN":1},"rights":null},{"id":511292,"article_id":"2620787070","title":"XPeng Sounds Alarm On China EV Demand With Disappointing Outlook","subtitle":"","subtitle_show":0,"pub_time":1774004037000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/earnings/26/03/51374363/xpeng-sounds-alarm-on-china-ev-demand-with-disappointing-outlook","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"07766":0.6,"09868":1.98,"CRSH":0.6,"EVS.SI":0.6,"TESL":0.6,"TEST":0.6,"TLA":0.6,"TSDD":0.6,"TSII":0.6,"TSL":0.6,"TSLG":0.6,"TSLI":0.6,"TSLL":0.6,"TSLO":0.6,"TSLP":0.6,"TSLQ":0.6,"TSLR":0.6,"TSLS":0.6,"TSLT":0.6,"TSLW":0.6,"TSLY":0.6,"TSLZ":0.6,"TSYY":0.6,"XPEG":0.6,"XPEV":1.98},"rights":null},{"id":511027,"article_id":"2620821727","title":"BitFuFu Q4 EPS $(0.59) Misses $(0.02) Estimate, Sales $101.657M Miss $103.623M Estimate","subtitle":"","subtitle_show":0,"pub_time":1774001568000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51373864/bitfufu-q4-eps-0-59-misses-0-02-estimate-sales-101-657m-miss-103-623m-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"FUFU":1},"rights":null},{"id":510915,"article_id":"2620782897","title":"Stock Market Today: S&P 500, Dow Futures Down Ahead Of 'Triple Witching' As Iran Warns Of 'Zero Restraint'—FedEx, Super Micro Computer In Focus","subtitle":"","subtitle_show":0,"pub_time":1774000692000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/equities/26/03/51373609/stock-market-today-sp-500-dow-futures-down-ahead-of-triple-witching-as-iran-warns-of-zero-restraint-fedex-super-micro-computer-in-focus","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".SPX":1.91,"BMAY":0.6,"FDX":1.93,"ESmain":0.6,"MESmain":0.6,"GPIX":0.6,"HIBL":0.6,"IVOO":0.6,"IVV":0.6,"IVW":0.6,"JEPI":0.6,"OEF":0.6,"OEX":0.6,"PLU":0.6,"RSP":0.6,"SCHL":1.87,"SDS":0.6,"SER":1.83,"SH":0.6,"SMCC":0.6,"SMCI":1.92,"SMCL":0.6,"SMCX":0.6,"SMCY":0.6,"SMCZ":0.6,"SMYY":0.6,"SPDN":0.6,"SPLV":0.6,"SPMO":0.6,"SPXL":0.6,"SPXS":0.6,"SPXU":0.6,"SPYG":0.6,"SPYI":0.6,"SPYM":0.6,"SPYV":0.6,"SSO":0.6,"TECL":0.6,"UPRO":0.6,"VTI":0.6,"VTV":0.6,"XDTE":0.6,"XYLD":0.6},"rights":null},{"id":510649,"article_id":"2620781548","title":"XPeng Q4 Adj. EPS per ADS $0.07, Sales $3.182B Miss $3.320B Estimate","subtitle":"","subtitle_show":0,"pub_time":1773998043000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/26/03/51373288/xpeng-q4-adj-eps-per-ads-0-07-sales-3-182b-miss-3-320b-estimate","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"09868":1.98,"EVS.SI":0.6,"XPEG":0.6,"XPEV":1.98},"rights":null},{"id":510241,"article_id":"2620778522","title":"China's Alibaba Eyes $100 Billion In Cloud, AI Revenue Over Five Years","subtitle":"","subtitle_show":0,"pub_time":1773994235000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/tech/26/03/51373015/chinas-alibaba-eyes-100-billion-in-cloud-ai-revenue-over-five-years","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"89988":0.6,"09988":1.98,"AIYY":0.6,"BABA":1.98,"BABO":0.6,"BABU":0.6,"BABW":0.6,"BABX":0.6,"BBYY":0.6,"ALBmain":0.6,"HBBD.SI":0.6,"KBAB":0.6},"rights":null},{"id":510164,"article_id":"2620785328","title":"Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","subtitle":"","subtitle_show":0,"pub_time":1773993250000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/03/51372905/bionano-genomics-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":0,"top_time":0,"symbols_score_info":{"BNGO":1.5},"rights":null},{"id":509899,"article_id":"2620004112","title":"Dow Declines 200 Points, Falls For A Second Day: Fear & Greed Index Remains In 'Extreme Fear' Zone","subtitle":"","subtitle_show":0,"pub_time":1773989299000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/markets/market-summary/26/03/51372541/dow-declines-200-points-greed-index-remains-in-extreme-fear-zone","is_publish_highlight":0,"top_time":0,"symbols_score_info":{".DJI":1.95,".SPX":1.86,"DJX":1.95,"EVS.SI":0.6,"XPEG":0.6},"rights":null}],"isFinancial":true,"allList":[{"id":548594989041080,"gmtCreate":1774958619640,"gmtModify":1774958623439,"author":{"id":"4092737024653350","authorId":"4092737024653350","name":"Investordude1301","avatar":"https://community-static.tradeup.com/news/800d9eeaf25151ecb80e9675139f8bc2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092737024653350","authorIdStr":"4092737024653350"},"themes":[],"title":"","htmlText":"Fantastic news for US shares and VOO!","listText":"Fantastic news for US shares and VOO!","text":"Fantastic news for US shares and VOO!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/548594989041080","repostId":"2623079093","repostType":2,"repost":{"id":"2623079093","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1774950374,"share":"https://ttm.financial/m/news/2623079093?lang=en_US&edition=fundamental","pubTime":"2026-03-31 17:46","market":"us","language":"en","title":"Stock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2623079093","media":"Benzinga","summary":"U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.","content":"<html><body><p>U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.</p>\n<p>In the latest on the U.S.-Iran war, President <strong>Donald Trump</strong> hinted at ending the U.S. military campaign against Iran even if the Strait of Hormuz remains largely closed, the Wall Street Journal reported.</p>\n<p>Iran’s foreign minister, <strong>Abbas Araghchi</strong>, called on Saudi Arabia to \"eject\" U.S. troops from the kingdom, following an Iranian strike on a major American air base. </p>\n<p>Meanwhile, Israeli Prime Minister <strong>Benjamin Netanyahu</strong> announced that the joint U.S.-Israel mission in Iran has crossed a significant threshold. </p>\n<p>The 10-year Treasury bond yielded 4.32%, and the two-year bond was at 3.82%. The CME Group's FedWatch tool‘s projections show markets pricing a 97.4% likelihood of the Federal Reserve leaving the current interest rates unchanged in its April meeting. </p>\n<figure><table><tbody><tr><td><strong>Index</strong></td><td><strong>Performance (+/-)</strong></td></tr><tr><td>Dow Jones</td><td>0.92%</td></tr><tr><td>S&amp;P 500</td><td>0.89%</td></tr><tr><td>Nasdaq 100</td><td>0.70%</td></tr><tr><td>Russell 2000</td><td>1.41%</td></tr></tbody></table></figure>\n<p>The <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:SPY) and <strong>Invesco QQQ Trust ETF</strong> (NASDAQ:QQQ), which track the S&amp;P 500 and Nasdaq 100, respectively, were higher in premarket on Tuesday. The SPY was up 0.86% at $637.38, while the QQQ advanced 0.80% to $562.73.</p>\n<h2><strong>Stocks In Focus</strong></h2>\n<h2>Allbirds</h2>\n<ul>\n<li><strong>Allbirds Inc.</strong> (NASDAQ:BIRD) surged 19.40% in premarket on Tuesday after it announced that it has entered into a definitive agreement with American Exchange Group to sell all of its intellectual property and certain assets.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that BIRD maintains a weak price trend over the medium and long terms but a strong trend in the short term.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 840px) 100vw, 840px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31.png 840w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31-768x113.png 768w\" width=\"840\"/></figure>\n<h2>Virgin Galactic Holdings</h2>\n<ul>\n<li><strong>Virgin Galactic Holdings Inc. </strong>(NYSE:SPCE) jumped 6.45% after reporting mixed financial results for the fourth quarter after the market closed on Monday.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that SPCE maintains a weak trend in the long, short, and medium terms.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 839px) 100vw, 839px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31.png 839w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31-768x114.png 768w\" width=\"839\"/></figure>\n<h2><a href=\"https://laohu8.com/S/NBIS\">Nebius</a> Group</h2>\n<ul>\n<li><strong>Nebius Group NV</strong> (NASDAQ:NBIS) was 2.12% higher after it announced that it will be constructing a 310 MW AI Factory in Finland.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that NBIS maintains a weak price trend over the short and medium terms but a strong trend in the long term, with a poor value score.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"125\" loading=\"lazy\" sizes=\"(max-width: 841px) 100vw, 841px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31.png 841w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31-300x45.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31-768x114.png 768w\" width=\"841\"/></figure>\n<h2><a href=\"https://laohu8.com/S/RKLB\">Rocket Lab</a></h2>\n<ul>\n<li><strong>Rocket Lab Corp. </strong>(NASDAQ:RKLB) was up 2.33% after receiving German regulatory approval for the Mynaric acquisition.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that RKLB maintains a weak price trend over the short and medium terms but a strong trend in the long term.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 844px) 100vw, 844px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31.png 844w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31-768x113.png 768w\" width=\"844\"/></figure>\n<h2>Nike</h2>\n<ul>\n<li><strong>Nike Inc.</strong> (NYSE:NKE) was up 1.19% as analysts expect it to post quarterly earnings of 28 cents per share on revenue of $11.24 billion, after the closing bell.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that NKE maintains a weak price trend in the short, medium, and long terms with a poor growth score.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"123\" loading=\"lazy\" sizes=\"(max-width: 848px) 100vw, 848px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31.png 848w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31-768x111.png 768w\" width=\"848\"/></figure>\n<h2><strong>Cues From Last Session</strong></h2>\n<p>Utilities, consumer staples, and financial shares led the S&amp;P 500 higher on Monday, though industrials and tech stocks lagged to leave U.S. markets mixed as the Nasdaq shed 150 points.</p>\n<figure><table><tbody><tr><td><strong>Index</strong></td><td><strong>Performance (+/-)</strong></td><td><strong>Value</strong></td></tr><tr><td>Dow Jones</td><td>0.11%</td><td>45,216.14</td></tr><tr><td>S&amp;P 500</td><td>-0.39%</td><td>6,343.72</td></tr><tr><td>Nasdaq Composite</td><td>-0.73%</td><td>20,794.64</td></tr><tr><td>Russell 2000</td><td>-1.46%</td><td>2,414.01</td></tr></tbody></table></figure>\n<h2><strong>Insights From Analysts</strong></h2>\n<p><strong>LPL Financial </strong>maintains a constructive long-term outlook for the U.S. stock market, primarily driven by the “resilience of corporate America” and a robust earnings backdrop.</p>\n<p>Despite a “heightened risk of some additional near-term downside” due to the ongoing Iran conflict and volatile oil prices, analysts expect 2026 to be a “good year for stocks on the back of solid economic growth.”</p>\n<p>LPL forecasts a sixth consecutive quarter of double-digit earnings growth for the S&amp;P 500, projecting a mid-teens increase for the first quarter. Key economic drivers include “massive artificial intelligence (AI) investment” and fiscal stimulus from the “One Big Beautiful Bill Act (OBBBA).”</p>\n<p>While technical indicators suggest market internals have weakened—with the S&amp;P 500 trading below its 200-day moving average—LPL views the current pullback as a potential “discounted price” for future earnings.</p>\n<p>Although management guidance may turn cautious due to “disruptions to commodity supply chains,” the fundamental outlook remains bright. LPL concludes that “once a path to ending the conflict becomes clear… stocks should get a nice jolt to the upside.”</p>\n<h2><strong>Upcoming Economic Data</strong></h2>\n<p>Here's what investors will be keeping an eye on Tuesday.</p>\n<ul>\n<li>January’s S&amp;P Case-Shiller home price index data for 20 cities will be released by 9:00 a.m., and March’s Chicago Business Barometer (PMI) data will be out by 9:45 a.m. ET.</li>\n<li>February’s job openings and March’s consumer confidence data will be out by 10:00 a.m., Chicago Fed President<strong> Austan Goolsbee </strong>will speak at 12:00 p.m., Fed governor <strong>Michael Barr</strong> will speak at 3:00 p.m., and Fed Vice Chair for Supervision <strong>Michelle Bowman</strong> will speak at 5:10 p.m. ET.</li>\n</ul>\n<h2><strong>Commodities, Crypto, And Global Equity Markets</strong></h2>\n<p>Crude oil futures were trading lower in the early New York session by 0.28% to hover around $102.59 per barrel.</p>\n<p>Gold Spot US Dollar rose 1.34% to hover around $4,571.41 per ounce. Its last record high stood at $5,595.46 per ounce. The U.S. Dollar Index spot was 0.09% lower at the 100.4190 level.</p>\n<p>Meanwhile, <strong>Bitcoin </strong>(CRYPTO: BTC) was trading 1.33% lower at $66,825.19 per coin, as per the last 24 hours.</p>\n<p>Asian markets closed lower on Tuesday, except Hong Kong's <a href=\"https://laohu8.com/S/HSNGF\">Hang Seng</a> and Australia's ASX 200 indices. China’s CSI 300, India’s Nifty 50, South Korea's Kospi, and Japan's Nikkei 225 indices fell. European markets were mostly higher in early trade.</p>\n<p><em>Photo courtesy: Shutterstock</em></p> </body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2026-03-31 17:46</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.</p>\n<p>In the latest on the U.S.-Iran war, President <strong>Donald Trump</strong> hinted at ending the U.S. military campaign against Iran even if the Strait of Hormuz remains largely closed, the Wall Street Journal reported.</p>\n<p>Iran’s foreign minister, <strong>Abbas Araghchi</strong>, called on Saudi Arabia to \"eject\" U.S. troops from the kingdom, following an Iranian strike on a major American air base. </p>\n<p>Meanwhile, Israeli Prime Minister <strong>Benjamin Netanyahu</strong> announced that the joint U.S.-Israel mission in Iran has crossed a significant threshold. </p>\n<p>The 10-year Treasury bond yielded 4.32%, and the two-year bond was at 3.82%. The CME Group's FedWatch tool‘s projections show markets pricing a 97.4% likelihood of the Federal Reserve leaving the current interest rates unchanged in its April meeting. </p>\n<figure><table><tbody><tr><td><strong>Index</strong></td><td><strong>Performance (+/-)</strong></td></tr><tr><td>Dow Jones</td><td>0.92%</td></tr><tr><td>S&amp;P 500</td><td>0.89%</td></tr><tr><td>Nasdaq 100</td><td>0.70%</td></tr><tr><td>Russell 2000</td><td>1.41%</td></tr></tbody></table></figure>\n<p>The <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:SPY) and <strong>Invesco QQQ Trust ETF</strong> (NASDAQ:QQQ), which track the S&amp;P 500 and Nasdaq 100, respectively, were higher in premarket on Tuesday. The SPY was up 0.86% at $637.38, while the QQQ advanced 0.80% to $562.73.</p>\n<h2><strong>Stocks In Focus</strong></h2>\n<h2>Allbirds</h2>\n<ul>\n<li><strong>Allbirds Inc.</strong> (NASDAQ:BIRD) surged 19.40% in premarket on Tuesday after it announced that it has entered into a definitive agreement with American Exchange Group to sell all of its intellectual property and certain assets.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that BIRD maintains a weak price trend over the medium and long terms but a strong trend in the short term.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 840px) 100vw, 840px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31.png 840w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31-768x113.png 768w\" width=\"840\"/></figure>\n<h2>Virgin Galactic Holdings</h2>\n<ul>\n<li><strong>Virgin Galactic Holdings Inc. </strong>(NYSE:SPCE) jumped 6.45% after reporting mixed financial results for the fourth quarter after the market closed on Monday.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that SPCE maintains a weak trend in the long, short, and medium terms.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 839px) 100vw, 839px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31.png 839w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31-768x114.png 768w\" width=\"839\"/></figure>\n<h2><a href=\"https://laohu8.com/S/NBIS\">Nebius</a> Group</h2>\n<ul>\n<li><strong>Nebius Group NV</strong> (NASDAQ:NBIS) was 2.12% higher after it announced that it will be constructing a 310 MW AI Factory in Finland.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that NBIS maintains a weak price trend over the short and medium terms but a strong trend in the long term, with a poor value score.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"125\" loading=\"lazy\" sizes=\"(max-width: 841px) 100vw, 841px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31.png 841w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31-300x45.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31-768x114.png 768w\" width=\"841\"/></figure>\n<h2><a href=\"https://laohu8.com/S/RKLB\">Rocket Lab</a></h2>\n<ul>\n<li><strong>Rocket Lab Corp. </strong>(NASDAQ:RKLB) was up 2.33% after receiving German regulatory approval for the Mynaric acquisition.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that RKLB maintains a weak price trend over the short and medium terms but a strong trend in the long term.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 844px) 100vw, 844px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31.png 844w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31-768x113.png 768w\" width=\"844\"/></figure>\n<h2>Nike</h2>\n<ul>\n<li><strong>Nike Inc.</strong> (NYSE:NKE) was up 1.19% as analysts expect it to post quarterly earnings of 28 cents per share on revenue of $11.24 billion, after the closing bell.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that NKE maintains a weak price trend in the short, medium, and long terms with a poor growth score.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"123\" loading=\"lazy\" sizes=\"(max-width: 848px) 100vw, 848px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31.png 848w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31-768x111.png 768w\" width=\"848\"/></figure>\n<h2><strong>Cues From Last Session</strong></h2>\n<p>Utilities, consumer staples, and financial shares led the S&amp;P 500 higher on Monday, though industrials and tech stocks lagged to leave U.S. markets mixed as the Nasdaq shed 150 points.</p>\n<figure><table><tbody><tr><td><strong>Index</strong></td><td><strong>Performance (+/-)</strong></td><td><strong>Value</strong></td></tr><tr><td>Dow Jones</td><td>0.11%</td><td>45,216.14</td></tr><tr><td>S&amp;P 500</td><td>-0.39%</td><td>6,343.72</td></tr><tr><td>Nasdaq Composite</td><td>-0.73%</td><td>20,794.64</td></tr><tr><td>Russell 2000</td><td>-1.46%</td><td>2,414.01</td></tr></tbody></table></figure>\n<h2><strong>Insights From Analysts</strong></h2>\n<p><strong>LPL Financial </strong>maintains a constructive long-term outlook for the U.S. stock market, primarily driven by the “resilience of corporate America” and a robust earnings backdrop.</p>\n<p>Despite a “heightened risk of some additional near-term downside” due to the ongoing Iran conflict and volatile oil prices, analysts expect 2026 to be a “good year for stocks on the back of solid economic growth.”</p>\n<p>LPL forecasts a sixth consecutive quarter of double-digit earnings growth for the S&amp;P 500, projecting a mid-teens increase for the first quarter. Key economic drivers include “massive artificial intelligence (AI) investment” and fiscal stimulus from the “One Big Beautiful Bill Act (OBBBA).”</p>\n<p>While technical indicators suggest market internals have weakened—with the S&amp;P 500 trading below its 200-day moving average—LPL views the current pullback as a potential “discounted price” for future earnings.</p>\n<p>Although management guidance may turn cautious due to “disruptions to commodity supply chains,” the fundamental outlook remains bright. LPL concludes that “once a path to ending the conflict becomes clear… stocks should get a nice jolt to the upside.”</p>\n<h2><strong>Upcoming Economic Data</strong></h2>\n<p>Here's what investors will be keeping an eye on Tuesday.</p>\n<ul>\n<li>January’s S&amp;P Case-Shiller home price index data for 20 cities will be released by 9:00 a.m., and March’s Chicago Business Barometer (PMI) data will be out by 9:45 a.m. ET.</li>\n<li>February’s job openings and March’s consumer confidence data will be out by 10:00 a.m., Chicago Fed President<strong> Austan Goolsbee </strong>will speak at 12:00 p.m., Fed governor <strong>Michael Barr</strong> will speak at 3:00 p.m., and Fed Vice Chair for Supervision <strong>Michelle Bowman</strong> will speak at 5:10 p.m. ET.</li>\n</ul>\n<h2><strong>Commodities, Crypto, And Global Equity Markets</strong></h2>\n<p>Crude oil futures were trading lower in the early New York session by 0.28% to hover around $102.59 per barrel.</p>\n<p>Gold Spot US Dollar rose 1.34% to hover around $4,571.41 per ounce. Its last record high stood at $5,595.46 per ounce. The U.S. Dollar Index spot was 0.09% lower at the 100.4190 level.</p>\n<p>Meanwhile, <strong>Bitcoin </strong>(CRYPTO: BTC) was trading 1.33% lower at $66,825.19 per coin, as per the last 24 hours.</p>\n<p>Asian markets closed lower on Tuesday, except Hong Kong's <a href=\"https://laohu8.com/S/HSNGF\">Hang Seng</a> and Australia's ASX 200 indices. China’s CSI 300, India’s Nifty 50, South Korea's Kospi, and Japan's Nikkei 225 indices fell. European markets were mostly higher in early trade.</p>\n<p><em>Photo courtesy: Shutterstock</em></p> </body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SSO":"2倍做多标普500ETF-ProShares","VOO":"Vanguard标普500ETF","BIRD":"Allbirds, Inc.","SPY":"标普500ETF","RSP":"平均加权指数ETF-Rydex S&P","VOOG":"Vanguard标普500成长ETF","MOAT":"VanEck Morningstar Wide Moat ETF","HIBL":"Direxion Daily S&P 500 High Beta Bull 3X Shares","IVOO":"Vanguard S&P Mid-Cap 400 ETF","VTV":"Vanguard Value ETF","SPYV":"SPDR Portfolio S&P 500 Value ETF","NBIG":"Leverage Shares 2X Long NBIS Daily ETF","VYM":"红利股ETF-Vanguard","NBIL":"GraniteShares 2x Long NBIS Daily ETF",".SPX":"S&P 500 Index","SPCE":"维珍银河","OEF":"标普100指数ETF-iShares","NBIZ":"Tradr 2X Short NBIS Daily ETF","SPXL":"三倍做多标普500ETF-Direxion","XDTE":"Roundhill S&P 500 0DTE Covered Call Strategy ETF","GPIX":"GOLDMAN SACHS S&P 500 CORE PREMIUM INCOME ETF","JEPI":"JPMorgan Equity Premium Income ETF","SPUS":"SP Funds S&P 500 Sharia Industry Exclusions ETF","SPYG":"SPDR Portfolio S&P 500 Growth ETF","VUG":"成长股指数ETF-Vanguard MSCI","NKE":"耐克","UPRO":"三倍做多标普500ETF-ProShares","VEU":"Vanguard FTSE All-World ex-US ETF","SPLV":"Invesco S&P 500 Low Volatility ETF","SCHG":"Schwab U.S. Large -Cap Growth ET","DBSC":"Deepwater Beachfront Small Cap ETF","RKLZ":"2倍做空RKLB ETF-Defiance","SPYI":"NEOS S&P 500 High Income ETF","SPUU":"Direxion Daily S&P 500 Bull 2x Shares","SPDN":"Direxion Daily S&P 500 Bear 1X Shares","SPXU":"三倍做空标普500ETF-ProShares","ALLW":"SPDR BRIDGEWATER ALL WEATHER ETF","VTI":"大盘指数ETF-Vanguard MSCI","SPYM":"投资组合标普500指数ETF-SPDR","SPHD":"标普500高股利投资组合ETF-PowerShares","IVE":"标普500价值指数ETF-iShares","OEX":"标普100","NEBX":"2倍做多NBIS ETF-Tradr","TECL":"Direxion DailyTechnology Bull 3x","SPYQ":"2倍做多SPY Quarterly ETF-Tradr","SPMO":"Invesco S&P 500 Momentum ETF"},"source_url":"https://www.benzinga.com/markets/equities/26/03/51560112/stock-market-today-sp-500-dow-futures-jump-as-trump-hints-at-ending-iran-war-even-if-hormuz-remains-closed-allbirds-rocket-labs-nebius-in-focus","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2623079093","content_text":"U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.\nIn the latest on the U.S.-Iran war, President Donald Trump hinted at ending the U.S. military campaign against Iran even if the Strait of Hormuz remains largely closed, the Wall Street Journal reported.\nIran’s foreign minister, Abbas Araghchi, called on Saudi Arabia to \"eject\" U.S. troops from the kingdom, following an Iranian strike on a major American air base. \nMeanwhile, Israeli Prime Minister Benjamin Netanyahu announced that the joint U.S.-Israel mission in Iran has crossed a significant threshold. \nThe 10-year Treasury bond yielded 4.32%, and the two-year bond was at 3.82%. The CME Group's FedWatch tool‘s projections show markets pricing a 97.4% likelihood of the Federal Reserve leaving the current interest rates unchanged in its April meeting. \nIndexPerformance (+/-)Dow Jones0.92%S&P 5000.89%Nasdaq 1000.70%Russell 20001.41%\nThe SPDR S&P 500 ETF Trust (NYSE:SPY) and Invesco QQQ Trust ETF (NASDAQ:QQQ), which track the S&P 500 and Nasdaq 100, respectively, were higher in premarket on Tuesday. The SPY was up 0.86% at $637.38, while the QQQ advanced 0.80% to $562.73.\nStocks In Focus\nAllbirds\n\nAllbirds Inc. (NASDAQ:BIRD) surged 19.40% in premarket on Tuesday after it announced that it has entered into a definitive agreement with American Exchange Group to sell all of its intellectual property and certain assets.\n\n\nBenzinga’s Edge Stock Rankings indicate that BIRD maintains a weak price trend over the medium and long terms but a strong trend in the short term.\n\n\nVirgin Galactic Holdings\n\nVirgin Galactic Holdings Inc. (NYSE:SPCE) jumped 6.45% after reporting mixed financial results for the fourth quarter after the market closed on Monday.\n\n\nBenzinga’s Edge Stock Rankings indicate that SPCE maintains a weak trend in the long, short, and medium terms.\n\n\nNebius Group\n\nNebius Group NV (NASDAQ:NBIS) was 2.12% higher after it announced that it will be constructing a 310 MW AI Factory in Finland.\n\n\nBenzinga’s Edge Stock Rankings indicate that NBIS maintains a weak price trend over the short and medium terms but a strong trend in the long term, with a poor value score.\n\n\nRocket Lab\n\nRocket Lab Corp. (NASDAQ:RKLB) was up 2.33% after receiving German regulatory approval for the Mynaric acquisition.\n\n\nBenzinga’s Edge Stock Rankings indicate that RKLB maintains a weak price trend over the short and medium terms but a strong trend in the long term.\n\n\nNike\n\nNike Inc. (NYSE:NKE) was up 1.19% as analysts expect it to post quarterly earnings of 28 cents per share on revenue of $11.24 billion, after the closing bell.\n\n\nBenzinga’s Edge Stock Rankings indicate that NKE maintains a weak price trend in the short, medium, and long terms with a poor growth score.\n\n\nCues From Last Session\nUtilities, consumer staples, and financial shares led the S&P 500 higher on Monday, though industrials and tech stocks lagged to leave U.S. markets mixed as the Nasdaq shed 150 points.\nIndexPerformance (+/-)ValueDow Jones0.11%45,216.14S&P 500-0.39%6,343.72Nasdaq Composite-0.73%20,794.64Russell 2000-1.46%2,414.01\nInsights From Analysts\nLPL Financial maintains a constructive long-term outlook for the U.S. stock market, primarily driven by the “resilience of corporate America” and a robust earnings backdrop.\nDespite a “heightened risk of some additional near-term downside” due to the ongoing Iran conflict and volatile oil prices, analysts expect 2026 to be a “good year for stocks on the back of solid economic growth.”\nLPL forecasts a sixth consecutive quarter of double-digit earnings growth for the S&P 500, projecting a mid-teens increase for the first quarter. Key economic drivers include “massive artificial intelligence (AI) investment” and fiscal stimulus from the “One Big Beautiful Bill Act (OBBBA).”\nWhile technical indicators suggest market internals have weakened—with the S&P 500 trading below its 200-day moving average—LPL views the current pullback as a potential “discounted price” for future earnings.\nAlthough management guidance may turn cautious due to “disruptions to commodity supply chains,” the fundamental outlook remains bright. LPL concludes that “once a path to ending the conflict becomes clear… stocks should get a nice jolt to the upside.”\nUpcoming Economic Data\nHere's what investors will be keeping an eye on Tuesday.\n\nJanuary’s S&P Case-Shiller home price index data for 20 cities will be released by 9:00 a.m., and March’s Chicago Business Barometer (PMI) data will be out by 9:45 a.m. ET.\nFebruary’s job openings and March’s consumer confidence data will be out by 10:00 a.m., Chicago Fed President Austan Goolsbee will speak at 12:00 p.m., Fed governor Michael Barr will speak at 3:00 p.m., and Fed Vice Chair for Supervision Michelle Bowman will speak at 5:10 p.m. ET.\n\nCommodities, Crypto, And Global Equity Markets\nCrude oil futures were trading lower in the early New York session by 0.28% to hover around $102.59 per barrel.\nGold Spot US Dollar rose 1.34% to hover around $4,571.41 per ounce. Its last record high stood at $5,595.46 per ounce. The U.S. Dollar Index spot was 0.09% lower at the 100.4190 level.\nMeanwhile, Bitcoin (CRYPTO: BTC) was trading 1.33% lower at $66,825.19 per coin, as per the last 24 hours.\nAsian markets closed lower on Tuesday, except Hong Kong's Hang Seng and Australia's ASX 200 indices. China’s CSI 300, India’s Nifty 50, South Korea's Kospi, and Japan's Nikkei 225 indices fell. European markets were mostly higher in early trade.\nPhoto courtesy: Shutterstock","news_type":1,"symbols_score_info":{"SPDN":0.6,"DBSC":0.6,"NBIG":0.6,"SPLV":0.6,"VTI":0.6,"VOOG":1.5,"OEX":0.6,"SPXU":0.6,".SPX":1.5,"OEF":0.6,"NBIZ":0.6,"SPXL":0.6,"NEBX":0.6,"SCHG":1.5,"SSO":0.6,"BIRD":1.5,"NBIL":0.6,"GPIX":0.6,"UPRO":0.6,"JEPI":0.6,"TECL":0.6,"SPYM":0.6,"SPUS":0.6,"MOAT":0.6,"HIBL":0.6,"VTV":0.6,"VEU":0.6,"ALLW":0.6,"VUG":1.5,"RSP":0.6,"SPHD":0.6,"IVOO":0.6,"XDTE":0.6,"IVE":0.6,"SPYV":0.6,"VOO":1.5,"SPYQ":0.6,"SPCE":1,"SPY":1.5,"SPYG":0.6,"SPYI":0.6,"SPMO":0.6,"VYM":1.5,"NKE":1,"SPUU":0.6,"RKLZ":0.6}},"isVote":1,"tweetType":1,"viewCount":9,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"essenList":[{"id":548594989041080,"gmtCreate":1774958619640,"gmtModify":1774958623439,"author":{"id":"4092737024653350","authorId":"4092737024653350","name":"Investordude1301","avatar":"https://community-static.tradeup.com/news/800d9eeaf25151ecb80e9675139f8bc2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737024653350","idStr":"4092737024653350"},"themes":[],"title":"","htmlText":"Fantastic news for US shares and VOO!","listText":"Fantastic news for US shares and VOO!","text":"Fantastic news for US shares and VOO!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/548594989041080","repostId":"2623079093","repostType":2,"repost":{"id":"2623079093","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1774950374,"share":"https://ttm.financial/m/news/2623079093?lang=en_US&edition=fundamental","pubTime":"2026-03-31 17:46","market":"us","language":"en","title":"Stock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2623079093","media":"Benzinga","summary":"U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.","content":"<html><body><p>U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.</p>\n<p>In the latest on the U.S.-Iran war, President <strong>Donald Trump</strong> hinted at ending the U.S. military campaign against Iran even if the Strait of Hormuz remains largely closed, the Wall Street Journal reported.</p>\n<p>Iran’s foreign minister, <strong>Abbas Araghchi</strong>, called on Saudi Arabia to \"eject\" U.S. troops from the kingdom, following an Iranian strike on a major American air base. </p>\n<p>Meanwhile, Israeli Prime Minister <strong>Benjamin Netanyahu</strong> announced that the joint U.S.-Israel mission in Iran has crossed a significant threshold. </p>\n<p>The 10-year Treasury bond yielded 4.32%, and the two-year bond was at 3.82%. The CME Group's FedWatch tool‘s projections show markets pricing a 97.4% likelihood of the Federal Reserve leaving the current interest rates unchanged in its April meeting. </p>\n<figure><table><tbody><tr><td><strong>Index</strong></td><td><strong>Performance (+/-)</strong></td></tr><tr><td>Dow Jones</td><td>0.92%</td></tr><tr><td>S&amp;P 500</td><td>0.89%</td></tr><tr><td>Nasdaq 100</td><td>0.70%</td></tr><tr><td>Russell 2000</td><td>1.41%</td></tr></tbody></table></figure>\n<p>The <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:SPY) and <strong>Invesco QQQ Trust ETF</strong> (NASDAQ:QQQ), which track the S&amp;P 500 and Nasdaq 100, respectively, were higher in premarket on Tuesday. The SPY was up 0.86% at $637.38, while the QQQ advanced 0.80% to $562.73.</p>\n<h2><strong>Stocks In Focus</strong></h2>\n<h2>Allbirds</h2>\n<ul>\n<li><strong>Allbirds Inc.</strong> (NASDAQ:BIRD) surged 19.40% in premarket on Tuesday after it announced that it has entered into a definitive agreement with American Exchange Group to sell all of its intellectual property and certain assets.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that BIRD maintains a weak price trend over the medium and long terms but a strong trend in the short term.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 840px) 100vw, 840px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31.png 840w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31-768x113.png 768w\" width=\"840\"/></figure>\n<h2>Virgin Galactic Holdings</h2>\n<ul>\n<li><strong>Virgin Galactic Holdings Inc. </strong>(NYSE:SPCE) jumped 6.45% after reporting mixed financial results for the fourth quarter after the market closed on Monday.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that SPCE maintains a weak trend in the long, short, and medium terms.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 839px) 100vw, 839px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31.png 839w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31-768x114.png 768w\" width=\"839\"/></figure>\n<h2><a href=\"https://laohu8.com/S/NBIS\">Nebius</a> Group</h2>\n<ul>\n<li><strong>Nebius Group NV</strong> (NASDAQ:NBIS) was 2.12% higher after it announced that it will be constructing a 310 MW AI Factory in Finland.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that NBIS maintains a weak price trend over the short and medium terms but a strong trend in the long term, with a poor value score.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"125\" loading=\"lazy\" sizes=\"(max-width: 841px) 100vw, 841px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31.png 841w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31-300x45.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31-768x114.png 768w\" width=\"841\"/></figure>\n<h2><a href=\"https://laohu8.com/S/RKLB\">Rocket Lab</a></h2>\n<ul>\n<li><strong>Rocket Lab Corp. </strong>(NASDAQ:RKLB) was up 2.33% after receiving German regulatory approval for the Mynaric acquisition.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that RKLB maintains a weak price trend over the short and medium terms but a strong trend in the long term.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 844px) 100vw, 844px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31.png 844w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31-768x113.png 768w\" width=\"844\"/></figure>\n<h2>Nike</h2>\n<ul>\n<li><strong>Nike Inc.</strong> (NYSE:NKE) was up 1.19% as analysts expect it to post quarterly earnings of 28 cents per share on revenue of $11.24 billion, after the closing bell.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that NKE maintains a weak price trend in the short, medium, and long terms with a poor growth score.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"123\" loading=\"lazy\" sizes=\"(max-width: 848px) 100vw, 848px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31.png 848w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31-768x111.png 768w\" width=\"848\"/></figure>\n<h2><strong>Cues From Last Session</strong></h2>\n<p>Utilities, consumer staples, and financial shares led the S&amp;P 500 higher on Monday, though industrials and tech stocks lagged to leave U.S. markets mixed as the Nasdaq shed 150 points.</p>\n<figure><table><tbody><tr><td><strong>Index</strong></td><td><strong>Performance (+/-)</strong></td><td><strong>Value</strong></td></tr><tr><td>Dow Jones</td><td>0.11%</td><td>45,216.14</td></tr><tr><td>S&amp;P 500</td><td>-0.39%</td><td>6,343.72</td></tr><tr><td>Nasdaq Composite</td><td>-0.73%</td><td>20,794.64</td></tr><tr><td>Russell 2000</td><td>-1.46%</td><td>2,414.01</td></tr></tbody></table></figure>\n<h2><strong>Insights From Analysts</strong></h2>\n<p><strong>LPL Financial </strong>maintains a constructive long-term outlook for the U.S. stock market, primarily driven by the “resilience of corporate America” and a robust earnings backdrop.</p>\n<p>Despite a “heightened risk of some additional near-term downside” due to the ongoing Iran conflict and volatile oil prices, analysts expect 2026 to be a “good year for stocks on the back of solid economic growth.”</p>\n<p>LPL forecasts a sixth consecutive quarter of double-digit earnings growth for the S&amp;P 500, projecting a mid-teens increase for the first quarter. Key economic drivers include “massive artificial intelligence (AI) investment” and fiscal stimulus from the “One Big Beautiful Bill Act (OBBBA).”</p>\n<p>While technical indicators suggest market internals have weakened—with the S&amp;P 500 trading below its 200-day moving average—LPL views the current pullback as a potential “discounted price” for future earnings.</p>\n<p>Although management guidance may turn cautious due to “disruptions to commodity supply chains,” the fundamental outlook remains bright. LPL concludes that “once a path to ending the conflict becomes clear… stocks should get a nice jolt to the upside.”</p>\n<h2><strong>Upcoming Economic Data</strong></h2>\n<p>Here's what investors will be keeping an eye on Tuesday.</p>\n<ul>\n<li>January’s S&amp;P Case-Shiller home price index data for 20 cities will be released by 9:00 a.m., and March’s Chicago Business Barometer (PMI) data will be out by 9:45 a.m. ET.</li>\n<li>February’s job openings and March’s consumer confidence data will be out by 10:00 a.m., Chicago Fed President<strong> Austan Goolsbee </strong>will speak at 12:00 p.m., Fed governor <strong>Michael Barr</strong> will speak at 3:00 p.m., and Fed Vice Chair for Supervision <strong>Michelle Bowman</strong> will speak at 5:10 p.m. ET.</li>\n</ul>\n<h2><strong>Commodities, Crypto, And Global Equity Markets</strong></h2>\n<p>Crude oil futures were trading lower in the early New York session by 0.28% to hover around $102.59 per barrel.</p>\n<p>Gold Spot US Dollar rose 1.34% to hover around $4,571.41 per ounce. Its last record high stood at $5,595.46 per ounce. The U.S. Dollar Index spot was 0.09% lower at the 100.4190 level.</p>\n<p>Meanwhile, <strong>Bitcoin </strong>(CRYPTO: BTC) was trading 1.33% lower at $66,825.19 per coin, as per the last 24 hours.</p>\n<p>Asian markets closed lower on Tuesday, except Hong Kong's <a href=\"https://laohu8.com/S/HSNGF\">Hang Seng</a> and Australia's ASX 200 indices. China’s CSI 300, India’s Nifty 50, South Korea's Kospi, and Japan's Nikkei 225 indices fell. European markets were mostly higher in early trade.</p>\n<p><em>Photo courtesy: Shutterstock</em></p> </body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Market Today: S&P 500, Dow Futures Jump As Trump Hints At Ending Iran War Even If Hormuz Remains Closed—Allbirds, Rocket Labs, Nebius In Focus\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2026-03-31 17:46</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.</p>\n<p>In the latest on the U.S.-Iran war, President <strong>Donald Trump</strong> hinted at ending the U.S. military campaign against Iran even if the Strait of Hormuz remains largely closed, the Wall Street Journal reported.</p>\n<p>Iran’s foreign minister, <strong>Abbas Araghchi</strong>, called on Saudi Arabia to \"eject\" U.S. troops from the kingdom, following an Iranian strike on a major American air base. </p>\n<p>Meanwhile, Israeli Prime Minister <strong>Benjamin Netanyahu</strong> announced that the joint U.S.-Israel mission in Iran has crossed a significant threshold. </p>\n<p>The 10-year Treasury bond yielded 4.32%, and the two-year bond was at 3.82%. The CME Group's FedWatch tool‘s projections show markets pricing a 97.4% likelihood of the Federal Reserve leaving the current interest rates unchanged in its April meeting. </p>\n<figure><table><tbody><tr><td><strong>Index</strong></td><td><strong>Performance (+/-)</strong></td></tr><tr><td>Dow Jones</td><td>0.92%</td></tr><tr><td>S&amp;P 500</td><td>0.89%</td></tr><tr><td>Nasdaq 100</td><td>0.70%</td></tr><tr><td>Russell 2000</td><td>1.41%</td></tr></tbody></table></figure>\n<p>The <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:SPY) and <strong>Invesco QQQ Trust ETF</strong> (NASDAQ:QQQ), which track the S&amp;P 500 and Nasdaq 100, respectively, were higher in premarket on Tuesday. The SPY was up 0.86% at $637.38, while the QQQ advanced 0.80% to $562.73.</p>\n<h2><strong>Stocks In Focus</strong></h2>\n<h2>Allbirds</h2>\n<ul>\n<li><strong>Allbirds Inc.</strong> (NASDAQ:BIRD) surged 19.40% in premarket on Tuesday after it announced that it has entered into a definitive agreement with American Exchange Group to sell all of its intellectual property and certain assets.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that BIRD maintains a weak price trend over the medium and long terms but a strong trend in the short term.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 840px) 100vw, 840px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31.png 840w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050121/BIRD-EDGE-MARCH-31-768x113.png 768w\" width=\"840\"/></figure>\n<h2>Virgin Galactic Holdings</h2>\n<ul>\n<li><strong>Virgin Galactic Holdings Inc. </strong>(NYSE:SPCE) jumped 6.45% after reporting mixed financial results for the fourth quarter after the market closed on Monday.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that SPCE maintains a weak trend in the long, short, and medium terms.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 839px) 100vw, 839px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31.png 839w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050045/SPCE-EDGE-MARCH-31-768x114.png 768w\" width=\"839\"/></figure>\n<h2><a href=\"https://laohu8.com/S/NBIS\">Nebius</a> Group</h2>\n<ul>\n<li><strong>Nebius Group NV</strong> (NASDAQ:NBIS) was 2.12% higher after it announced that it will be constructing a 310 MW AI Factory in Finland.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that NBIS maintains a weak price trend over the short and medium terms but a strong trend in the long term, with a poor value score.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"125\" loading=\"lazy\" sizes=\"(max-width: 841px) 100vw, 841px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31.png 841w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31-300x45.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31050013/NBIS-EDGE-MARCH-31-768x114.png 768w\" width=\"841\"/></figure>\n<h2><a href=\"https://laohu8.com/S/RKLB\">Rocket Lab</a></h2>\n<ul>\n<li><strong>Rocket Lab Corp. </strong>(NASDAQ:RKLB) was up 2.33% after receiving German regulatory approval for the Mynaric acquisition.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that RKLB maintains a weak price trend over the short and medium terms but a strong trend in the long term.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"124\" loading=\"lazy\" sizes=\"(max-width: 844px) 100vw, 844px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31.png 844w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045946/RKLB-EDGE-MARCH-31-768x113.png 768w\" width=\"844\"/></figure>\n<h2>Nike</h2>\n<ul>\n<li><strong>Nike Inc.</strong> (NYSE:NKE) was up 1.19% as analysts expect it to post quarterly earnings of 28 cents per share on revenue of $11.24 billion, after the closing bell.</li>\n</ul>\n<ul>\n<li><strong>Benzinga’s Edge Stock Rankings</strong> indicate that NKE maintains a weak price trend in the short, medium, and long terms with a poor growth score.</li>\n</ul>\n<figure><img decoding=\"async\" height=\"123\" loading=\"lazy\" sizes=\"(max-width: 848px) 100vw, 848px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31.png 848w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/03/31045913/NKE-EDGE-MARCH-31-768x111.png 768w\" width=\"848\"/></figure>\n<h2><strong>Cues From Last Session</strong></h2>\n<p>Utilities, consumer staples, and financial shares led the S&amp;P 500 higher on Monday, though industrials and tech stocks lagged to leave U.S. markets mixed as the Nasdaq shed 150 points.</p>\n<figure><table><tbody><tr><td><strong>Index</strong></td><td><strong>Performance (+/-)</strong></td><td><strong>Value</strong></td></tr><tr><td>Dow Jones</td><td>0.11%</td><td>45,216.14</td></tr><tr><td>S&amp;P 500</td><td>-0.39%</td><td>6,343.72</td></tr><tr><td>Nasdaq Composite</td><td>-0.73%</td><td>20,794.64</td></tr><tr><td>Russell 2000</td><td>-1.46%</td><td>2,414.01</td></tr></tbody></table></figure>\n<h2><strong>Insights From Analysts</strong></h2>\n<p><strong>LPL Financial </strong>maintains a constructive long-term outlook for the U.S. stock market, primarily driven by the “resilience of corporate America” and a robust earnings backdrop.</p>\n<p>Despite a “heightened risk of some additional near-term downside” due to the ongoing Iran conflict and volatile oil prices, analysts expect 2026 to be a “good year for stocks on the back of solid economic growth.”</p>\n<p>LPL forecasts a sixth consecutive quarter of double-digit earnings growth for the S&amp;P 500, projecting a mid-teens increase for the first quarter. Key economic drivers include “massive artificial intelligence (AI) investment” and fiscal stimulus from the “One Big Beautiful Bill Act (OBBBA).”</p>\n<p>While technical indicators suggest market internals have weakened—with the S&amp;P 500 trading below its 200-day moving average—LPL views the current pullback as a potential “discounted price” for future earnings.</p>\n<p>Although management guidance may turn cautious due to “disruptions to commodity supply chains,” the fundamental outlook remains bright. LPL concludes that “once a path to ending the conflict becomes clear… stocks should get a nice jolt to the upside.”</p>\n<h2><strong>Upcoming Economic Data</strong></h2>\n<p>Here's what investors will be keeping an eye on Tuesday.</p>\n<ul>\n<li>January’s S&amp;P Case-Shiller home price index data for 20 cities will be released by 9:00 a.m., and March’s Chicago Business Barometer (PMI) data will be out by 9:45 a.m. ET.</li>\n<li>February’s job openings and March’s consumer confidence data will be out by 10:00 a.m., Chicago Fed President<strong> Austan Goolsbee </strong>will speak at 12:00 p.m., Fed governor <strong>Michael Barr</strong> will speak at 3:00 p.m., and Fed Vice Chair for Supervision <strong>Michelle Bowman</strong> will speak at 5:10 p.m. ET.</li>\n</ul>\n<h2><strong>Commodities, Crypto, And Global Equity Markets</strong></h2>\n<p>Crude oil futures were trading lower in the early New York session by 0.28% to hover around $102.59 per barrel.</p>\n<p>Gold Spot US Dollar rose 1.34% to hover around $4,571.41 per ounce. Its last record high stood at $5,595.46 per ounce. The U.S. Dollar Index spot was 0.09% lower at the 100.4190 level.</p>\n<p>Meanwhile, <strong>Bitcoin </strong>(CRYPTO: BTC) was trading 1.33% lower at $66,825.19 per coin, as per the last 24 hours.</p>\n<p>Asian markets closed lower on Tuesday, except Hong Kong's <a href=\"https://laohu8.com/S/HSNGF\">Hang Seng</a> and Australia's ASX 200 indices. China’s CSI 300, India’s Nifty 50, South Korea's Kospi, and Japan's Nikkei 225 indices fell. European markets were mostly higher in early trade.</p>\n<p><em>Photo courtesy: Shutterstock</em></p> </body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SSO":"2倍做多标普500ETF-ProShares","VOO":"Vanguard标普500ETF","BIRD":"Allbirds, Inc.","SPY":"标普500ETF","RSP":"平均加权指数ETF-Rydex S&P","VOOG":"Vanguard标普500成长ETF","MOAT":"VanEck Morningstar Wide Moat ETF","HIBL":"Direxion Daily S&P 500 High Beta Bull 3X Shares","IVOO":"Vanguard S&P Mid-Cap 400 ETF","VTV":"Vanguard Value ETF","SPYV":"SPDR Portfolio S&P 500 Value ETF","NBIG":"Leverage Shares 2X Long NBIS Daily ETF","VYM":"红利股ETF-Vanguard","NBIL":"GraniteShares 2x Long NBIS Daily ETF",".SPX":"S&P 500 Index","SPCE":"维珍银河","OEF":"标普100指数ETF-iShares","NBIZ":"Tradr 2X Short NBIS Daily ETF","SPXL":"三倍做多标普500ETF-Direxion","XDTE":"Roundhill S&P 500 0DTE Covered Call Strategy ETF","GPIX":"GOLDMAN SACHS S&P 500 CORE PREMIUM INCOME ETF","JEPI":"JPMorgan Equity Premium Income ETF","SPUS":"SP Funds S&P 500 Sharia Industry Exclusions ETF","SPYG":"SPDR Portfolio S&P 500 Growth ETF","VUG":"成长股指数ETF-Vanguard MSCI","NKE":"耐克","UPRO":"三倍做多标普500ETF-ProShares","VEU":"Vanguard FTSE All-World ex-US ETF","SPLV":"Invesco S&P 500 Low Volatility ETF","SCHG":"Schwab U.S. Large -Cap Growth ET","DBSC":"Deepwater Beachfront Small Cap ETF","RKLZ":"2倍做空RKLB ETF-Defiance","SPYI":"NEOS S&P 500 High Income ETF","SPUU":"Direxion Daily S&P 500 Bull 2x Shares","SPDN":"Direxion Daily S&P 500 Bear 1X Shares","SPXU":"三倍做空标普500ETF-ProShares","ALLW":"SPDR BRIDGEWATER ALL WEATHER ETF","VTI":"大盘指数ETF-Vanguard MSCI","SPYM":"投资组合标普500指数ETF-SPDR","SPHD":"标普500高股利投资组合ETF-PowerShares","IVE":"标普500价值指数ETF-iShares","OEX":"标普100","NEBX":"2倍做多NBIS ETF-Tradr","TECL":"Direxion DailyTechnology Bull 3x","SPYQ":"2倍做多SPY Quarterly ETF-Tradr","SPMO":"Invesco S&P 500 Momentum ETF"},"source_url":"https://www.benzinga.com/markets/equities/26/03/51560112/stock-market-today-sp-500-dow-futures-jump-as-trump-hints-at-ending-iran-war-even-if-hormuz-remains-closed-allbirds-rocket-labs-nebius-in-focus","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2623079093","content_text":"U.S. stock futures rose on Tuesday following Monday’s mixed close. Futures of the major benchmark indices were higher.\nIn the latest on the U.S.-Iran war, President Donald Trump hinted at ending the U.S. military campaign against Iran even if the Strait of Hormuz remains largely closed, the Wall Street Journal reported.\nIran’s foreign minister, Abbas Araghchi, called on Saudi Arabia to \"eject\" U.S. troops from the kingdom, following an Iranian strike on a major American air base. \nMeanwhile, Israeli Prime Minister Benjamin Netanyahu announced that the joint U.S.-Israel mission in Iran has crossed a significant threshold. \nThe 10-year Treasury bond yielded 4.32%, and the two-year bond was at 3.82%. The CME Group's FedWatch tool‘s projections show markets pricing a 97.4% likelihood of the Federal Reserve leaving the current interest rates unchanged in its April meeting. \nIndexPerformance (+/-)Dow Jones0.92%S&P 5000.89%Nasdaq 1000.70%Russell 20001.41%\nThe SPDR S&P 500 ETF Trust (NYSE:SPY) and Invesco QQQ Trust ETF (NASDAQ:QQQ), which track the S&P 500 and Nasdaq 100, respectively, were higher in premarket on Tuesday. The SPY was up 0.86% at $637.38, while the QQQ advanced 0.80% to $562.73.\nStocks In Focus\nAllbirds\n\nAllbirds Inc. (NASDAQ:BIRD) surged 19.40% in premarket on Tuesday after it announced that it has entered into a definitive agreement with American Exchange Group to sell all of its intellectual property and certain assets.\n\n\nBenzinga’s Edge Stock Rankings indicate that BIRD maintains a weak price trend over the medium and long terms but a strong trend in the short term.\n\n\nVirgin Galactic Holdings\n\nVirgin Galactic Holdings Inc. (NYSE:SPCE) jumped 6.45% after reporting mixed financial results for the fourth quarter after the market closed on Monday.\n\n\nBenzinga’s Edge Stock Rankings indicate that SPCE maintains a weak trend in the long, short, and medium terms.\n\n\nNebius Group\n\nNebius Group NV (NASDAQ:NBIS) was 2.12% higher after it announced that it will be constructing a 310 MW AI Factory in Finland.\n\n\nBenzinga’s Edge Stock Rankings indicate that NBIS maintains a weak price trend over the short and medium terms but a strong trend in the long term, with a poor value score.\n\n\nRocket Lab\n\nRocket Lab Corp. (NASDAQ:RKLB) was up 2.33% after receiving German regulatory approval for the Mynaric acquisition.\n\n\nBenzinga’s Edge Stock Rankings indicate that RKLB maintains a weak price trend over the short and medium terms but a strong trend in the long term.\n\n\nNike\n\nNike Inc. (NYSE:NKE) was up 1.19% as analysts expect it to post quarterly earnings of 28 cents per share on revenue of $11.24 billion, after the closing bell.\n\n\nBenzinga’s Edge Stock Rankings indicate that NKE maintains a weak price trend in the short, medium, and long terms with a poor growth score.\n\n\nCues From Last Session\nUtilities, consumer staples, and financial shares led the S&P 500 higher on Monday, though industrials and tech stocks lagged to leave U.S. markets mixed as the Nasdaq shed 150 points.\nIndexPerformance (+/-)ValueDow Jones0.11%45,216.14S&P 500-0.39%6,343.72Nasdaq Composite-0.73%20,794.64Russell 2000-1.46%2,414.01\nInsights From Analysts\nLPL Financial maintains a constructive long-term outlook for the U.S. stock market, primarily driven by the “resilience of corporate America” and a robust earnings backdrop.\nDespite a “heightened risk of some additional near-term downside” due to the ongoing Iran conflict and volatile oil prices, analysts expect 2026 to be a “good year for stocks on the back of solid economic growth.”\nLPL forecasts a sixth consecutive quarter of double-digit earnings growth for the S&P 500, projecting a mid-teens increase for the first quarter. Key economic drivers include “massive artificial intelligence (AI) investment” and fiscal stimulus from the “One Big Beautiful Bill Act (OBBBA).”\nWhile technical indicators suggest market internals have weakened—with the S&P 500 trading below its 200-day moving average—LPL views the current pullback as a potential “discounted price” for future earnings.\nAlthough management guidance may turn cautious due to “disruptions to commodity supply chains,” the fundamental outlook remains bright. LPL concludes that “once a path to ending the conflict becomes clear… stocks should get a nice jolt to the upside.”\nUpcoming Economic Data\nHere's what investors will be keeping an eye on Tuesday.\n\nJanuary’s S&P Case-Shiller home price index data for 20 cities will be released by 9:00 a.m., and March’s Chicago Business Barometer (PMI) data will be out by 9:45 a.m. ET.\nFebruary’s job openings and March’s consumer confidence data will be out by 10:00 a.m., Chicago Fed President Austan Goolsbee will speak at 12:00 p.m., Fed governor Michael Barr will speak at 3:00 p.m., and Fed Vice Chair for Supervision Michelle Bowman will speak at 5:10 p.m. ET.\n\nCommodities, Crypto, And Global Equity Markets\nCrude oil futures were trading lower in the early New York session by 0.28% to hover around $102.59 per barrel.\nGold Spot US Dollar rose 1.34% to hover around $4,571.41 per ounce. Its last record high stood at $5,595.46 per ounce. The U.S. Dollar Index spot was 0.09% lower at the 100.4190 level.\nMeanwhile, Bitcoin (CRYPTO: BTC) was trading 1.33% lower at $66,825.19 per coin, as per the last 24 hours.\nAsian markets closed lower on Tuesday, except Hong Kong's Hang Seng and Australia's ASX 200 indices. China’s CSI 300, India’s Nifty 50, South Korea's Kospi, and Japan's Nikkei 225 indices fell. European markets were mostly higher in early trade.\nPhoto courtesy: Shutterstock","news_type":1,"symbols_score_info":{"SPDN":0.6,"DBSC":0.6,"NBIG":0.6,"SPLV":0.6,"VTI":0.6,"VOOG":1.5,"OEX":0.6,"SPXU":0.6,".SPX":1.5,"OEF":0.6,"NBIZ":0.6,"SPXL":0.6,"NEBX":0.6,"SCHG":1.5,"SSO":0.6,"BIRD":1.5,"NBIL":0.6,"GPIX":0.6,"UPRO":0.6,"JEPI":0.6,"TECL":0.6,"SPYM":0.6,"SPUS":0.6,"MOAT":0.6,"HIBL":0.6,"VTV":0.6,"VEU":0.6,"ALLW":0.6,"VUG":1.5,"RSP":0.6,"SPHD":0.6,"IVOO":0.6,"XDTE":0.6,"IVE":0.6,"SPYV":0.6,"VOO":1.5,"SPYQ":0.6,"SPCE":1,"SPY":1.5,"SPYG":0.6,"SPYI":0.6,"SPMO":0.6,"VYM":1.5,"NKE":1,"SPUU":0.6,"RKLZ":0.6}},"isVote":1,"tweetType":1,"viewCount":9,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"allBottom":false,"essenBottom":false}